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ABSTRACT 
Lauren Latshaw Cline: Design of Well-Folded β-Hairpin Peptides for Molecular Recognition 
of RNA and Improved Resistance to Proteolysis 
(Under the direction of Marcey L. Waters) 
 
Ribonucleic acid (RNA) plays a vital role in many biological processes of the cell, which 
makes it an attractive target for drug discovery.  In this work, small β-hairpin peptides were 
used to better understand RNA molecular recognition.  Specifically, peptides were designed 
with the capability to bind via aromatic, electrostatic, and hydrogen bonding interactions to 
the single stranded RNA.   
To investigate RNA recognition using a conjugated system of different binding motifs, a 
β-hairpin peptide was connected to an RNA intercalator.  It was found that the individual 
parts did not bind well to RNA, but the conjugated system binds RNA with a dissociation 
constant of 3.7 μM.  RNase footprinting experiments showed that the intercalator threads the 
stem region while the peptide interacts with an internal bulge region, and that the β-hairpin 
structure of the peptide is important for binding.   
     Combinatorial chemistry and de novo peptide design were used to improve binding of 
the BIV Tat (bTat) peptide for BIV TAR RNA (bTAR).  A combinatorial library was 
designed which incorporated natural and unnatural residues in the N-terminal region of bTat 
with the purpose of inducing interactions with the bTAR hairpin loop region.  Two peptides 
were isolated from fluorescent library screens, one which had one less charge than bTat and 
contained an unnatural homophenylalanine residue.  It was determined by gel shift assays 
 iv 
that the two peptides bound equally as well to bTAR as the native sequence.  In a separate 
project, strong cation-π side chain interactions were used to promote β-hairpin structure of a 
bTAR-binding peptide without the need for cyclization.  The side-chain interactions were 
enough to stabilize the hairpin structure; however some RNA binding affinity was lost.       
  To successfully develop peptide drugs that bind RNA, the receptors need to be stable to 
proteolytic degradation.  For this purpose, it was investigated whether stable β-hairpin 
peptides have increased resistance to proteolysis due to their structure.  A series of peptides 
with ranging amount of thermodynamic stability were designed and digested using a variety 
of specific and non-specific proteases.  It was determined that increased thermodynamic 
stability of the β-hairpin peptides does correlate to an increase in proteolytic stability. 
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Chapter I 
INTRODUCTION 
 
A. Significance of this work 
Ribonucleic acid (RNA) plays several vital roles in the life cycle of the cell.  The most 
prominent role is as messenger RNA (mRNA), which carrys genetic information from the 
DNA to ribosomes which produce proteins.  RNA is also found as ribozymes, ribo-protein 
complexes (rRNA and snRNPs), gene silencers (siRNA), carriers of amino acids (tRNA), the 
primary genetic material of retroviruses, and possibly more roles that haven’t been 
discovered yet.1  Because RNA affects so many processes of the cell, it is now believed that 
targeting it may be an alternative to traditional drug discovery which targets proteins.2  In 
order to design effective RNA ligands, it is imperative to understand the structure and 
dynamics of binding this complex biomolecule.3
 
  It is only then that we will be able to 
control cellular events at an RNA level.  
 
 
                                                 
1 Campbell, M. K.; Farrell, S. O.; 6th ed.; Thompson Brooks/Cole: Belmont, CA, 2009. 
2 Melnikova, I. Nat Rev Drug Discovery 2007, 6, 863-864. 
3 (a) Tor, Y. Angew Chem Int Ed Engl 1999 38, 1579-1582. (b) Tor, Y. Chembiochem 2003, 
4, 998-1007.  
 2 
B. Targeting RNA 
i. DNA vs. RNA  
Molecular recognition of double stranded DNA structure has been well-studied and many 
synthetic molecules and protein motifs have been developed which bind sequence 
specifically to DNA.  These interactions generally occur by base pairing through Hoogsten 
interactions in the major and minor grooves.4  On the other hand, double stranded RNA is not 
as amenable to molecular recognition through hydrogen bonding in the groove.  Due to the 
2’hydroxyl groups, double stranded RNA exists in an A-form helix.  The minor groove of an 
A-form helix is wide and shallow and cluttered with 2’hydroxyl groups and the major groove 
is narrow and deep and sterically hindered by phosphate groups (Figure 1.1).5
Unlike DNA, RNA often folds into a complex tertiary structure, which commonly 
contains exposed loops, bulges, and psuedoknots (Figure 1.2).  Many structures have been 
solved in which single stranded regions of RNA are recognized by proteins through a 
combination of aromatic, electrostatic, and hydrogen bonding interactions.
   
6
                                                 
4 (a) Wemmer, D. E. Annu Rev Biophys Biomol Struct 2000, 29, 439-461. (b) Segal, D. J.; 
Barbas, C. F., 3rd Curr Opin Chem Biol 2000, 4, 34-9. 
 It is through 
these interactions that proteins can recognize specific RNA sequences.  If we can design 
molecules that target the single stranded regions of RNA, it may also provide selectivity for 
binding a particular RNA.   
 
5 Carlson, C. B.; Stephens, O. M.; Beal, P. A. Biopolymers 2003, 70, 86-102. 
6 (a) Nagai, K. Curr Opin Chem Biol 1992, 2, 131-137. (b) Deo, R. C.; Bonanno, J. B.; 
Sonenberg, N.; Burley, S. K. Cell 1999, 98, 835-45. (c) Handa, N.; Nureki, O.; Kurimoto, K.; 
Kim, I.; Sakamoto, H.; Shimura, Y.; Muto, Y.; Yokoyama, S. Nature 1999, 398, 579-85. (d) 
Price, S. R.; Evans, P. R.; Nagai, K. Nature 1998, 394, 645-50. (e) Legault, P.; Li, J.; 
Mogridge, J.; Kay, L. E.; Greenblatt, J. Cell 1998, 93, 289-99. (f) Oubridge, C.; Ito, N.; 
Evans, P. R.; Teo, C. H.; Nagai, K. Nature 1994, 372, 432-8. 
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It has also been noted that upon ligand binding, induced fit interactions are more extreme 
for RNA rather than DNA.7
 
  This makes it even more difficult to rationally design an RNA 
binding ligand.  For this reason, scientists have found creative methods, such as 
combinatorial chemistry, to discover novel compounds.  These methods offer a high-
throughput way of screening large numbers of compounds, and it allows the system to 
determine the best ligand.     
Duplex RNA 
(PDB 1RNA)
Duplex DNA 
(PDB 1BNA)  
Figure 1.1.  Space filling models of the structures of duplex DNA and RNA.  Highlighted in 
red are the phosphate groups on DNA and both the phosphate groups and the 2’hydroxyl 
groups of RNA.   
 
 
                                                 
7 Cheng, A. C.; Calabro, V.; Frankel, A. D. Curr Opin Struct Biol 2001, 11, 478-84. 
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Figure 1.2.  Possible types of structural features found in RNA tertiary structure.8
 
   
ii. Molecular recognition of RNA: An emerging field 
Despite the challenges of designing molecules that bind RNA, for the efforts toward drug 
discovery RNA may be an even better target than DNA or proteins.  For molecular 
recognition of DNA sequence selectivity is imperative because it exists primarily as a double 
stranded helix.  However RNA’s tertiary structure offers regions that could be targeted in 
either a structure or sequence specific manner.  RNA also has the advantage of being found 
both inside and outside the nucleus, making it more accessible to designed ligands.  In 
composition, RNA resembles DNA, but in many ways RNA molecules are more like 
proteins.  They are similar in that they both form complex structures that form pockets and 
surfaces available for binding.7  Yet the chemical composition is less complex in RNA than 
in proteins, because there are only four RNA bases as opposed to 20 natural amino acids.  
                                                 
8 Reviewed in: Zamen, G. J. R.; Michiels, P. J. A.; van Boeckel, C. A. A. Drug Discovery 
Today 2003, 8, 297-306. 
 5 
This may simplify the design of ligands because there are fewer types of chemical moieties 
exposed on the surface, making RNA an even better target than proteins.    
However, the field of RNA molecular recognition has significantly lagged behind studies 
of DNA and protein recognition due mainly to the lack of structural information.  Before 
1992, the only RNA-protein crystal structures were of tRNAs in aminoacyl-tRNA synthetase  
complex and the 50S subunit.6a   Since then, there have been an abundance of crystal 
structure and NMR structures of RNA and RNA-protein complexes published in the PDB.  
This sudden increase of information has intensified the search for RNA molecules that could 
be effective medicinal targets.  One class of molecules that is actively studied is viral RNA 
sequences such as the trans-activating response (TAR) RNA and the Rev response element 
(RRE) both from the HIV-1 genome.  Other attractive targets that are currently being studied 
are ribozymes, mRNAs, microRNAs, and rRNAs.9
There are now many different synthetic molecules found that bind well to RNA9 such as 
aminoglycosides,
   
10 polyamines,11 deoxystreptamine dimers,12 peptidomimetics,13 peptides,14
                                                 
9 Reviewed in: Thomas, J. R.; Hergenrother, P. J. Chem Rev 2008, 108, 1171-224. 
 
10 Silva, J. G.; Carvalho, I. Curr Med Chem 2007, 14, 1101-19. 
11 Lawton, G. R.; Appella, D. H. J Am Chem Soc 2004, 126, 12762-3. 
12 (a) Liu, X.; Thomas, J. R.; Hergenrother, P. J. J Am Chem Soc 2004, 126, 9196-7. (b) 
Thomas, J. R.; Liu, X.; Hergenrother, P. J. J Am Chem Soc 2005, 127, 12434-5. (c) Thomas, 
J. R.; Liu, X.; Hergenrother, P. J. Biochemistry 2006, 45, 10928-38. 
13 (a) Athanassiou, Z.; Dias, R. L.; Moehle, K.; Dobson, N.; Varani, G.; Robinson, J. A. J Am 
Chem Soc 2004, 126, 6906-13. (b) Leeper, T. C.; Athanassiou, Z.; Dias, R. L.; Robinson, J. 
A.; Varani, G. Biochemistry 2005, 44, 12362-72. (c) Athanassiou, Z.; Patora, K.; Dias, R. L.; 
Moehle, K.; Robinson, J. A.; Varani, G. Biochemistry 2007, 46, 741-51. (d) Burns, V. A.; 
Bobay, B. G.; Basso, A.; Cavanagh, J.; Melander, C. Bioorg Med Chem Lett 2008, 18, 565-7. 
(e) McNaughton, B. R.; Gareiss, P. C.; Miller, B. L. J Am Chem Soc 2007, 129, 11306-7. 
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and small intercalating agents15.  One of these classes of molecules has already been proven 
to be an effective drug.  Aminoglycosides make up a family of antibiotics that target RNA, 
specifically the 16S rRNA subunit of the ribosome.8  Two things to be learned from this 
application are that (1) effectiveness can be attained by either selectivity against size of 
binding pocket or the sequence of binding pocket, and (2) even moderate binding affinities in 
the micromolar range can make effective drugs.  Most aminoglycosides work by targeting the 
bacterial ribosomes using hydrogen bonding and electrostatic interactions with an interior 
loop of the RNA.8  The aminoglycosides do not affect 12S human mitochondrial rRNA 
because the human rRNA has a larger interior loop at the same site and it doesn’t bind the 
18S human cytoplamic rRNA because of differences in sequence.  The binding affinities of 
the aminoglycosides for the RNA range from 0.1 μM to 10 μM.16
 
  Despite the moderate 
binding affinity, this is tight enough to be effective.  This offers hope that even with a 
moderate binding affinities RNA can be a viable therapeutic target.         
                                                                                                                                                       
14 (a) Hyun, S.; Kim, H. J.; Lee, N. J.; Lee, K. H.; Lee, Y.; Ahn, D. R.; Kim, K.; Jeong, S.; 
Yu, J. J Am Chem Soc 2007, 129, 4514-5. (b) Pustowka, A.; Dietz, J.; Ferner, J.; Baumann, 
M.; Landersz, M.; Konigs, C.; Schwalbe, H.; Dietrich, U. Chembiochem 2003, 4, 1093-7. (c) 
Raja, C.; Ferner, J.; Dietrich, U.; Avilov, S.; Ficheux, D.; Darlix, J. L.; de Rocquigny, H.; 
Schwalbe, H.; Mely, Y. Biochemistry 2006, 45, 9254-65. (d) Kawakami, J.; Sugimoto, N.; 
Tokitoh, H.; Tanabe, Y. Nucleosides Nucleotides Nucleic Acids 2006, 25, 397-416. (e) 
Austin, R. J.; Xia, T.; Ren, J.; Takahashi, T. T.; Roberts, R. W. J Am Chem Soc 2002, 124, 
10966-7. 
15 (a) Carlson, C. B.; Beal, P. A. Bioorg Med Chem Lett 2000, 10, 1979-82. (b) Carlson, C. 
B.; Spanggord, R. J.; Beal, P. A. Chembiochem 2002, 3, 859-65. 
16 (a) Wong, C. H.; Hendrix, M.; Manning, D. D.; Rosenbohm, C.; Greenberg, W. A. J Am 
Chem Soc 1998, 120, 8319-8327. (b) Griffey, R. H.; Hofstadler, S. A.; Sannes-Lowery, K. 
A.; Ecker, D. J.; Crooke, S. T. Proc Nat Acad Sci USA 1999, 96, 10129-10133. (c) Carter, A. 
P.; Clemons, W. M.; Brodersen, D. E.; Morgan-Warren, R. J.; Wimberly, B. T.; 
Ramakrishnan, V. Nature 2000, 407, 340-348. (d) Wang, Y.; Hamasaki, K.; Rando, R. R. 
Biochemistry 1997, 36, 768-779. 
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iii. Current state of research 
RNA molecular recognition is still in its early stages of discovery, which makes it an 
exciting and important field to study.  Although many classes of small molecules have been 
discovered that bind RNA, only moderate binding affinities have been achieved and 
specificity is a significant challenge.  Aminoglycosides are still the only class of RNA drugs, 
because most other compounds fail to show efficacy in cell culture or animal studies.9  The 
“holy grail” of this field would be the discovery of a set of rules for designing ligands that are 
sequence or structure specific for RNA.  
C. RNA-protein interactions 
i. Classes of RNA binding proteins 
In order to be able to design molecules that bind to RNA, it is imperative to understand 
how nature has designed RNA-binding proteins.  There are several motifs that are commonly 
found in RNA-binding proteins, some of which will be highlighted below because of their 
relevance to this work.  By studying RNA binding motifs it is possible to learn what types of 
interactions that are important for affinity and the way specificity is achieved. 
The RNA recognition motif, RRM, is a binding domain that is found in a majority of 
RNA-binding proteins in higher vertebrates.17
                                                 
17 Reviewed in: (a) Cheng, A. C.; Calabro, V.; Frankel, A. D. Curr Opin Struct Biol 2001, 
11, 478-84. (b) Auweter, S. D.; Oberstrass, F. C.; Allain, F. H. Nucleic Acids Res 2006, 34, 
4943-59. (c) Messias, A. C.; Sattler, M. Acc Chem Res 2004, 37, 279-87. 
  It is characterized by a mixed α/β structure 
made up of approximately 100 amino acids.  The interactions with RNA are primarily 
located on the β-sheet portion of the protein.  The RRM domain has been found to bind 
anywhere from 2-8 nucleotides simultaneously with 4 being the most common number.  The 
binding occurs when the nucleotides stack with three conversed aromatic residues on the 
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protein.  One example of this interaction is the small nuclear ribonucleoprotein U1A (U1 
snRNP) binding to a hairpin loop region of RNA derived from U1 snRNA (Figure 1.3).18
Zinc finger motifs are frequently found in proteins that bind to DNA sequence 
selectively, but they have also been found in RNA binding proteins.  The zinc ions 
coordinate to an an α-helix and β-sheet region of the peptide that is made up of 
approximately 30 residues.7  Like the RRM motif, if has been found that aromatic residues 
are important for the binding of zinc finger domains.  The zinc ion is required to maintain 
protein structure but it is the conserved aromatic residues that create a binding pocket for 
exposed RNA bases.  For example in the crystal structure for MMLV nucleocapsid protein, a 
tyrosine residue (Tyr28) stacks between a uridine (U306) and a cytosine (C307) (Figure 
1.4).
  It 
can be noted from the structure that the RNA bases in the loop are flipped out in solution so 
as to be accessible for protein binding.  The protein recognizes the RNA through stacking 
interactions between aromatic residues in the β-sheet domain and the nucleotide bases.       
19
For both RRM and zinc finger domains the pre-formed structure is very important for 
binding as are aromatic interactions.  However in the arginine rich motif (ARM), short, 
unstructured, arginine-rich peptides (~20 residues) fold into a variety of secondary structures 
upon binding to RNA.17a  Arginine is well equipped to bind RNA because of the guandinium 
group on the side chain.   
  A second conserved aromatic residue is found nearby, Trp35, and it stacks with a 
guanosine (G309).   
                                                 
18 Oubridge, C.; Ito, N.; Evans, P. R.; Teo, C. H.; Nagai, K. Nature 1994, 372, 432-8. 
19 D'Souza, V.; Summers, M. F. Nature 2004, 431, 586-90. 
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One example of an ARM motif is the bovine immunodeficiency virus (BIV) Tat peptide 
that recognizes BIV TAR RNA (bTAR).  Unlike the human version of this complex, HIV-1 
bTat/TAR, the NMR structure of bTat/bTAR has been solved (Figure 1.5).20  The peptide is 
found to be unstructured in solution, but when bound to bTAR RNA it adopts a β-hairpin 
structure and lies in the major groove.21
 
  The specificity in this system originates from 
hydrogen bonding between the arginine residues and guanine bases in the major groove.  
Also important for this interaction is the hydrophobic packing of isoleucine and glycine on 
the peptide.  This example provides evidence that a β-hairpin peptide has the ability to fit in 
the RNA groove.   
 
 
 
 
 
                                                 
20 Ye, X.; Kumar, R. A.; Patel, D. J. Chem Biol 1995, 2, 827-40. 
21 Reviewed in: Patel, D. J. Curr Opin Struct Biol 1999, 9, 74-87. 
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U1A-RNA loop interaction
 
Figure 1.3.  Crystal structure of the RRM domain of U1A snRNP binding to an RNA hairpin 
loop.18  The RNA phosphate backbone is colored orange with the important hairpin loop 
residues highlighted in yellow.  The protein backbone is colored magenta, and the aromatic 
residues that participate in binding RNA are highlighted in green. 
   
 
Figure 1.4.  Crystal structure of the zinc finger binding domain of MMLV nucleocapsid 
protein binding to RNA (PDB 1U5P).19  The zinc coordination site is labeled red, the RNA is 
colored magenta, and the two conserved aromatic residues, Tyr28 and Trp 35, are highlighted 
in green.   
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Figure 1.5. NMR structure of BIV TAR RNA stem-loop bound to Tat peptide (PDB 
1BIV).21  The C-terminus of the peptide is shown in the foreground with the β-hairpin 
extending to the bottom left.  The N-terminus loop is near the RNA hairpin loop at the top of 
the picture.  
 
   
 
 
ii. Types of interactions involved  
By examining the specific examples above, it is clear that hydrogen bonding, 
electrostatics, and aromatic interactions are important in protein-nucleic acid recognition.  It 
is well-known that polar interactions, specifically hydrogen bonding, are responsible for the 
complementary base pairing in double stranded RNA, but they are also the basis of 
specificity in protein binding.  It is energetically favorable for hydrogen bonding to occur as 
polar residues are buried in the RNA-protein interface.  Using statistical analysis, it has been 
found that 90% of the time the hydrogen bond donor group is the protein whereas the 
acceptor is the nucleic acid.22
                                                 
22 Nadassy, K.; Wodak, S. J.; Janin, J. Biochemistry 1999, 38, 1999-2017. 
  The analysis also revealed that the negatively charge 
phosphate groups make excellent hydrogen bond acceptors, but about 20% of the time the 
 12 
hydrogen bonds occur with the 2’-hydroxyl group.  For proteins the most common hydrogen 
bond donors are lysines, arginines, and amide protons.  It has been estimated that the energy 
for a neutral hydrogen bond is between 2.1-6.3 kJ/mol, but a hydrogen bond where one of the 
species is charged can yield 15-19 kJ/mol.23
Electrostatic interactions are equally as important, but they contribute more toward 
binding affinity rather than sequence selectivity.  Statistical analysis shows that the surfaces 
of proteins that bind RNA are primarily positively charged, and it is extremely rare to see an 
acidic residue at the RNA interface.23  In fact an RNA-protein binding event is believed to 
release into solution a large number of counterions that are associated with the phosphate 
backbone and other charged moieties.  Therefore it is entropically favorable for electrostatic 
interactions to form between the RNA and the protein.  These interactions are believed to 
contribute greatly to the overall free energy of binding.
  This amount of energy can add up to be a 
substantial amount when there is a network of hydrogen bonds occurring at the protein-
nucleic acid interface.  This is believed to be the source of sequence selectivity.    
24
The aromatic composition of the RNA bases makes π-stacking interactions possible.  
This interaction is partially responsible for the stability of double stranded RNA, but in single 
stranded RNA the unstacked bases are free to interact with proteins.  Statistical analysis 
reveals that all the bases are able to stack with aromatic amino acids, however phenylalanine 
is most commonly found.
     
25
                                                 
23 Fersht, A. R.; Shi, J. P.; Knill-Jones, J.; Lowe, D. M.; Wilkinson, A. J.; Blow, D. M.; 
Brick, P.; Carter, P.; Waye, M. M.; Winter, G. Nature 1985, 314, 235-8. 
  The “jack-of-all-trades” amino acid, arginine, can also 
24 Reviewed in: (a) Bloomfield, V. A.; Crothers, D. M.; Tinoco, J. I. Nucleic Acids: 
Structures, Properties, and Functions; University Science Books: Sausalito, CA, 2000. (b) 
Auweter, S. D.; Oberstrass, F. C.; Allain, F. H. Nucleic Acids Res 2006, 34, 4943-59. 
25 Allers, J.; Shamoo, Y. J Mol Biol 2001, 311, 75-86. 
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participate in aromatic interactions with RNA.  This protonated residue can form a cation-π 
interaction with the electron-rich π-cloud of the aromatic bases.  These interaction have also 
been observed with lysines and histidines.25b      
Stacking interactions are particularly common in loop regions where bases are more 
solvent exposed.  As was evident with the RRM motifs and the zinc binding domains, the 
single stranded regions provide good targets for protein binding.  They also may be good 
targets for designing inhibitors of protein-RNA interactions.     
iii. Using β-hairpin peptides to mimic β-sheet structure 
We have investigated mimicking β-sheet interactions with single stranded regions of 
RNA by using small β-hairpin peptides that are well-folded in aqueous solution.  The use of 
β-hairpin peptides as model systems dates back to 1993 when the first monomeric, water-
soluble β-hairpin was discovered.26
In these past 15 years, it has been determined that there are three main contributors to the 
stability of β-hairpin structure, (1) turn sequence, (2) side chain interactions, and (3) amino 
acid β-sheet propensity.  In the following projects, these characteristics were optimized in 
order to find the best peptides for binding RNA.  One way we have optimized the turn 
sequence was to investigate both Asn-Gly and D-Pro-Gly sequences which have different 
effects when incorporated into a β-hairpin peptide.   The Asn-Gly turn is type I’ and is 
  This discovery launched a field of research focused on 
determining the rules for designing small peptide systems that accurately portray the large β-
sheet domains of peptides.  These model systems can not only be used to study the intricacies 
of biomolecular interactions, they can also be used to design inhibitors of those interactions. 
                                                 
26 Reviewed in: Hughes, R. M.; Waters, M. L. Curr Opin Struct Biol 2006, 16, 514-24. 
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commonly found in the β-hairpin loops of protein crystal structures.27  The DPro-Gly turn has 
been found to be an even better promoter of β-hairpin formation which adopts a type II’ 
turn.28
We also optimized the side chain interactions in several of the following projects.  Both 
cation-π and π-π stacking interactions were used to stabilize the peptide structures by 
incorporating aromatic tryptophan residues and cationic lysine residues into non-hydrogen 
bonded positions.  This design strategy has been extensively studied in the past and is shown 
to yield some of the most stable β-hairpin peptides published to date.
  Due to the unnatural chirality of this turn sequence it is not found in native proteins, 
but the proline residue provides rigidity to the turn region. 
29
The rules for designing well-folded β-hairpin peptides are known and it has been shown 
that β-sheet proteins bind well to RNA, but it is still difficult to design β-hairpin peptides 
which bind RNA as well as proteins.   One interesting observation regarding how peptides 
and proteins bind RNA is that there is a difference between their modes of binding.  Peptides 
tend to alter their conformation upon binding RNA but the RNA seems to stay rigid, whereas 
large proteins seem to stay rigid when they bind and the RNA undergoes conformational 
  In Chapter IV, we 
used the two different faces of a β-hairpin peptide for two different roles.  The face 
displaying the hydrogen bonded residues was designed to bind RNA by inserting the amino 
acids known to bind bTAR RNA.  The non-hydrogen bonded face contained residues that 
were able to make side chain-side chain interactions which stabilized the overall structure.      
                                                 
27 Hutchinson, E. G.; Thornton, J. M. Protein Sci 1994, 3, 2207-16. 
28 Stanger, H. E.; Gellman, S. H. J Am Chem Soc 1998, 120, 4236-4237. 
29 (a) Riemen, A. J.; Waters, M. L. Biochemistry 2009, 48, 1525-31. (b) Hughes, R. M.; 
Waters, M. L. J Am Chem Soc 2005, 127, 6518-9. (c) Cochran, A. G.; Skelton, N. J.; 
Starovasnik, M. A. Proc Natl Acad Sci U S A 2001, 98, 5578-83. 
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changes.30
iv. Previously designed peptide-based systems which bind RNA 
  If this is true, there are two options for design.  Either design a peptide that is so 
stable the RNA will conform to it, similar to what occurs with proteins, or design a peptide 
that has the potential to be both well-folded and flexible.  In this case, the peptide will have a 
pre-defined binding pocket, but upon RNA binding will be able to adapt its conformation to 
fit.  We have attempted to do both in the projects herein.     
There have been other published reports of groups developing peptide-based systems to 
bind to the single stranded regions of RNA by taking advantage of the same interactions used 
in RNA-binding proteins.  Austin et al. designed an arginine-rich α-helical peptide which was 
modeled after the P22N21 and the λN22 proteins that bind to hairpin loop regions of P22boxB 
and λboxB RNA, respectively.31  The conjugate peptide combined the native stability of the 
P22N21-P22boxB complex with the specific loop-binding structure of the λN22 protein.  The 
mutant λN22 peptides increased the stability of the peptide-RNA complex and achieved 
picomolar binding affinity.  Kawakami et al. used in vitro selection methods to find RNA 
hairpin loop sequences that bound to a model peptide from lambda N protein using hydrogen 
bonding and π-π stacking interactions.32
Many groups have used combinatorial methods and found that peptides containing 
aromatic-rich sequences where commonly selected.  These residues could potentially make 
 The consensus sequence for the RNA hairpin loop 
selected from the library, -GCUAA-, creates a novel peptide-RNA pair which has higher 
specificity although slightly lower affinity than the native RNA sequence.   
                                                 
30 Hermann, T. Angew Chem Int Ed Engl 2000, 39, 1890-1904. 
31 Austin, R.; Xia, T.; Ren, J.; Takahashi, T.; Roberts, R.  J Am Chem Soc 2002, 124, 10966-
10967. 
32 Kawakami, J.; Sugimoto, N.; Nucleosides, Nucleotides Nucleic Acids 2006, 25, 397-416. 
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π-π or hydrogen bonding interactions with flexible bases in single stranded regions of RNA.  
Dietrich and coworkers have used phage display technologies to discover peptide ligands that 
bind specifically to the RNA packaging structure psi (ψ) in HIV-1.33  The resulting hits were 
aromatic-rich peptides which resembled the natural ligand, NCp7, which uses aromatic 
residues to interact with the hairpin loop RNA.  In a related study, Mély and coworkers used 
one of the selected peptides, Ac-HKWPWW-NH2, and studied the affinity and interactions 
involved in binding TAR and PBS RNA sequences.34  They determined that the peptide uses 
stacking interactions between the tryptophan residues and the RNA to bind with low 
micromolar affinity.  Burns et al. have found a cyclic peptide system using combinatorial 
methods that binds to bTAR RNA.35
D. Purpose of this work 
  Both of the peptides that were further characterized 
contained a tryptophan residue and one or two histidine residues.  Computer modeling of the 
system suggests that contacts are being with the internal bulge region of bTAR.  The authors 
hypothesize that the peptides are making specific interactions due to fact that the sequences 
are not polycationic. 
We have investigated the important features of RNA-protein interactions by studying 
minimized systems involving peptides binding to RNA.  We set out to discover how these 
interactions can be used to design novel substrates for RNA.  We proposed to do this using a 
three-fold approach, (1) designing a conjugated binding system with the potential to bind 
                                                 
33 Pustowka, A.; Dietz, J.; Ferner, J.; Baumann, M.; Landersz, M.; Konigs, C.; Schwalbe, H.; 
Dietrich, U. ChemBioChem, 2003, 4,  1093-1097. 
34 Raja, C.; Ferner, J.; Dietrich, U.; Avilov, S.; Ficheux, D.; Darlix J.; de Rocquigny, H.; 
Schwalbe, H.; Mély, Y.; Biochemistry, 2006, 45, 9254-9265. 
35 Burns, V.; Bobay, B.; Basso, A.; Cavanagh, J.; Melander, C.  Bioorg Med Chem Lett 2008, 
18, 565-567.    
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using two different modes, (2) utilizing combinatorial chemistry, and (3) incorporation of 
side-chain interactions to stabilize the structure of an RNA binding peptide.   
The ultimate goal for our studies would be to design an inhibitor for medicinal 
applications.  That is difficult to accomplish when working with peptides, because of how 
quickly they are degraded in the body.  With that in mind, we also investigated whether β-
hairpin peptides, similar to the ones used to bind RNA, have increased resistance to 
proteolysis because they are well-structured.   
   
Chapter II 
DESIGN OF A CONJUGATED β-HAIRPIN PEPTIDE-INTERCALATOR PROBE 
FOR BINDING RNA 
 
A. Background  
In our first approach to designing peptides that bind to RNA, we have designed a 
multivalent system which uses both intercalation and non-covalent interactions for the 
recognition of multiple regions of a single RNA strand.  The advantage of using this system 
is that the individual parts do not bind with high affinity, but when linked together the 
affinity is greatly increased as is the specificity.     
i. Previous work using conjugated systems 
As is often seen in biology, proteins are multivalent receptors making numerous weak 
interactions to a target which add together to provide overall high binding affinity.1
                                                 
1 Mammen, M.; Choi, S. K.; Whitesides, G. M. Angew Chem Int Ed 1998, 37, 2755-2794. 
  Several 
groups have tried to mimic this by designing molecules that combine several binding motifs 
in an attempt to improve RNA binding affinity.  Kirk et al. covalently linked an 
aminoglycoside, neomycin, to an intercalating agent, acridine, and found that the 
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multivalent molecule had a much higher binding affinity to RRE RNA than the individual 
parts, and the neomycin-acridine conjugate could competitively inhibit the natural receptor, 
Rev peptide.2  Kaiser et al. also synthesized an aminoglycoside-quinacridine intercalator 
conjugate and found improved binding to telomerase RNA.3
Several groups have also found success by attaching peptides to RNA intercalators.  In 
one example, a crystal structure was determined for an ethidium-arginine conjugate bound to 
TAR RNA of HIV-1.
  Both of these groups used 
aminoglycosides and intercalators, which were relatively promiscuous binders.  Kirk et al. 
found that their complex binds near an internal bulge in RRE and could effectively inhibit the 
native Rev peptide from binding.  However, they did not screen against any other RNA 
sequence containing a bulge to investigate its specificity for that target.  Likewise, Kaiser et 
al. found that their complexes required a loop region to bind to the duplex RNA but they did 
not test different loop sequences to show selectivity.      
4  Yu and coworkers have designed several multivalent systems, 
including a neomycin-peptide nucleic acid conjugate5, an aminoglycoside-small molecule 
conjugate6, and a neomycin-dipeptide conjugate.7
                                                 
2 Kirk, S. R.; Luedtke, N. W.; Tor, Y. J Am Chem Soc 2000, 122, 980-981. 
  Another molecule designed by the Yu lab 
is particularly relevant to this project because it uses an intercalator and a structured peptide.  
 
3 Kaiser, M.; Sainlos, M.; Lehn, J. M.; Bombard, S.; Teulade-Fichou, M. P. Chembiochem 
2006, 7, 321-329. 
 
4 Peytou, V.; Condom, R.; Patino, N.; Guedj, R.; Aubertin, A. M.; Gelus, N.; Bailly, C.; 
Terreux, R.; Cabrol-Bass, D. J Med Chem 1999, 42, 4042-4053. 
 
5 Hyun, S.; Lee, K. H.; Yu, J. H. Bioorg  Med Chem Lett 2006, 16, 4757-4759. 
 
6 Lee, J. K.; Kwon, M. Y.; Lee, K. H.; Jeong, S. J.; Hyun, S.; Shin, K. J.; Yu, J. H. J Am 
Chem Soc 2004, 126, 1956-1957. 
 
7 Ahn, D. R.; Yu, J. Bioorg Med Chem 2005, 13, 1177-83. 
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They synthesized a helical, polycationic peptide and attached acridine molecules at various 
locations throughout the peptide.8
ii. Goal of this project 
 The peptide interacts with the RNA in the stem regions 
with additional π-π interactions being made by the acridine molecule.  The addition of two 
acridine molecules resulted in peptides with dramatic increases in the binding affinities to 
TAR RNA (170-fold increase) and RRE RNA (40-fold increase).  This group extensively 
investigated the structure and sequence specificity of their helical peptide-acridine 
conjugates.  They found that the binding of their complexes significantly decreased when 
they removed the bulge regions, but was not affected by the size and shape of the loop 
regions.  
We wanted to develop a two-part probe that binds RNA in both the single stranded loop 
region and the double stranded stem regions simultaneously.  By linking the two parts, we 
wanted to increase the overall affinity and induce structural selectivity.  To do this we 
designed a conjugated system that contains an RNA intercalator connected to a well-folded 
β-hairpin peptide through a flexible linker.  The peptide portion used in these studies was the 
WKWK peptide, which is named for the Trp-Lys-Trp-Lys residues on one face of the 
hairpin.  This peptide has been shown to bind ATP with a KD of 170 μM and as a dimer bind 
single stranded DNA (ssDNA) with low micromolar affinity.  This peptide has a high 
propensity to form a β-hairpin and has been characterized by NMR to be 95% folded in an 
aqueous environment.9
                                                 
8 Lee, Y.; Hyun, S.; Kim, H. J.; Yu, J. Angew Chem Int Ed Engl 2007, 46, 1-5. 
 From mutational studies, it is hypothesized that ATP interacts with 
 
9 (a) Butterfield, S. M.; Waters, M. L. J Am Chem Soc 2003, 125, 9580-1. (b) Butterfield, S. 
M.; Sweeney, M. M.; Waters, M. L. J Org Chem 2005, 70, 1105-14. (c) Butterfield, S. M.; 
Cooper, W. J.; Waters, M. L. J Am Chem Soc 2005, 127, 24-5. 
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the two tryptophan residues through π-π stacking and also makes electrostatic interactions 
with the lysine side chains.9  
The intercalator portion used in these studies was the quinoline-based RNA intercalator 
developed by Beal et al. to intercalate into double stranded regions of RNA.10  This 
intercalator and a related acridine intercalator have been found to preferentially thread 
between two G-C base pairs which are directly adjacent to bulge sites.10, 11
These two pieces utilize two different methods for binding the RNA, and by connecting 
them together we expected to gain a more selective system with a tighter binding affinity due 
to cooperatively.  The WKWK peptide should target single, unpaired bases in the single 
stranded regions of RNA, while the intercalator will orient the complex by binding a specific 
site in the duplex RNA.  Our results indicate that the use of a multivalent system greatly 
improves the binding affinity as compared to the individual parts.  We also determined that 
the peptide makes specific contacts with at least one RNA base and protects it from RNase 
cleavage.   
  The Beal lab 
synthesized a small five residue peptide, aminobutyric acid-Ser-Val-Quin-Arg, which 
contained this intercalator (Quin)  as an unnatural amino acid and footprinting experiments 
found that it bound to a specific RNA sequence with low micromolar affinity.  We chose to 
use this particular intercalator due its site specificity and ease of incorporation into peptide 
synthesis.    
                                                 
10 Krishnamurthy, M.; Gooch, B. D.; Beal, P. A. Org Biomol Chem 2006, 4, 639-45. 
 
11 (a) Carlson, C. B.; Beal, P. A. Bioorg Med Chem Lett 2000, 10, 1979-82. (b) Carlson, C. 
B.; Vuyisich, M.; Gooch, B. D.; Beal, P. A. Chem Biol 2003, 10, 663-72. (c) Gooch, B. D.; 
Beal, P. A. J Am Chem Soc 2004, 126, 10603-10. (d) Krishnamurthy, M.; Gooch, B. D.; 
Beal, P. A. Org Lett 2004, 6, 63-6. (e) Gooch, B. D.; Krishnamurthy, M.; Shadid, M.; Beal, 
P. A. Chembiochem 2005, 6, 2247-54. (f) Krishnamurthy, M.; Simon, K.; Orendt, A. M.; 
Beal, P. A. Angew Chem Int Ed Engl 2007, 46, 7044-7. 
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B. Results and discussion  
i. General design 
We have designed a conjugated probe that contains a β-hairpin peptide connected through 
a β-alanine (βAla) linker to an RNA threading intercalator, WKWK-Int (Figure 2.1).  We 
selected βAla for the linker region because of its flexibility and ability to provide additional 
points of hydrogen bonding interactions.  During early studies the probes were synthesized 
with one, two, or three βAla residues linking the two pieces.  The results from initial binding 
experiments suggested that a linker made with one βAla did not bind as well as the probes 
made with two or three β-alanines, which both had comparable binding.  For ease of 
synthesis and to eliminate additional entropic costs of using a longer linker all the probes 
were made with a two residue linker.   
 
Figure 2.1.  Structure and sequence of the WKWK-Int probe.  The nucleotide binding 
pocket on the β-hairpin, WKWK, is colored red and blue and the position for attachment of 
the fluorophore is green.   
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ii. Design of the control peptides 
Control peptides were also designed in order to test what features of the peptide-
intercalator probe were contributing to binding.  The WKWK-control contains the β-hairpin 
peptide and linker regions alone and the Int-control peptide contains the intercalator and 
linker regions only (Figure 2.2a and b).  Additionally, two controls were designed to 
determine the influence of the peptide structure on RNA binding.  The GKGK-Int control 
was designed to have all the amino acids in the β-hairpin portion replaced with glycine 
except the charged residues (Figure 2.2c).  This gives GKGK-Int the same charge state as 
WKWK-Int, but it lacks secondary structure.  The GWKWK-Int control peptide was 
designed to have glycines replace all the residues except the charged residues and the 
aromatic tryptophan residues (Figure 2.2d).  This control peptide is also unstructured because 
it lacks an Asn-Gly turn sequence and key side chain-side chain interactions, but it has the 
same charge state as WKWK-Int and has the ability to make aromatic interactions.   
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Figure 2.2.  Structure and sequences of the control peptides.  The cationic residues from the 
WKWK peptide portion of the probes are highlighted in red and the aromatic residues are 
highlighted in blue.  a) WKWK-control. b) Int-control. c) GKGK-Int. d) GWKWKG-Int. 
 
 
iii. Design of the RNA target 
The RNA sequence chosen for these experiments contains regions of double stranded and 
single stranded bases which are suitable for binding both parts of the WKWK-Int probe 
(Figure 2.3).  We wanted to target the hairpin loop region of the RNA, and there was no 
structural information known about the RNA sequence used by the Beal Lab.  We chose to 
substitute the hairpin loop region for a more biologically relevant target that also has 
structural information known about it.  The selected sequence, GGAGloop RNA, contains a 
single stranded GGAG hairpin loop that which is part of the SL3 Ψ-RNA recognition 
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element of the HIV-1 nucleocapsid protein and the published NMR structure shows that three 
of the four residues are unstacked and potentially flipped out from the hairpin loop (Figure 
2.4).12  The remainder of the GGAGloop RNA sequence is identical to the sequence used in 
Beal’s studies, including a single stranded internal AAUU bulge that is located near the 
intercalation site which may also contain bases that are solvent exposed.  This bulge also 
contributes to the flexibility of the intercalation site, which consists of two G-C base pairs 
surrounded by a 5’U bulge and 3’bulge.10 
 
Figure 2.3.  Structure and sequences of the GGAGloop RNA.  The intercalation site is 
denoted by parentheses, and the significant bases in the hairpin loop and internal bulge are 
labeled with numbers.  
                                                 
12 De Guzman, R. N.; Wu, Z. R.; Stalling, C. C.; Pappalardo, L.; Borer, P. N.; Summers, M. 
F. Science 1998, 279, 384-388. 
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90°
 
Figure 2.4.  Structure of GGAG RNA hairpin loop (PDB 1A1T)12.  The stem region is 
highlighted in purple, guanosine residues are blue, and adenosine residues are green.  
 
 
iv. Synthetic scheme 
All of the probes were synthesized on bead using standard FMOC solid phase peptide 
synthesis.  The intercalator amino acid was synthesized following the previously published 
procedure. 10  This unnatural amino acid was then incorporated into the synthesis using an 
HOBT/HBTU activator solution.  Orthogonal deprotection of the N-terminus was then done 
using Pd(PPh3)4 and phenylsilane, and the reaction was followed using the Kaiser test.13
To use fluorescence anisotropy for measuring binding, the probes needed to be labeled 
with a fluorophore.  We chose to attach the 5,6-carboxytetramethylrhodamine (TAMRA) 
through a lysine side chain that is on the opposite face of the nucleotide binding pocket.  The 
modification of that particular lysine in WKWK was previously shown to not disrupt β-
hairpin formation.
  The 
synthesis of the probe was then completed by adding the final valine and serine residues and 
deprotecting the N-terminus.   
14
                                                 
13 Kaiser, E.; Colescott, R. L.; Bossinger, C. D.; Cook, P. I. Anal Biochem 1970, 34, 595-8. 
  In order to label the peptide, a slightly different procedure for synthesis 
14 Cooper, W. J.; Waters, M. L. Org Lett 2005, 7, 3825-3828. 
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was developed (Scheme 2.1).  At the site where the fluorophore label was to be incorporated, 
an ivDde-protected lysine residue was added instead of the traditional FMOC-Orn(Boc)-OH.  
The rest of the peptide synthesis was completed as stated above with the exception of the 
final serine, which was changed to Boc-protected serine in order to protect the N-terminus 
during the labeling reaction.  The Boc group was then easily removed during the acid 
cleavage from the resin.   
 
Scheme 2.1.  Synthesis of the TAMRA-labeled peptide-intercalator probes. 
 
v. Circular dichroism studies 
Circular dichroism (CD) studies were done to confirm that GKGK-Int and GWKWK-
Int are unstructured compared to WKWK-Int (Figure 2.5).  The CD studies help determine 
the global secondary structure of the peptides.  A peptide which folds into a β-sheet type 
structure will typically show a minimum mean residue ellipticity (MRE, [Θ]) around 215 nm.  
Whereas a peptide which is unstructured or contains a random coil type structure will show a 
minimum MRE value around 200 nm.  The results show that the WKWK-Int probe 
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resembles a β-sheet structure, but the GKGK-Int and GWKWKG-Int controls are 
unstructured.       
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Figure 2.5.  Circular dichroism spectrum for the WKWK-Int probe (blue) and the 
unstructured controls, GKGK-Int (red) and GWKWKG-Int (green). The CD experiments 
were run using 100 μM peptide in 10 mM sodium phosphate buffer (pH 7.6) at 25°C in a 0.1 
cm cell.  The spectra that are shown are an average of three scans.    
  
vi. Fluorescence anisotropy binding assays 
Fluorescence anisotropy was used to find the binding affinities of each of the peptide-
intercalator probes to the RNA.  As described above, the peptides were labeled with TAMRA 
through a lysine side chain on the opposite face of the WKWK binding pocket.  The 
anisotropy experiments showed that WKWK-control and Int-control peptides did not 
measurably bind to the GGAGloop RNA (Figure 2.6).  However, when the two pieces were 
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connected together, as in WKWK-Int, the binding affinity greatly increased (Kd= 3.7 ± 0.7 
μM).  It was determined that the unstructured GKGK-Int bound to the RNA with slightly 
lower binding affinity (Kd= 9.7 ± 2.2 μM) and the GWKWKG-Int bound with a dissociation 
constant of 31.8 ± 13.2 μM (Figure 2.7).  This suggests that although electrostatic 
interactions contribute significantly to the binding, there is some increased binding due to 
either the β-hairpin structure or specific contact with non-charged side chains.   
To test the specificity of the binding event, we investigated the binding of WKWK-Int to 
BIV TAR RNA, which has similar secondary structure to that of GGAGloop RNA but a 
different sequence.  The BIV TAR RNA (bTAR) sequence comes from the bovine 
immunodeficiency virus and is known to bind with low nanomolar affinity to the β-hairpin 
peptide, BIV Tat.  This RNA sequence contains two uridine bulges and a four member 
hairpin loop with the sequence 5’-CAUU-3’ (Figure 2.8).  The fluorescence anisotropy 
binding experiments show that the WKWK-Int probe binds more tightly to the GGAGloop 
RNA than it does to the bTAR RNA (Figure 2.8).  The specificity is most likely due to the 
intercalator which has been shown to preferentially insert between G-C base pairs that are 
surrounded by bulge regions.10, 11  This type of binding site is not present in the bTAR RNA.       
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Figure 2.6.  Fluorescence anisotropy binding experiments of TAMRA-labeled probes (0.5 
μM) with GGAGloop RNA.  WKWK-Int (blue) binds in the low micromolar range (3.7 ± 
0.7 μM) whereas WKWK-control (green) and Int-control (red) do not measureably bind.  
Experiments were done in PBS buffer (containing 10 mM sodium phosphate, 140 mM 
Na+/K+Cl-, 1 mM MgCl2, pH 7.4) at 25°C and each curve is an average of 3 or 4 runs.     
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Figure 2.7.  Fluorescence anisotropy binding experiments of TAMRA-labeled probes (0.5 
μM) with GGAGloop RNA.  WKWK-Int (blue) binds with the highest affinity (3.7 ± 0.7 
μM) whereas GKGK-Int (green) and GWKWKG-Int (red) bind less tightly (9.7 ± 2.2 μM 
and 31.8 ± 13.2 μM, respectively).  Experiments were done in PBS buffer (containing 10 mM 
sodium phosphate, 140 mM Na+/K+Cl-, 1 mM MgCl2, pH 7.4) at 25°C and each curve is an 
average of 3 or 4 runs.     
 
 
 32 
 
Figure 2.8.  Fluorescence anisotropy binding experiments of TAMRA-labeled WKWK-Int 
(0.5 μM) binding to BIV TAR RNA or GGAGloop RNA.  WKWK-Int binds more tightly 
to GGAGloop RNA (Kd= 3.7 ± 0.7 μM) than it does to BIV TAR RNA. Experiments were 
done with 0.5 μM WKWK-Int in PBS buffer (containing 10 mM sodium phosphate, 140 
mM Na+/K+Cl-, 1 mM MgCl2, pH 7.4) at 25°.     
 
vii. RNase footprinting assays with WKWK-Int and GGAGloop RNA 
Enzymatic footprinting experiments were done to identify which regions of the RNA 
were making contacts with the conjugated probes.  The GGAGloop RNA sequence was 3’-
labeled with 32pCp, and enzymatic digestions were preformed with RNases that target single 
stranded regions of RNA (RNase T1 and RNase 1) (Figure 2.9a) and double stranded regions 
of RNA (RNase V1) (Figure 2.9b).  These experiments helped to identify whether contacts 
were being made in the hairpin loop region, the bulge region, or the stem region.    
The RNase footprinting experiments show that WKWK-Int binds to GGAGloop RNA 
with low micromolar affinity, which is consistent with the fluorescence anisotropy results.  
Unlike the fluorescence experiments, the footprinting experiments were all done in the 
presence of unlabeled yeast tRNA to slow down the enzymatic degradation of the target 
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RNA.  The fact that the binding affinities are similar for the two methods is further proof that 
the peptide is specific for this sequence of RNA.  The WKWK-Int probe specifically 
protects residues G16, A23, and U24 in the single stranded regions and it seems to also 
protect much of the double stranded stem region.  
 The resulting bands from cleavage at bases G16, A23, and U24 were quantified using 
ImageQuant analysis program and plotted as fraction bound versus the concentration of 
peptide (Figure 2.10).  The results confirm that A23 and U24 are protected from RNase 
cleavage.  There was moderate binding at position G16, which suggests that there are 
multiple orientations of binding, but binding at the internal bulge is slightly preferred.  
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Figure 2.9.  RNase footprinting experiments with WKWK-Int and GGAGloop RNA.  
Shown is the phosphor image of a 20% denaturing polyacrylamide gel.  Structure lanes: 
RNA only, folded RNA in buffer; AH, alkaline hydrolysis; T1, RNase T1 (G-lane); A, 
RNase A (C and U lane).  Increasing concentrations (0 to 100 μM) of WKWK-Int  were 
added to GGAGloop RNA (0.18 μM) in 10 mM PBS buffer (140 mM Na+/K+Cl-, 1 mM 
MgCl2, pH 7.4) and 5 ng/μL yeast tRNA.  a) RNase T1 (cleaves G residues) was used to 
visualize the G-rich loop region and RNase 1 (cleaves ssRNA) was used to visualize both the 
loop and internal bulge regions.  Bases G14 and G16 were the major cleavage sites for 
RNase T1, whereas bases A23 and U24 were the major cleavage sites for RNase 1.  b) RNase 
V1 (cleaves dsRNA) was used to visualize the stem regions of the RNA. 
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Figure 2.10.  ImageQuant analysis of RNase footprinting assay of WKWK-Int binding 
GGAGloop RNA.  The tightest binding occurs in the internal bulge region (dark and light 
green, local binding affinity for A23 equals 0.9 ± 0.2 μM and affinity for U24 was 1.0 ± 0.2 
μM), and moderate binding occurs in the loop region (dark blue, local binding affinity for 
G16 =7.8 ± 2.3 μM).  The band intensities were the average of at least two RNase 
footprinting assays.       
 
 
 
viii. RNase footprinting assays with WKWK-control and Int-control 
The binding of the WKWK-control and the Int-control peptides to GGAGloop RNA 
was also investigated using footprinting assays (Figures 2.11 and 2.12).  Neither of the 
control peptides protects the observable regions of the GGAGloop RNA from enzyme 
cleavage as well as WKWK-Int protected the RNA.  These results are consistent with the 
fluorescence anisotropy binding data which showed there was no measurable binding affinity 
for the control peptides.  For both control peptides there is no binding detected in the single 
stranded regions, but the Int-control peptide shows minimal binding in the double stranded 
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regions at the highest concentration (100 μM).  This confirms the published results showing 
that the intercalator binds by threading through the stem regions of the RNA.10       
 
 
Figure 2.11.  RNase footprinting experiments with WKWK-control and GGAGloop RNA.  
Shown is the phosphor image of a 20% denaturing polyacrylamide gel.  Structure lanes: 
RNA only, folded RNA in buffer; AH, alkaline hydrolysis; T1, RNase T1 (G-lane); A, 
RNase A (C and U lane).  Increasing concentrations (0 to 100 μM) of WKWK-control  were 
added to GGAGloop RNA (0.18 μM) in 10 mM PBS buffer (140 mM Na+/K+Cl-, 1 mM 
MgCl2, pH 7.4) and 5 ng/μL yeast tRNA.  a) RNase T1 (cleaves G residues) was used to 
visualize the G-rich loop region and RNase 1 (cleaves ssRNA) was used to visualize both the 
loop and internal bulge regions.  b) RNase V1 (cleaves dsRNA) was used to visualize the 
stem regions of the RNA. 
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Figure 2.12.  RNase footprinting experiments with Int-control and GGAGloop RNA.  
Shown is the phosphor image of a 20% denaturing polyacrylamide gel.  Structure lanes: 
RNA only, folded RNA in buffer; AH, alkaline hydrolysis; T1, RNase T1 (G-lane); A, 
RNase A (C and U lane).  Increasing concentrations (0 to 100 μM) of Int-control  were 
added to GGAGloop RNA (0.18 μM) in 10 mM PBS buffer (140 mM Na+/K+Cl-, 1 mM 
MgCl2, pH 7.4) and 5 ng/μL yeast tRNA.  a) RNase T1 (cleaves G residues) was used to 
visualize the G-rich loop region and RNase 1 (cleaves ssRNA) was used to visualize both the 
loop and internal bulge regions.  b) RNase V1 (cleaves dsRNA) was used to visualize the 
stem regions of the RNA. 
 
ix. RNase footprinting assays with GKGK-Int control  
The results from the footprinting assay for GKGK-Int binding to GGAGloop RNA 
show that this peptide also makes contacts with the loop, stem, and bulge regions of the RNA 
(Figure 2.13).  However, in comparing the cleavage pattern of GKGK-Int to that of 
WKWK-Int, we see some differences in the bulge region.  The WKWK-Int protects residue 
 38 
A23 from RNase 1 cleavage, whereas GKGK-Int does not.  This peptide has the same 
charge but not the same structure as WKWK-Int and is lacking aromatic residues.  These 
results suggest that protection of that particular base is due to the structure of the peptide or 
aromatic interactions and not electrostatic interactions.    
The footprinting assays done with GKGK-Int were analyzed and plotted in the same 
way as the WKWK-Int results (Figure 2.14).  The results confirm that A23 is not protected 
from RNase cleavage by the GKGK-Int peptide, but G16 and U24 are protected.  The 
binding in the loop region resembles that of WKWK-Int, and this agrees with the hypothesis 
that there are multiple orientations of binding, but binding at the internal bulge is preferred.   
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Figure 2.13.  RNase footprinting experiments with GKGK-Int and GGAGloop RNA.  
Shown is the phosphor image of a 20% denaturing polyacrylamide gel.  Structure lanes: 
RNA only, folded RNA in buffer; AH, alkaline hydrolysis; T1, RNase T1 (G-lane); A, 
RNase A (C and U lane).  Increasing concentrations (0 to 100 μM) of GKGK-Int  were 
added to GGAGloop RNA (0.18 μM) in 10 mM PBS buffer (140 mM Na+/K+Cl-, 1 mM 
MgCl2, pH 7.4) and 5 ng/μL yeast tRNA.  a) RNase T1 (cleaves G residues) was used to 
visualize the G-rich loop region and RNase 1 (cleaves ssRNA) was used to visualize both the 
loop and internal bulge regions.  b) RNase V1 (cleaves dsRNA) was used to visualize the 
stem regions of the RNA. 
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Figure 2.14.  ImageQuant analysis of RNase footprinting assay of GKGK-Int binding 
GGAGloop RNA.  There is no RNase protection observed at bases G14 (dark blue) or A23 
(dark green), but binding is detected at bases G16 (light blue) and U24 (light green).  The 
band intensities were the average of at least two RNase footprinting assays.       
 
x. RNase footprinting assays with GWKWKG-Int control  
The GWKWKG-Int control peptide was designed to test what effect aromatic 
interactions have on RNA binding.  The footprinting assays show that this peptide makes 
similar contacts with the loop, stem, and bulge regions of the RNA as the other peptides 
(Figure 2.15).  By comparing the cleavage pattern at the A23 site, we saw that it protects this 
base but it has a weaker affinity than the structured WKWK-Int peptide.  We can conclude 
from these results that the aromatic residues are important for binding in the bulge region, but 
the β-hairpin structure of the WKWK peptide preorganizes it for binding.    
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The analysis of these footprinting assays confirm that although A23 is protected from 
RNase cleavage by the GWKWKG-Int peptide, it is a weaker interaction (Figure 2.16).  
Both bases G16 and U24 continue to be protected from RNase cleavage as was shown for the 
other peptides.  The curves for all the peptides were fit using a nonlinear least squares 
binding equation and local binding affinities were determined for the individual bases (Table 
2.1).  These values clearly show that the binding at A23 was greatly affected by the lack of 
structure of the peptide.      
 
Figure 2.15.  RNase footprinting experiments with GWKWKG-Int and GGAGloop RNA.  
Shown is the phosphor image of a 20% denaturing polyacrylamide gel.  Structure lanes: 
RNA only, folded RNA in buffer; AH, alkaline hydrolysis; T1, RNase T1 (G-lane); A, 
RNase A (C and U lane).  Increasing concentrations (0 to 100 μM) of GWKWKG-Int  were 
added to GGAGloop RNA (0.18 μM) in 10 mM PBS buffer (140 mM Na+/K+Cl-, 1 mM 
MgCl2, pH 7.4) and 5 ng/μL yeast tRNA.  a) RNase T1 (cleaves G residues) was used to 
visualize the G-rich loop region and RNase 1 (cleaves ssRNA) was used to visualize both the 
loop and internal bulge regions.  b) RNase V1 (cleaves dsRNA) was used to visualize the 
stem regions of the RNA. 
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Figure 2.16.  ImageQuant analysis of RNase footprinting assay of GWKWKG-Int binding 
GGAGloop RNA.  Tightest binding was detected at bases G16 (dark blue) and U24 (light 
green), and moderate binding was detected at A23 (dark green).  The band intensities were 
the average of two RNase footprinting assays.       
 
Table 2.1. Comparison of Binding Affinitiesa of the Peptide-Intercalator Conjugates to 
GGAGloop RNA 
 
6.0 (2.6)19.6 (6.9)8.8 (1.0)GWKWKG-Int
1.6 (0.8)n.b.b5.2 (2.3)GKGK-Int
1.0 (0.2)0.9 (0.2)7.8 (2.3)WKWK-Int
U24A23G16Peptide
Local binding affinity / μM (± error)
 
a Local binding affinities were determined by plotting the RNase footprinting results as band 
intensity versus concentration of peptide and fitting the data using equation 1.   
b no binding detected or binding too weak to determine a dissociation constant 
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xi. Investigation of cyclic WKWK-Int binding GGAGloop RNA 
A cyclic version of the WKWK-Int probe, cycWKWK-Int, was synthesized using a 
disulfide linkage between the N- and C-termini of the β-hairpin portion of the probe (Figure 
2.17).  This peptide has a pre-formed binding pocket, and does not need to overcome the 
entropic cost of folding.  CD studies show that cycWKWK-Int has a large minimum 
between 200-215 nm (Figure 2.18).  This unexpected spectrum may be caused by the mixture 
of highly structured peptide and unstructured intercalator region.  The disulfide bond may 
also be perturbing the β-hairpin structure.  The maximum signal at 225 nm confirms that the 
peptide is well-folded because the peak is caused by the exciton coupling of the two 
tryptophan residues when they are oriented in a folded structure.  
Fluorescence anisotropy was used to measure the binding affinity of cycWKWK-Int to 
the GGAGloop RNA (Figure 2.19).  These experiments showed that cycWKWK-Int binds 
with a dissociation constant of 3.0 ± 0.8 μM, which is nearly the same binding affinity that 
WKWK-Int probe showed.   These data suggest that the WKWK peptide has a comparable 
structure to the cyclic version and therefore binds with a similar affinity.  
The RNase footprinting assays confirm that both cycWKWK-Int and WKWK-Int bind 
in the same orientation (Figure 2.20).  There is moderate protection of the bases in the hairpin 
loop region and there is strong binding observed at bases A23 and U24.  The binding in the 
double stranded region of RNA also matches what was detected for all the other peptides.  
By quantifying the footprinting results for cycWKWK-Int, the local binding affinities were 
determined and compared to that for the WKWK-Int probe (Figure 2.21, Table 2.2).  The 
cyclized version of WKWK seems to bind worse to the hairpin loop region, but with a 
comparable affinity in the bulge region.     
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Figure 2.17.  Structure and sequence of cycWKWK-Int.  The cationic residues from the 
WKWK peptide portion of the probes are highlighted in red and the aromatic residues are 
highlighted in blue.   
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Figure 2.18.  CD spectrum for WKWK-Int (blue) and cycWKWK-Int (red). The CD 
experiments were run using 100 μM peptide in 10 mM sodium phosphate buffer (pH 7.6) at 
25°C in a 0.1 cm cell.  The spectra that are shown are an average of three scans.    
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Figure 2.19.  Fluorescence anisotropy binding experiments of TAMRA-labeled cycWKWK-
Int and WKWK-Int binding to GGAGloop RNA.  Experiments were done with 0.5 μM 
peptide in PBS buffer (containing 10 mM sodium phosphate, 140 mM Na+/K+Cl-, 1 mM 
MgCl2, pH 7.4) at 25°.  Experimental data is an average of at least three runs.     
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Figure 2.20.  RNase footprinting experiments with cycWKWK-Int and GGAGloop RNA.  
Shown is the phosphor image of a 20% denaturing polyacrylamide gel.  Structure lanes: 
RNA only, folded RNA in buffer; AH, alkaline hydrolysis; T1, RNase T1 (G-lane); A, 
RNase A (C and U lane).  Increasing concentrations (0 to 100 μM) of cycWKWK-Int  were 
added to GGAGloop RNA (0.18 μM) in 10 mM PBS buffer (140 mM Na+/K+Cl-, 1 mM 
MgCl2, pH 7.4) and 5 ng/μL yeast tRNA.  a) RNase T1 (cleaves G residues) was used to 
visualize the G-rich loop region and RNase 1 (cleaves ssRNA) was used to visualize both the 
loop and internal bulge regions.  b) RNase V1 (cleaves dsRNA) was used to visualize the 
stem regions of the RNA. 
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Figure 2.21.  ImageQuant analysis of RNase footprinting assay of cycWKWK-Int binding 
GGAGloop RNA.  Weak binding was observed in the hairpin loop regions (G16, blue), but 
tighter binding was detected in the bulge region (A23, dark green; U24, light green).  The 
band intensities were the average of two RNase footprinting assays.       
 
 
Table 2.2. Comparison of Local Binding Affinitiesa for cycWKWK-Int and WKWK-Int 
3.9 (1.7)3.8 (1.6)10.4 (5.1)cycWKWK-Int
1.0 (0.2)0.9 (0.2)7.8 (2.3)WKWK-Int
U24A23G16Peptide
Local binding affinity / μM (± error)
 
 
a Local binding affinities were determined by plotting the RNase footprinting results as band 
intensity versus concentration of peptide and fitting the data using equation 1.   
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xii. Investigation of a WKWK-Int probe with reversed orientation 
In the design of the WKWK-Int probe, the intercalator was placed on the N-terminus of 
the peptide.  The footprinting results have shown that the C-terminal β-hairpin peptide 
interacts with the both the bulge region and the hairpin loop region.  To test whether there is 
a preference for which terminus of the intercalator threads the RNA, we designed a probe 
where the intercalator and the peptide have been switched, revWKWK-Int (Figure 2.22).  
The fluorescence anisotropy data show that by reversing the orientation there is a six-fold 
decrease in binding affinity (Figure 2.23).  The dissociation constant for revWKWK-Int is 
18.2 ± 8.3 μM as compared to 3.7 ± 0.7 μM for WKWK-Int.       
However, the footprinting experiments show the same regions of the RNA are protected 
from RNase cleavage for revWKWK-Int as they were for WKWK-Int (Figure 2.24).  
Analysis of the protected regions showed that the local binding affinities for bases A23 and 
U24 are 1.5 (± 0.5) μM and 0.7 (± 0.1) μM, respectively and the dissociation constant for 
G16 was 6.8 (± 1.8) μM (Figure 2.25, Table 2.3).  These binding affinities are within error of 
WKWK-Int binding GGAG RNA.  This suggests that the intercalator can thread either 
direction, but the peptide promotes binding in the bulge region.  It also suggests that the 
TAMRA-fluorophore used in the fluorescence anisotropy binding experiments may be 
interfering with binding in the case of revWKWK-Int.  This would explain the discrepancies 
between the binding affinities determined using the two different methods.     
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Figure 2.22.  Structure and sequence of revWKWK-Int.  The cationic residues from the 
WKWK peptide portion of the probes are highlighted in red and the aromatic residues are 
highlighted in blue.   
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Figure 2.23.  Fluorescence anisotropy binding experiments of TAMRA-labeled revWKWK-
Int (red) and WKWK-Int (blue) binding to GGAGloop RNA.  Peptide concentration was 
0.5 μM in all experiments.  Experiments were done in 10 mM PBS buffer (140 mM 
Na+/K+Cl-, 1 mM MgCl2, pH 7.4) at 25°C and the revWKWK-Int data is an average of six 
runs.     
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Figure 2.24.  RNase footprinting experiments with revWKWK-Int and GGAGloop RNA.  
Shown is the phosphor image of a 20% denaturing polyacrylamide gel.  Structure lanes: 
RNA only, folded RNA in buffer; AH, alkaline hydrolysis; T1, RNase T1 (G-lane); A, 
RNase A (C and U lane).  Increasing concentrations (0 to 100 μM) of revWKWK-Int  were 
added to GGAGloop RNA (0.18 μM) in 10 mM PBS buffer (140 mM Na+/K+Cl-, 1 mM 
MgCl2, pH 7.4) and 5 ng/μL yeast tRNA.  a) RNase T1 (cleaves G residues) was used to 
visualize the G-rich loop region and RNase 1 (cleaves ssRNA) was used to visualize both the 
loop and internal bulge regions.  b) RNase V1 (cleaves dsRNA) was used to visualize the 
stem regions of the RNA. 
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Figure 2.25.  ImageQuant analysis of RNase footprinting assay of revWKWK-Int binding 
GGAGloop RNA.  Only moderate binding was observed at base G16 (dark blue), but tighter 
binding was detected at bases A23 (dark green) and U24 (light green).  The band intensities 
were calculated from the average of two RNase footprinting assays.       
 
 
Table 2.3. Comparison of Local Binding Affinitiesa for revWKWK-Int and WKWK-Int 
0.7 (0.1)1.5 (0.5)6.8 (1.8)revWKWK-Int
1.0 (0.2)0.9 (0.2)7.8 (2.3)WKWK-Int
U24A23G16Peptide
Local binding affinity / μM (± error)
 
a Local binding affinities were determined by plotting the RNase footprinting results as band 
intensities versus concentration of peptide and fitting the data using equation 1.   
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xiii. Studies using an AUCA hairpin loop RNA sequence 
In the initial design we had chosen a hairpin loop sequence which is expected to have 
solvent exposed bases in the hairpin loop available for peptide binding.  Our results have 
showed that the peptide preferentially binds to the internal 5’-AAUU-3’ bulge region and 
minimally binds in the loop region.  Therefore we designed a second RNA sequence, 
AUCAloop RNA, which has a 5’-AUCA-3’ hairpin loop sequence.  The change in sequence 
could make better contacts with the β-hairpin peptide or it could change the structure of the 
loop which may facilitate binding (Figure 2.26).  This structural data for this sequence shows 
that the loop residues are also solvent exposed (Figure 2.27).15  This sequence is a member of 
a class of RNA tetraloop structures with the consensus sequence of RNYA or ANYA (R = 
purine, N= any nucleotide, Y = pyrimidine, A = adenine).  These loops have been found to be 
important in recognition of phage coat proteins, and the RNA-protein complexes easily 
crystallize.16
Fluorescence anisotropy experiments were run to determine the binding affinity of the 
TAMRA-labeled WKWK-Int probe for the new RNA sequence, AUCAloop RNA (Figure 
2.28).  WKWK-Int binds the RNA with a dissociation constant of 7.1 ± 1.3 μM, which is 
  This particular sequence is derived from the RNA aptamer-MS2 phage coat 
protein complex, and it was chosen because it contains an adenine base that is flipped out of 
the loop and not stacked with any nearby bases.  The native RNA sequence is adjacent to 
5’GG-CC-3’ base paired stem region, and this was maintained in our RNA design so as to 
most accurately mimic the native loop structure.12       
                                                 
15 Rowsell, S.; Stonehouse, N. J.; Convery, M. A.; Adams, C. J.; Ellington, A. D.; Hirao, I.; 
Peabody, D. S.; Stockley, P. G.; Phillips, S. E. Nat Struct Biol 1998, 5, 970-5. 
 
16 Klosterman, P. S.; Hendrix, D. K.; Tamura, M.; Holbrook, S. R.; Brenner, S. E. Nucleic 
Acids Res 2004, 32, 2342-52. 
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slightly weaker than its affinity for GGAGloop RNA (Table 2.4).  The new loop sequence 
could make changes to the global structure of the RNA, but because binding was nearly the 
same we can conclude that the structural changes are only minor. 
RNase footprinting assays were also done to investigate whether WKWK-Int is 
interacting differently with the AUCAloop RNA.  To visualize the hairpin loop region, 
RNase A was used because it cleaves uridine and cytidine residues, which are both present in 
the loop.  As was done in previous studies, RNase 1 was used to visualize the bulge region.  
The footprinting results using AUCAloop RNA were very similar to the results with 
GGAGloop RNA (Figure 2.29).  We have maintained low micromolar binding affinity in the 
bulge region, and there is some minimal binding in the loop region.  The local binding 
affinities were calculated for the A23 and U24 residues in the bulge and were found to be 9.4 
± 3.9 μM and 6.9 ± 2.6 μM, respectively (Figure 2.30, Table 2.5).  An average of these 
values is consistent with the binding affinity determined by fluorescence anisotropy.  All 
further studies were done with the GGAGloop RNA because the affinity for the AUCAloop 
RNA was not any better and the peptide still seems to prefer binding the internal loop.             
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AUCAloop RNA  
Figure 2.26.  Structure and sequence of the AUCAloop RNA.  The RNA hairpin loop 
region, which differs in sequence from GGAGloop RNA, is highlighted in red.  
 
 
90°
 
 
Figure 2.27.  Structure of AUCA RNA hairpin loop (5MSF)14.  The stem region is 
highlighted in purple, adenosine residues are blue, cytidine residues are green, and uridine 
residues are red.  
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Figure 2.28.  Fluorescence anisotropy binding experiments of TAMRA-labeled WKWK-Int 
binding to GGAGloop RNA (blue) or AUCAloop RNA (red).  Peptide concentration was 
500 nM in all experiments.  Experiments were done in 10 mM PBS buffer (140 mM 
Na+/K+Cl-, 1 mM MgCl2, pH 7.4) at 25°C and each curve is an average of 3 runs.     
 
 
Table 2.4.  Dissociation Constants for the WKWK-Int Binding to the GGAGloop RNA and 
AUCAloop RNA.a 
7.1 (1.3)AUCAloop RNAWKWK-Int
3.7 (0.7)GGAGloop RNAWKWK-Int
KD (uM)    (± error)RNA SequencePeptide-Intercalator Probe
 a As determined by fluorescence anisotropy experiments.  Binding constants were determined 
by fitting the data to equation 1.  
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Figure 2.29.  RNase footprinting experiments with WKWK-Int and AUCAloop RNA.  
Shown is the phosphor image of a 20% denaturing polyacrylamide gel.  Structure lanes: 
RNA only, folded RNA in buffer; AH, alkaline hydrolysis; T1, RNase T1 (G-lane); A, 
RNase A (C and U lane).  Increasing concentrations (0 to 100 μM) of WKWK-Int  were 
added to AUCAloop RNA (0.18 μM) in 10 mM PBS buffer (140 mM Na+/K+Cl-, 1 mM 
MgCl2, pH 7.4) and 5 ng/μL yeast tRNA.  RNase A (cleaves C and U residues) was used to 
visualize the loop region and RNase 1 (cleaves ssRNA) was used to visualize both the loop 
and internal bulge regions.   
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Figure 2.30.  ImageQuant analysis of RNase footprinting assay of WKWK-Int binding 
AUCAloop RNA.  There was weak binding detected in hairpin loop region (blue), but the 
peptide does bind to the bulge region (dark and light green).  The band intensities are the 
average of three RNase footprinting assays.       
 
 
 
 
 
Table 2.5. Local Binding Affinitiesa for WKWK-Int binding to AUCAloop RNA 
4.5 (1.3)5.6 (1.4)16.7 (6.7)WKWK-Int
U29A27G18Peptide
Local binding affinity / μM (± error)
 a Local binding affinities were determined by plotting the RNase footprinting results as band 
intensity versus concentration of peptide and fitting the data using equation 1.   
 
 
 
 
 
 58 
xiv. Studies using an extended length RNA.   
The footprinting results showed that the WKWK-Int probe bound tightly to the internal 
AAUU bulge region, but that some weaker binding was occurring in the hairpin loop region.  
In order to isolate the binding to the bulge region, the GGAGloop RNA sequence was 
extended in length so that the hairpin loop region would be farther away from the 
intercalation site.  The extended RNA, GGAGext RNA, made it impossible for the probes to 
interact with the hairpin loop region, and therefore eliminate any binding in that region 
(Figure 2.31).   
The footprinting experiments with the GGAGext RNA showed that WKWK-Int no 
longer binds in the hairpin loop region, but the interaction in the bulge region remained the 
same (Figure 2.32).  Quantitation and analysis of the band densities supports the conclusion 
that binding in the loop region has been removed, and the binding in the bulge region 
remains (Figure 2.33).  The local dissociation constants for bases A27 and U28 are 2.9 (± 
1.7) μM and 2.4 (± 2.2) μM, respectively (Table 2.6).  These values are within error of the 
binding affinities for A23 and U24 in the GGAGloop RNA.  
The binding experiments show that although we have isolated the peptide binding to the 
bulge region, the probes have a lower binding affinity.  Both WKWK-Int and the 
unstructured GKGK-Int have a three-fold lower binding affinity for GGAGext RNA than 
for the shorter RNA sequence (Figure 2.34, Table 2.7).  This confirms that the probe has lost 
the ability to reach the single stranded hairpin loop region, and therefore shows an overall 
decrease in the binding affinity. 
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Figure 2.31.  Structure and sequence of the GGAGext RNA.  The additional bases pairs are 
denoted by parentheses and the key bases in the hairpin loop and internal bulge are labeled 
with numbers.  
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Figure 2.32.  RNase footprinting experiments with WKWK-Int and GGAGext RNA.  
Shown is the phosphor image of a 20% denaturing polyacrylamide gel.  Structure lanes: 
RNA only, folded RNA in buffer; AH, alkaline hydrolysis; T1, RNase T1 (G-lane); A, 
RNase A (C and U lane).  Increasing concentrations (0 to 100 μM) of WKWK-Int  were 
added to GGAGext RNA (0.18 μM) in 10 mM PBS buffer (140 mM Na+/K+Cl-, 1 mM 
MgCl2, pH 7.4) and 5 ng/μL yeast tRNA.  a) RNase T1 (cleaves G residues) was used to 
visualize the G-rich loop region and RNase 1 (cleaves ssRNA) was used to visualize both the 
loop and internal bulge regions.  b) RNase V1 (cleaves dsRNA) was used to visualize the 
stem regions of the RNA. 
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Figure 2.33.  ImageQuant analysis of RNase footprinting assay of WKWK-Int binding 
GGAGext RNA.  There was no binding detected in hairpin loop region (dark and light blue), 
but the peptide does bind to the bulge region (dark and light green).  The band intensity data 
are the average of two RNase footprinting assays.       
 
 
 
 
 
 
Table 2.6. Local Binding Affinitiesa for WKWK-Int binding to GGAGext RNA 
2.4 (2.2)2.9 (1.7)n.b.bWKWK-Int
U29A27G18Peptide
Local binding affinity / μM (± error)
 
 
a Local binding affinities determined by plotting the RNase footprinting results as band 
intensity versus concentration of peptide and fitting the data using equation 1.   
b no binding detected or binding too weak to determine a dissociation constant 
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Figure 2.34.  Fluorescence anisotropy experiments of TAMRA-labeled probes binding to 
GGAGloop RNA or GGAGext RNA.  There is a consistent decrease in binding affinity for 
WKWK-Int (dark blue and light blue circles) and GKGK-Int (dark green and light green 
triangles) binding to the extended length RNA.  Increasing concentrations of RNA was 
incubated with the peptide (500 nM) for 30 minutes in 10 mM PBS buffer (140 mM 
Na+/K+Cl-, 1 mM MgCl2, pH 7.4) at 25°C.  Each curve is an average of 3 or 4 runs.     
 
 
Table 2.7. Dissociation Constants for the Different Peptide Probes Binding to the 
GGAGloop RNA and GGAGext RNA.a 
25.6 (5.1)GGAGext RNAGKGK-Int
9.9 (1.3)GGAGloop RNAGKGK-Int
9.7 (2.2)GGAGext RNAWKWK-Int
3.7 (0.7)GGAGloop RNAWKWK-Int
KD (uM)    (± error)RNA SequencePeptide-Intercalator Probe
 
 
a As determined by fluorescence anisotropy.  Peptide concentration was 500 nM in all 
experiments.  Binding constants were determined by fitting the data to equation 1.  
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xv. Studies using GGAGloop RNA with an abasic site at A23.   
We wanted to investigate further the importance of base A23 in the internal loop of 
GGAGloop RNA for the binding of WKWK-Int probe.  In order to do this a new RNA 
sequence was designed, GGAGloop A23 abasic, which has an abasic site incorporated at 
position 23 (Figure 2.35).  Fluorescence anisotropy was used to find the dissociation constant 
of WKWK-Int for the abasic RNA sequence.  This value was then compared to the Kd found 
for GGAGloop RNA.  The anisotropy experiments show that the binding affinity is very 
similar for both RNA sequences (Figure 2.36).  The dissociation constant determined for 
WKWK-Int binding to GGAG A23 abasic RNA was 2.6 ± 1.2 μM, which is within error of 
the value determined for GGAGloop RNA (3.7 ± 0.7 μM).  These data are somewhat 
inconclusive, because the effect of eliminating binding at position A23 may be too small to 
detect when measuring the global binding affinity.  Footprinting studies were done, but no 
relevant information was learned because the RNase 1 enzyme does not cleave at abasic 
sites.  Future work would include incorporation of different RNA bases at that site, and using 
footprinting to determine whether there is sequence selectivity. 
 
 
 64 
GGAGloop A23 
abasic site  
Figure 2.35.  Structure and sequence of the GGAG A23 abasic site RNA.  The A23 abasic 
site is labeled.  
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Figure 2.36.  Fluorescence anisotropy experiments of TAMRA-labeled probes with 
WKWK-Int binding to GGAG A23 abasic and GGAGloop RNA sequences.  The binding 
affinity of WKWK-Int for each sequence is comparable.  Increasing concentrations of RNA 
was incubated with the WKWK-Int (500 nM) for 30 minutes in 10 mM PBS buffer (140 
mM Na+/K+Cl-, 1 mM MgCl2, pH 7.4) at 25°C.  Each curve is an average of 2 or 3 runs.     
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C. Conclusions 
We have designed a peptide-intercalator conjugate that recognizes RNA by interacting 
with both the double stranded stem region and single stranded bulge region simultaneously.  
The binding data shows that both the intercalator and the peptide portion of the probe are 
required for low micromolar binding to occur.  This system provides an example of how two 
ligands with low affinity for a substrate can together create a tighter binding system.  This 
dual-mode method of binding creates a system that is specific for two types of structure, and 
may be a viable way of providing specificity for RNA binding molecules.     
The RNase footprinting experiments showed that WKWK-Int interacts strongly with the 
internal bulge region (residues A23 and U24) and moderately with the hairpin loop region 
(residue G16).  The cleavage patterns for GKGK-Int and Int-control probe looked similar, 
but neither of these probes protected the A23 residue.  The cleavage pattern for GWKWK-
Int also looked similar, but it had a weak affinity for the A23 residue.  We can conclude that 
specific interactions are being made between the structured peptide and this residue.  
Aromatic interactions are important for this interacation to occur, but the β-hairpin structure 
increases the affinity.  Because the residue is located in the single stranded bulge, the base 
may be exposed and binding into the aromatic pocket of the peptide.  This hypothesis is 
supported by structural data for a similar adenine-rich bulge.17
The design of a probe that contained a fully folded version of the WKWK peptide, 
cycWKWK-Int, lowered the entropic cost for folding but also caused the peptide structure to 
be more constrained.  The results showed that this did not seem to help nor hurt the binding 
  
                                                 
17 Hermann, T.; Patel, D. J. Structure 2000, 8, R47-54. 
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affinities, and both cycWKWK-Int and WKWK-Int bound the GGAGloop RNA in a 
similar conformation.     
When the directionality of the peptide-intercalator probe was reversed, we found 
comparable protection from RNase cleavage.  Therefore, we conclude that the intercalator is 
threading in either direction and the peptide is driving the binding to the bulge region.  If the 
intercalator was driving the binding orientation, we would have seen either a loss of 
protection at the bulge or a different region of the RNA would have been protected, as the 
revWKWK-Int would place the peptide in the opposite groove. 
The sequence of the RNA hairpin loop was changed in an attempt to create more 
favorable interactions with that region.  The WKWK-Int probe bound nearly the same to 
AUCAloop RNA as it did to GGAGloop RNA.  The results show that the sequence of this 
region can be changed without a negative affect on binding.  However it also further proves 
that the loop region does not make significant interacations with the peptide portion of 
WKWK-Int.    
We have also shown that by extending the length of the RNA, we can terminate binding 
in the hairpin loop region.  The loss of binding results in a three-fold decrease in the binding 
affinity of both the structured and unstructured peptide intercalators for the RNA.  The 
intermolecular distance between the intercalator and the β-hairpin peptide is such that it is not 
long enough to reach the hairpin loop once the RNA sequence is extended.   
In this study, we have tested a β-hairpin “mini-protein” that has a binding pocket for 
unpaired nucleotides for binding to RNA loop and bulge regions.  We used an RNA 
intercalator that not only added an additional point of binding, but also helped to orient the 
peptide near the bulge region.  This is one of the only examples of a multivalent RNA 
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binding motif that interacts with a specific site on the RNA and simultaneously makes 
multiple interactions.   
Further studies using this probe would focus on identifying whether there is sequence 
specificity in the bulge region.  This could be done using an RNA sequence where the 
sequence of the bulge region is changed, especially the A23 base which seems to be 
important for binding the β-hairpin peptide.  Additionally the tryptophan binding pocket 
could be mutated to scan which of the residues are making important interactions with the 
RNA.  We suspect that the RNA is interacting with the non-hydrogen bonded face (Trp-Lys-
Trp-Lys) of the peptide, but it could be confirmed through peptide mutations.   
 
D. Experimental section 
i. Synthesis of the TAMRA-labeled intercalator-peptide probes 
The intercalator portion, 4-(4’-Methylaminoallyoxycarbamate)aniline-quinoline-8-carboxylic 
acid, was synthesized following the previously published procedure by Krishnamurthy et al. 
(Scheme 2.2) 10 One-dimensional NMR was used to confirm the identity of the intermediates 
and final product (Figures 2.37-2.42).  The peptide portions were synthesized on FMOC-
PAL-PEG-PS resin (0.07 mmol scale, 150 mg resin) using standard FMOC solid phase 
peptide synthesis methodology on a Creosalus Tetras automated synthesizer until the position 
where FMOC-Lys(ivDde)-OH (0.14 mmol, 2 eq.) was coupled manually.  The peptide was 
put back onto the synthesizer for coupling of the remainder of the natural amino acids.  After 
the βAla-βAla-Arg linker was added, the intercalator portion was manually coupled 
overnight using HOBT/HBTU (4 eq. each) and DIPEA (8 eq.).  The N-terminal Alloc 
protecting group was deprotected using Pd(PPh3)4 (1 eq.) and phenylsilane (24 eq.) in dry 
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dichloromethane.  The FMOC-Val-OH and BOC-Ser-OH amino acids, respectively, were 
coupled using HOBT/HBTU and DIPEA (0.4 mmol of each) in DMF.   The peptides were 
fluorescently labeled by first deprotecting the ivDde protecting group with 2% hydrazine in 
DMF three times for 3 minutes each time.  The free amine on the lysine side chain was 
coupled overnight to 5-(and -6)-carboxytetramethylrhodamine (TAMRA) (0.16 mmol).  The 
BOC group on the N-terminus was used in order to keep the N-terminus protected during the 
hydrazine deprotection and fluorophore coupling steps.  All the peptides were cleaved and 
deprotected by treating the resin with a (95:2.5:2.5) TFA:TIPS:Water mixture and bubbling 
with N2 for 3 hours.  The peptides were isolated by evaporating the TFA with nitrogen gas, 
then precipitating the peptide in cold diethyl ether, and then peptide extraction using MilliQ 
water.  The resulting solution was frozen and lyophilized to give a dark pink powder.  The 
peptides were purified using a Waters reverse-phase HPLC system.  During purification a 
C18 column was used, and the peptides were eluted using Standard A (95% water, 5% 
acetonitrile, 0.1% TFA) and Standard B (95% acetonitrile, 5% water, 0.1% TFA).  The 
masses of the peptides were confirmed using ESI-TOF mass spectrometry (Table 2.8).   
ii. Cyclization reaction for cycWKWK-Int 
After cleavage from the resin, cycWKWK-Int peptide was lyophilized to dryness then 
redissolved in 25 mL of 10 mM phosphate buffer (pH 7.5) and 250 μL DMSO.  The solution 
was stirred at room temperature overnight and then lyophilized to dryness.  The peptide was 
purified using reverse-phase HPLC and masses were confirmed by mass spectrometry as 
described above. 
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iii.  Secondary structure determination using circular dichroism 
Studies were done using an Aviv Model 62DS Circular Dichroism Spectrometer.  A 
wavelength scan (185nm-260nm) was done of WKWK-Int, GKGK-Int, GWKWK-Int, 
and cycWKWK-Int in 10 mM sodium phosphate buffer (pH 7.6) at 37°C in a 0.1 cm cell.  
The peptide concentration was 100 μM in both cases and the scans were done in triplicate.    
iv. Fluorescence anisotropy binding experiments 
The RNAs with defined sequences were purchased as a purified, lyophilized powder from 
Integrated DNA Technologies.  The RNA was dissolved in DEPC-treated water to a 
concentration of 500 μM and annealed by heating to 95°C for 2 min, then slowly cooling to 
room temperature.  The folded RNA solution was separated into smaller aliquots and stored 
at -20°C.  The peptide-intercalator probes were dissolved in DEPC-treated water and the 
concentration of the solution was determined using UV-Vis (λ559=91000 M-1 cm-1) 18.  The 
binding experiments were done by incubating 0.5 μM TAMRA-labeled peptide-intercalator 
with increasing concentrations of folded RNA in reaction buffer (10 mM phosphate buffer, 
140 mM Na+/K+Cl-, 1 mM MgCl2, pH 7.4) for 30 minutes at room temperature.  The 
anisotropy data were collected at 25°C in a 1 cm pathlength quartz microcuvette (excited at 
548 nm and emission monitored at 580 nm).  The anisotropy data were plotted as a function 
of fluorescence anisotropy versus concentration of RNA added.  Each of the curves was 
normalized so that the initial fluorescence anisotropy point equaled zero.  The plot was fitted 
using equation 1 derived from a previous report:19
                                                 
18 Extinction coefficient provided by Integrated DNA Technologies, www.idtdna.com. 
 
 
19 Wang, Y.; Killian, J.; Hamasaki, K.; Rando, R. R. Biochemistry 1996, 35, 12338-46. 
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where r is anisotropy, r0 is initial anisotropy value, r∞ is the maximum anisotropy, a is the 
total peptide-intercalator conjugate concentration, x is the concentration of RNA added, KD is 
the dissociation constant. 
v. Quantitative RNase footprinting experiments 
3’-32P RNA labeling.  Approximately 10 μg of RNA construct was treated with T4 RNA 
ligase (2 U/μL), T4 RNA ligase buffer (1X), DMSO (10%), RNase inhibitor (1 U/μL), and 
32pCp (0.05 mCi) and incubated at 4°C overnight.  The labeled RNA was run through an 
RNA spin column and loaded onto a 20% denaturing polyacrylamide gel for purification.  
The labeled RNA was visualized by autoradiography, excised from the gel and eluted 
overnight with elution buffer (0.5 M NH4OAc, 1 mM EDTA, 0.1 % SDS, pH 8.0).  After 
filtration through a Millipore centrifugal filter device (PTFE membrane 0.20 μM), the RNA 
was precipitated with 95% ethanol, sodium acetate buffer, and linear acrylamide overnight at 
-20°C.  The RNA was brought up in DEPC-treated water and the concentration was 
determined by UV absorbance using the equation: concentration of RNA SAMPLE = 40 × 
OD260 × dilution factor.     
RNase footprinting experiments.  The labeled RNA was brought up in DEPC-treated water 
(360 nM) and annealed at 95°C for 2 min and slowly cooled to room temperature.  The 
peptide-intercalator ligands were synthesized using the same procedure as above except 
without the fluorophore label.  Instead of inserting an FMOC-Lys(ivDde)-OH residue, an 
FMOC-Orn(Boc)-OH residue was used.  The unlabeled peptide-intercalator probes were 
dissolved in DEPC-treated water and the concentration of the solution was determined using 
 71 
the absorbance of the quinoline molecule (ε359=11700 M-1 cm-1).10  The folded RNA (final 
concentration =180 nM) was incubated with increasing concentrations of the peptide ligands, 
5 μg/mLyeast tRNA, and 10 mM PBS buffer (140 mM Na+/K+Cl-, 1 mM MgCl2, pH 7.4) for 
30 minutes at room temperature.  RNase digestions were done with RNase T1 (0.1 U/μL), 
RNase 1 (10 U/μL), and RNase V1 (0.01 U/μL) for 5 min, 30 s, and 1 min, respectively, and 
quenched with loading dye.  Sequencing lanes were done using unfolded RNA and 1X 
alkaline hydrolysis buffer (purchased from Ambion), RNase T1, and RNase A (1 μg/mL).  
Digested RNA and sequencing reactions were heat denatured and loaded onto a 20% 
denaturing polyacrylamide gel electrophoresis (51W, 2.5 h).  The gel was visualized by 
phosphorimaging, and the intensity of the bands was quantified using ImageQuant analysis 
program.  In order to correct the data for differences in loading, the intensity of each band 
was divided by the intensity of a control lane which is unchanged during the reaction.  To 
normalize the data, the corrected band intensity was then divided by the intensity of the RNA 
band when no peptide-intercalator probe was added.  The data were averaged and plotted on 
Kaleidograph as normalized band intensitry versus concentration of peptide-intercalator 
added and fit using equation 1.  In this case, r is the normalized band intensity, r0 is initial 
band intensity, r∞ is band intensity at the maximum peptide-intercalator conjugate 
concentration, a is the total RNA concentration, x is the total concentration of peptide-
intercalator conjugate added, Kd is the dissociation constant.  
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Scheme 2.2.  Synthesis of the intercalator, 4-(4’-Methylaminoallyoxycarbamate)aniline-
quinoline-8-carboxylic acid. 10   
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Figure 2.37.  1HNMR of Product 1 dissolved in CDCl3. 
 
 
 
Figure 2.38.  1HNMR of Product 2 dissolved in CDCl3. 
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Figure 2.39.  1HNMR of Product 3 dissolved in CDCl3. 
 
 
 
Figure 2.40.  1HNMR of the Alloc-protected benzyl amine, allyl-4-
aminobenzylaminocarbamate, dissolved in CDCl3. 
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Figure 2.41.  1HNMR of Product 4 dissolved in (CD3)2SO. 
 
 
Figure 2.42.  1HNMR of Product 5 dissolved in (CD3)2SO. 
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Table 2.8.  Mass Spectrometry Data Obtained for Peptides Studied in this Work  
2711.12710.5revWKWK(TAMRA)-Int
2286.02285.3revWKWK-Int
2915.82915.5cycWKWK(TAMRA)-Int
2489.62489.3cycWKWK-Int
2444.92445.3GWKWKG(TAMRA)-Int
2017.12017.1GWKWKG-Int
2186.12187.2GKGK(TAMRA)-Int
1758.91759.0GKGK-Int
2711.52711.5WKWK(TAMRA)-Int
2285.02285.3WKWK-Int
1316.81316.6Intcontrol(TAMRA)
776.6776.4Intcontrol
2136.22136.1WKWKcontrol(TAMRA)
1710.41710.0WKWKcontrol
Observed Mass (Da)Expected Mass (Da)Peptide
 
Chapter III 
DESIGN OF A BIV TAT PEPTIDE LIBRARY FOR INCREASING BINDING 
AFFINITY TO BIV TAR RNA 
 
A. Background 
In a second approach toward investigating peptides that interact with RNA, we have used 
combinatorial chemistry to improve the affinity of a peptide to an RNA hairpin loop region.  
RNA is different from DNA because it commonly contains unique structural elements such 
as loops and bulges.  These elements are often recognized by proteins using an induced fit 
mode of binding.  For these reasons the design of RNA binding molecules is challenging 
because it is difficult to predict how the RNA structure will change to accommodate the 
ligand.  We believe a combinatorial chemistry approach may overcome these design hurdles.   
The use of combinatorial chemistry to find different molecules that bind RNA targets has 
become prevalent in the past decade.  Some recent examples use computation methods to 
design libraries,1 high throughput fluorescence polarization assays,2
                                                 
1 (a) Schueller, A.; Suhartono, M.; Fechner, U.; Tanrikulu, Y.; Breitung, S.; Scheffer, U.; 
Goebel, M. W.; Schneider, G. J Comput -Aided Mol Des 2008, 22, 59-68. (b) Mayer, M.; 
James, T. L. Nuclear Magnetic Resonance of Biological Macromolecules, Part C 2005, 394, 
571-587. 
 high throughput cellular 
 
2 Galicia-Vazquez, G.; Lindqvist, L.; Wang, X.; Harvey, I.; Liu, J.; Pelletier, J. Anal Biochem 
2009, 384, 180-8. 
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assays, 3 and dynamic combinatorial chemistry.4  Several groups have used combinatorial 
methods to find peptide-based ligands that bind to RNA.5  The use of a peptide library has 
the advantage of being amenable to solid phase synthesis of the library and which also 
simplifies the screening process.  This was exemplified by the work of Hwang et al., who 
synthesized a tri-peptide library and performed an on-bead screen for ligands that bound the 
bulge loop of TAR RNA.6
We proposed to use a similar on-bead screening methodology, but instead of trying to 
find novel RNA-binding ligands, we wanted to improve upon a known RNA-peptide 
interaction.  The benefit of this approach was that we were able to use the binding affinity of 
the native peptide as a guideline to compare to newly discovered molecules.  We also used 
this as a gauge to tell how well our library screens worked.  We chose to investigate a well-
characterized RNA-protein interaction, the transactivation response (TAR) RNA sequence 
  They found that even though some of the peptide is displayed on 
the interior of the resin bead, the peptides were still accessible for RNA binding.  The on-
bead method also made it possible to screen against non-specific binding to undesirable RNA 
sequences.    
                                                 
3 Jimenez Bueno, G.; Klimkait, T.; Gilbert, I. H.; Simons, C. Bioorg Med Chem 2003, 11, 87-
94. 
 
4 (a) McNaughton, B. R.; Gareiss, P. C.; Miller, B. L. J Am Chem Soc 2007, 129, 11306-7. 
(b) Karan, C.; Miller, B. L. J Am Chem Soc 2001, 123, 7455-6. (c) Gareiss, P. C.; Sobczak, 
K.; McNaughton, B. R.; Palde, P. B.; Thornton, C. A.; Miller, B. L. J Am Chem Soc 2008, 
130, 16254-61. (d) Bugaut, A.; Toulme, J. J.; Rayner, B. Org Biomol Chem 2006, 4, 4082-8. 
 
5 (a) Tisne, C.; Dardel, F. Comb Chem High Throughput Screen 2002, 5, 523-9. (b) Tisne, C.; 
Guilliere, F.; Dardel, F. Biochimie 2005, 87, 885-8. (c) Hamy, F.; Felder, E. R.; Heizmann, 
G.; Lazdins, J.; Aboul-ela, F.; Varani, G.; Karn, J.; Klimkait, T. Proc Natl Acad Sci U S A 
1997, 94, 3548-53. (d) Ahn, D. R.; Yu, J. Bioorg Med Chem 2005, 13, 1177-83. 
 
6 Hwang, S.; Tamilarasu, N.; Ryan, K.; Huq, I.; Richter, S.; Still, W. C.; Rana, T. M. Proc 
Natl Acad Sci U S A 1999, 96, 12997-3002. 
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from bovine immunodeficiency virus (BIV) bound to the transactivation (bTat) protein 
(Figure 3.1).  This was an attractive system to study because (1) there was extensive 
structural information known about it, (2) the bTat binding domain is a small peptide that is 
amenable to combinatorial chemistry, and (3) previous results suggested that one region of 
the peptide was not making tight contacts with the RNA loop region which allowed us to 
investigate binding to RNA loops.   
The TAR RNA stem-loop-bulge structure and sequence has been shown to be required 
for Tat binding and that interaction is required for viral replication.7  The bTat-TAR 
interaction has high specificity and affinity, and unlike human immunodeficiency virus Tat-
TAR, there is a published NMR structure of the TAR RNA sequence bound to the minimal 
recognition sequence of bTat (Figure 3.1).8  Mutagenesis studies have shown that the 
residues important for binding are all located in the C-terminal β-hairpin of the bTat peptide 
(Figure 3.2).9
                                                 
7 (a) Fisher, A. G.; Feinberg, M. B.; Josephs, S. F.; Harper, M. E.; Marselle, L. M.; Reyes, 
G.; Gonda, M. A.; Aldovini, A.; Debouk, C.; Gallo, R. C; et al. Nature 1986, 320, 367-71. 
(b) Dayton, A. I.; Sodroski, J. G.; Rosen, C. A.; Goh, W. C.; Haseltine, W. A. Cell 1986, 44, 
941-7. 
  However, the NMR structure shows that residues in the N-terminal loop 
(residues 65-69) of the peptide are in close proximity to the RNA hairpin loop, although 
these interactions are not detected in the mutagenesis studies.  The TAR RNA hairpin loop 
has bases 17-20 flipped out and not base-paired to each other, and there have been no 
reported studies to date that alter the N-terminal loop of bTat peptide in order to better 
interact with the exposed bases.  We proposed to improve binding by using combinatorial 
 
8 Ye, X.; Kumar, R. A.; Patel, D. J. Chem Biol 1995, 2, 827-40. 
 
9 Chen, L.; Frankel, A. D. Proc Natl Acad Sci U S A 1995, 92, 5077-81. 
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chemistry to find mutations in that region which improve binding to the RNA hairpin loop 
which would also improve the overall binding of the system (Figure 3.2).     
We also wanted to incorporate some rational design elements in the combinatorial 
libraries, so we have incorporated both natural and unnatural residues that could make 
aromatic, cation-π, hydrogen bonding, and hydrophobic interactions.  We also aimed to avoid 
library screens resulting in hits that are dominated by electrostatic interactions, as they 
typically lead to nonspecific interactions. 
     
 
 
Figure 3.1. NMR structure of BIV Tat-TAR (PDB 1BIV).  TAR RNA stem-loop  bound to 
Tat peptide.  The C-terminus of the peptide is shown in the foreground with the β-hairpin 
extending to the bottom left.  The N-terminus loop is near the RNA hairpin loop at the top of 
the picture.  
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bTAR RNA bTat native 
peptide
bTat library
(a) (b) (c)
65
70 80
75
 
Figure 3.2.  Sequence and secondary structure of bTAR RNA, the binding domain of the 
bTat protein, and the proposed bTat library.  (a) bTAR RNA sequence and secondary 
structure.  Expected base pairing is indicated by dashed lines.  (b) bTat native peptide 
sequence and bound structure with β-sheet portion and frayed ends.  Mutagenesis studies 
have isolated the residues important for binding (highlighted in blue and purple), but the 
NMR structure showed that N-terminal residues also contact the RNA (highlighted in red and 
purple). (c) Proposed design of a bTat peptide library.     
 
 
B. Library design and synthesis 
The bTat library was designed after studying the NMR structure of the bTat peptide 
bound to bTAR.  The structure showed that there are several possible contacts between 
Pro69, Arg68, and Pro67, but that the Ser65 did not significantly interact (Figure 3.3).  A 
variety of residues were incorporated at these positions in an attempt to increase binding in 
that region.  We used aromatic residues to promote hydrophobic or π-stacking interactions, 
polar residues to increase hydrogen bond interactions, basic residues for cation-π or 
electrostatic interactions, and non-polar residues to find favorable hydrophobic interactions 
(Figure 3.4).  We also included several non-natural amino acids to increase the possibility of 
finding a novel RNA binding interaction (Figure 3.5).  There were 2640 total possible 
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compounds in the biased library, and two glycine residues were used a spacer between the 
bead the bTat library.  We also synthesized a positive control which was the bTat native 
peptide synthesized on the Tentagel beads. 
Synthesis of the library was done by the split and pool method (Scheme 3.1).10
  
  The 
benefits of using split and pool synthesis is that each bead only contains one compound.  This 
simplifies hit identification, because single bead sequencing can be done to determine which 
peptide bound to the RNA.  Tentagel resin was used because it contains a non-cleavable 
linker, and because the swelling properties of the resin work well in aqueous media.   
 
Figure 3.3. RNA-peptide interactions near the N-terminal loop of bTat peptide (PDB BIV1) 
displayed using PyMol.  The peptide is shown in magenta with Arg68 and Pro67 side chains 
interacting with two uracils (green), an adenine (red), and a cytosine (purple).       
 
 
 
 
 
                                                 
10 Lam, K. S.; Lebl, M.; Krchnak, V. Chem Rev 1997, 97, 411-448. 
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-Non-cleavable linker-GGRRIRRGKGRTGRX4X3X2GX1-NH3+
X1=     S, K, R, W, Y, or A
X2=     P, F, W, PhG, or A
X3=    R, R(Me)2, K(Me)2, Cit , F, W, Y, hF, PhG, pfF, or A
X4=     P, G, R, K, Y, W, F, or A  
Figure 3.4.  BIV Tat library sequence including all the possible amino acid substitutions.  
One letter abbreviations are used for all the residues except the non-natural amino acids 
which are labeled as followed: phenylglycine (PhG), dimethyl arginine (R(Me)2), dimethyl 
lysine (K(Me)2), citrulline (Cit), homophenylalanine (hF), and parafluorophenyalanine (pfF). 
 
 
(a) (b) (c)
(f)(e)(d)
 
Figure 3.5.  Stuctures of the non-natural amino acids used in the synthesis of bTat library.  
(a) dimethyl arginine, (b) dimethyl lysine, (c) citrulline, (d) homophenylalanine, (e) 
phenylglycine, and (f) parafluorophenyalanine. 
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Scheme 3.1. Diagram of split and pool synthesis used to make the bTat peptide library.  This 
method of synthesis results in each bead containing one peptide sequence.   
 
 
 
C. Results and discussion 
i. Identification of the best screening method 
Initially the library screening was done by incubating the biotinylated BIV TAR RNA 
with streptavidin-labeled alkaline phosphatase in a high salt PBS buffer.  This mixture was 
then added to the peptide library and incubated for 3 h.  After extensive washing a mixture of 
BCIP (5-Bromo-4-Chloro-3’-Indolyphosphate p-Toluidine salt) and NBT (Nitro-Blue 
Tetrazolium Chloride) was added.  It was expected that any of the beads that bound well to 
the TAR RNA would have alkaline phosphatase attached which would reacts with 
BCIP/NBT to give a purple precipitate that dyes the bead.11
                                                 
11 Morken, J. P.; Kapoor, T. M.; Feng, S. B.; Shirai, F.; Schreiber, S. L. J Am Chem Soc 
1998, 120, 30-36. 
  However, a negative control 
reaction was done where no biotinylated TAR RNA was added, and this resulted in all the 
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beads turning purple.  It was hypothesized that the bTat library binds to one of the other 
components of the screening method. 
To eliminate the need for alkaline phosphatase and the BCIP/NBT, we used an 
AlexaFluor488-streptavidin conjugate and monitored binding using fluorescence microscopy.   
The results showed that the beads did fluorescence in the presence of 100 nM each of biotin-
bTAR and AlexaFluor488-streptavidin (Figure 3.6).  However when the negative control 
experiment (without biotin-bTAR added) was done, the beads were equally as fluorescent.  It 
was hypothesized that since the streptavidin was the only constant variable between these 
and the previous experiments, it must be binding to the bTatlibrary.  However we were 
unsure if the streptavidin was binding the bTat peptides or if it was merely adhering to the 
Tentagel resin.  To test this theory, Tentagel beads without any peptide attached were 
incubated with 100 nM AlexaFluor488-streptavidin.  Microscopy showed that the beads were 
not fluorescent, and so we can conclude that it is the bTatlibrary that binds to streptavidin.        
1745ms exp 1745ms exp
(a) (b)
 
 
Figure 3.6.  Fluorescence microscopy images of bTatlibrary beads with and without bTAR 
RNA added and incubation with AlexaFluor488-streptavidin conjugate. (a) Reaction with 
100 nM biotin-bTAR RNA and 100 nM AlexaFluor488-streptavidin added.  (b) Reaction 
with 100 nM AlexaFluor488-streptavidin added but no RNA. 
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In order to remove the streptavidin from the screening conditions, we chose to directly 
label the bTAR RNA with a Cy3 fluorophore and forego a multi-step colorimetric assay.  We 
switched fluorophores because we were able to purchase the RNA with Cy3 already attached, 
which we were unable to do using AlexaFluor488.  The negative control experiment for this 
screening method was done using Tentagel beads containing peptides (labeled WKWKlib) 
which do not bind bTAR RNA.  The negative control was successful, because none of the 
resin beads were fluorescent after addition of the Cy3-bTAR (Figure 3.7a).  A positive 
control was also done with Tentagel beads containing the native bTat peptide.  This 
experiment resulted in all fluorescent beads (Figure 3.7b).  However, under the same buffer 
conditions with the bTatlibrary, all of the beads in the library were found to bind Cy3-bTAR 
(Figure 3.7c).  This result suggested that electrostatic interactions dominated and so there 
was no way to distinguish between peptides with different binding affinities.  
To minimize the number of hits detected, the experiments were repeated using more 
stringent salt conditions in an attempt to eliminate non-specific electrostatic binding.  Several 
rounds of screening were done using varying concentrations of Cy3-bTAR and varying salt 
conditions until only a few beads were fluorescent (Figure 3.7d).  The most effective 
screening conditions were using 5 nM Cy3-bTAR and 10 mM phosphate buffer with 1 M 
NaCl and 1 mM MgCl2 at pH 7.4.  
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(a) (b)
(c) (d)
 
Figure 3.7. Fluorescence microscopy images of affinity screens using Cy3-bTAR RNA.  
(a) negative control reaction using WKWKlib beads: 10 nM Cy3-bTAR, 10 mM phosphate, 
500 mM NaCl, 1 mM MgCl2, pH 7.4 (b) positive control reaction using bTatnative beads: 10 
nM Cy3-bTAR, 10 mM phosphate, 500 mM NaCl, 1 mM MgCl2, pH 7.4  (c) bTat library 
screening: 10 nM Cy3-bTAR, 10 mM phosphate, 500 mM NaCl, 1 mM MgCl2, pH 7.4 (d) 
bTat library screening: 5 nM bTAR-Cy3 in 10 mM phosphate, 1 M NaCl, 1 mM MgCl2, pH 
7.4 
ii. Hit identification 
The fluorescent beads were picked out individually using a pipette tip and sequenced by 
single bead Edman degradation.  In the first round of sequencing, thirteen of the darkest 
beads were selected and analyzed.  The sequencing results are tabulated in Table 3.1.  At 
position X1 basic residues were preferred, at X2 there were both aromatic and non-polar 
residues selected, and at both positions X3 and X4 charged residues were preferred.  None of 
the selected beads contained peptides with non-natural amino acids.  All of the peptides that 
were selected contained either a +1 or +2 charge over the native sequence.  These results 
suggest that even in the high salt (1 M NaCl) screening conditions, electrostatic interactions 
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were contributing to binding, but in a sequence selective manner.  The consensus sequence 
from the first group of hits was (NH3-RGFRKRGTRGKGRRIRR-GG-resin).   
After letting the beads sit in solution for two weeks, some of the beads were still 
fluorescent, so six beads were chosen for the second round of sequencing (Table 3.1).    The 
second batch of peptide sequences were similar to the original sequences because charged 
residues were preferred as X1, X3, and X4, and aromatic residues were preferred at X2.  
However this round of sequencing did produce several peptides that contained non-natural 
amino acids.  One interesting peptide, NH3-YGFhFPRGTRGKGRRIRR-GG-resin, had one 
less positive charge than the native sequence and no charged residues at any of the varied 
positions.  Both this sequence, bTatYGFhFP, and the consensus sequence, bTatRGFRK, 
were chosen for further investigation. 
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Table 3.1.  Sequencing Results for Hits Selected in Screening the bTatlibrary 
Overall 
Peptide 
Charge
X4X3X2GX1
11RRPhGGRBead 6
11RRPGRBead 5
11RRPhGGKBead 4
11RRFGRBead 3
11RRPGRBead 2
8PhFFGYBead 1
Hits after 2 weeks
10WRAGRBead 13
10KKPGSBead 12
11KRWGKBead 11
10ARFGKBead 10
11KRAGRBead 9
11RRPGRBead 8
11RKPGRBead 7
11KRFGKBead 6
10KRWGSBead 5
11RRAGRBead 4
10RYFGRBead 3
11KRAGKBead 2
11RRFGRBead 1
9PRPGSNative Seq.
+NH3-X1GX2X3X4 RGTRGKGRRIRRGG-
 
 
iii. Binding studies: Fluorescence anisotropy 
The full-length bTatYGFhFP and bTatRGFRK sequences were synthesized along with the 
native bTat sequence (bTatnative) and the binding affinities were characterized using 
fluorescence anisotropy.  To the N-terminus of the peptides was attached 5-(6)-
carboxytetramethylrhodamine (TAMRA) with a spacer of two β-alanine residues included in 
order to avoid the fluorophore interfering with binding.  Unlike the library screening, the 
binding studies were done at physiological salt concentration (10 mM PBS, 137 mM NaCl, 
10 mM MgCl2, pH 7.4).  The bTAR RNA was unlabeled for the fluorescence experiments.  
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During the experiment, unlabeled RNA was titrated into a solution of labeled peptide and as 
binding occurs the mobility of the RNA slows down and changes the amount of parallel and 
perpendicular polarized light that is emitted.  The ratio of emitted parallel and perpendicular 
polarized light is used to determine the anisotropy value which can then be correlated to 
binding affinity.12
Previously published results have shown that the interaction of the native bTat peptide 
and bTAR RNA has dissociation constant in the nanomolar range.
   
13
For these experiments the ideal concentration of labeled peptide would be 1/10th the Kd 
value.  So for a binding affinity of approximately 100 pM, the ideal concentration would be 
around 10 pM and not 2 nM at which these were done.  However the sensitivity of our 
fluorimeter is too low to measure picomolar concentrations.  Therefore the experiments were 
repeated using a high salt buffer (250 mM NaCl) in an attempt to weaken the binding by 
screening the electrostatic charges.  This still allowed us to compare the binding affinities, 
and we were able to work at a higher concentration of TAMRA-labeled peptide.  The 
experiments done at a higher salt concentration showed more discrepancy in the binding 
  Our fluorescence 
anisotropy studies showed that the bTatnative peptide binds bTAR with a binding affinity of 
approximately 110 pM, and the two mutants have very similar binding affinities (Figure 3.8, 
Table 3.2).  The discrepancy in measured binding affinity between our results and previously 
published values can be attributed to the different methods used to determine binding and 
slightly different buffer conditions.    
                                                 
12 Gelman, M. A.; Richter, S.; Cao, H.; Umezawa, N.; Gellman, S. H.; Rana, T. M. Org Lett 
2003, 5, 3563-3565. 
 
13 (a) Chen, L.; Frankel, A. D. Biochemistry 1994, 33, 2708-15. (b) Athanassiou, Z.; Dias, R. 
L.; Moehle, K.; Dobson, N.; Varani, G.; Robinson, J. A. J Am Chem Soc 2004, 126, 6906-13. 
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affinity of the three peptides (Figure 3.9).  The bTatnative bound with a Kd of 1.2 ± 0.4 nM, 
the bTatRGFRK bound three-fold better with a Kd of 0.4 ± 0.2 nM, and bTatYGFhFP 
bound the weakest with a Kd of 4.6 ± 2.3 nM (Table 3.3).  The large errors associated with 
those values suggest that the conditions for the experiment are still not ideal.  Therefore, 
another method of measure binding affinity was used to confirm the results.     
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Figure 3.8.  Fluorescence anisotropy experiments for measuring the binding affinity of 
bTAR RNA to the bTatnative, bTatRGFRK, and bTatYGFhFP.  Experiments were done 
in 10 mM phosphate buffer, 140 mM NaCl, 1 mM MgCl2 pH 7.4.  The peptides (2 nM) were 
labeled with a TAMRA-fluorophore and were excited at 548 nm and emission was collected 
at 580 nm.   
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Table 3.2.  Dissociation constants determined from the fluorescence anisotropy experiments 
done at physiological conditions. 
 
0.17 (0.03)bTatYGFhFP
0.08 (0.04)bTatRGFRK
0.11 (0.02)bTatnative
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Figure 3.9.  Fluorescence anisotropy experiments for measuring the binding affinity of 
bTAR RNA to the bTatnative, bTatRGFRK, and bTatYGFhFP.  Experiments were done 
in 10 mM phosphate buffer, 250 mM NaCl, 1 mM MgCl2 pH 7.4.  The peptides (5 nM) were 
labeled with a TAMRA-fluorophore and were excited at 548 nm and emission was collected 
at 580 nm.   
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Table 3.3.  Dissociation constants determined from the fluorescence anisotropy experiments 
done with high salt buffer. 
 
4.6 (2.3)bTatYGFhFP
0.4 (0.2)bTatRGFRK
1.2 (0.4)bTatnative
Kd (nM) (± error)Peptide
 
 
iv. Binding studies: Gel shift assays 
Gel shift assays were done to supplement the fluorescence anisotropy binding results.  
Each of the peptides was synthesized without the N-terminal TAMRA label leaving a free 
amine.  This mimics how the original bTatlibrary was synthesized.  An additional control 
peptide was made in which the last five residues of the N-terminus were omitted, +NH3-
RGTRGKGRRIRR-NH2 (bTatnoloop).  This peptide served as a negative control because it 
cannot make any contacts in the hairpin loop region. 
The procedure for the gel shift assays was a modified version of the one used by 
Athanassiou et al.13b  This group also reported a dissociation constant of approximately 50 
nM for the native bTat peptide binding to bTAR RNA.  Therefore, we were able to directly 
compare our results with theirs.  The binding studies were done using a 50 mM Tris-HCl 
buffer containing 50 mM KCl, 200 mM DTT, and 0.05% Triton-X at pH 8.  The gel shift 
assays with the positive and negative control peptides were done in duplicate, whereas the 
binding experiments for the bTat mutants were done in triplicate.  We expected the binding 
affinity to be in the low nanomolar range, so the bTAR RNA concentration was held constant 
at 0.5 nM.  After the gels were phosphorimaged, the band densities were quantified using 
ImageQuant software.  In all cases the lowest and highest concentrations of peptide added 
 94 
were estimated to be 0% and 100% peptide bound, so the data were normalized to reflect the 
values as fraction bound.  In order to compare the binding affinities, the curves were fit using 
a 4-parameter logistical model (Equation 2) than analyzed to find the concentration of 
peptide when 50% of the RNA was bound (Keff).   
The positive control peptide (bTatnative) and the negative control peptide (bTatnoloop) 
bound bTAR RNA with measurable differences in Keff (Figures 3.10 and 3.11).  The 
bTatnative peptide bound with an Keff of 6.3 ± 0.4 nM (Figure 3.12, Table 3.4), which is on 
the same order of magnitude of those values previously reported.13a  For the bTatnoloop 
peptide, the Keff was 40.8 ± 3.3 nM (Figure 3.12, Table 3.3).  The fact that the binding 
affinity was about six-fold worse when the N-terminal loop of the peptide is not present 
confirms that this portion of the peptide contributes to binding with the RNA.  However 
because binding was not completely lost, that portion is not essential for binding to occur. 
The two bTat mutant peptides that were identified from the library screens were found to 
have a similar binding affinity for bTAR as the native peptide (Figures 3.13 and 3.14).  The 
Keff for bTatRGFRK peptide was 8.5 ± 0.6 nM (Figure 3.15, Table 3.4), and had a similar 
shaped binding curve as bTatnative.  This peptide sequence was derived from the consensus 
sequence of first round of screening.  The sequence has one more positive charge than the 
native sequence, but the binding affinity is nearly the same.  The bTatYGFhFP was found to 
have an Keff of 9.9 ± 0.4 nM (Figure 3.15, Table 3.3).  This peptide has one less positive 
charge than the native sequence, and the binding affinity was only slightly worse.   
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Figure 3.10.  Electromobility gel shift assay for bTatnative peptide binding to bTAR 
RNA.  The 32pCp-bTAR RNA (0.5 nM) was incubated with increasing concentrations of 
bTatnative peptide in Tris-HCl buffer (50 mM Tris-HCl, 50 mM KCl, 200 mM DTT, 
0.05% Triton-X pH 8) for 30 min.  The reactions were then run on a native 12% PAGE at 
12W and 4°C in 1X TBE buffer.    
 
 
 
 
 
Figure 3.11.  Electromobility gel shift assay for bTatnoloop peptide binding to bTAR 
RNA.  The 32pCp-bTAR RNA (0.5 nM) was incubated with increasing concentrations of 
bTatnoloop peptide in Tris-HCl buffer (50 mM Tris-HCl, 50 mM KCl, 200 mM DTT, 
0.05% Triton-X pH 8) for 30 min.  The reactions were then run on a native 12% PAGE at 
12W and 4°C in 1X TBE buffer. 
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Figure 3.12.  Plot of the fraction of bTAR RNA bound by the bTatnative (blue) and 
bTatnoloop (red) peptides as determined by electromobility gel shift assays.  The data 
were averaged from two gel shift assays.  Keff values were determined by fitting the curve 
to Equation 2.    
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Figure 3.13.  Electromobility gel shift assay for bTatRGFRK peptide binding to bTAR 
RNA.  The 32pCp-bTAR RNA (0.5 nM) was incubated with increasing concentrations of 
bTatRGFRK peptide in Tris-HCl buffer (50 mM Tris-HCl, 50 mM KCl, 200 mM DTT, 
0.05% Triton-X pH 8) for 30 min.  The reactions were then run on a native 12% PAGE at 
12W and 4°C in 1X TBE buffer.    
 
 
 
 
Figure 3.14.  Electromobility gel shift assay for bTatYGFhFP peptide binding to bTAR 
RNA.  The 32pCp-bTAR RNA (0.5 nM) was incubated with increasing concentrations of 
bTatYGFhFP peptide in Tris-HCl buffer (50 mM Tris-HCl, 50 mM KCl, 200 mM DTT, 
0.05% Triton-X pH 8) for 30 min.  The reactions were then run on a native 12% PAGE at 
12W and 4°C in 1X TBE buffer.    
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Figure 3.15.  Plot of the fraction of bTAR RNA bound by the bTatRGFRK (blue) and 
bTatYGFhFKP (red) peptides as determined by electromobility gel shift assays.  The data 
were averaged from two gel shift assays.  Keff values were determined by fitting the curves to 
Equation 2. 
 
 
Table 3.4. Keff values for bTAR binding to bTatnative and the bTat mutants peptides as 
determined by electromobility shift assays. 
 
9.9 (0.4)bTatYGFhFP
8.5 (0.6)bTatRGFRK
40.8 (3.3)bTatnoloop
6.3 (0.4)bTatnative
Keff, nM (± error)Peptide
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D. Conclusions 
 In beginning this project, we set out to improve the bTat/bTAR binding affinity by 
finding novel substrates with through optimization of hairpin loop binding.  We tried to 
incorporate non-natural amino acids into the peptide substrates which would be able to bind 
with RNA using interactions other than electrostatics.   
 After working out the screening methodology, we set out to investigate two of the 
interesting hits that were chosen, bTatRGFRK and bTatYGFhFP.  The goal was to find a 
novel bTAR substrate which had a higher binding affinity than the native bTat peptide.  More 
specifically we were searching for peptides which made tighter interactions between the N-
terminus of the peptide and the hairpin loop of the RNA.  Initial attempts to use fluorescence 
anisotropy to determine dissociation constants were unsuccessful because of issues with 
instrument sensitivity at low concentrations of peptide.  Gel shift assays were used instead, 
and the results showed that both of the bTat mutants both had low nM affinity for the RNA, 
but neither bound tighter than the bTatnative.  However, all three of those peptides bound 
better than the negative control, bTatnoloop.  Despite our efforts, we did not discover a 
novel substrate that bound better than the native peptide.  We were able to find a peptide, 
bTatYGFhFP, which had one less positive charge which did not seem to cause a loss in 
binding affinity. 
 The other interesting aspect of the bTatYGFhFP peptide was that it contained a non-
natural residue, homophenylalanine.  During the screening process, high salt buffers were 
used in order to reduce the amount of electrostatic interactions, and promote peptides that 
bound with different types of interactions (aromatic, hydrophobic, cation-π, etc).  We also 
included several non-natural amino acids that could participate in these types of interactions.  
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The initial screen did not yield peptides containing unnatural amino acids, but after the beads 
had incubated in buffer for two weeks several hits did contain interesting residues.  We can 
conclude from this result that there may have only been a few hits that contained non-natural 
amino acids, but the peptides that did had undiminished binding affinity over time.  
 In summary, we have screened an on-bead bTat peptide library for increased binding to 
bTAR RNA.  Despite the fact that we discovered novel substrates for this RNA sequence, 
there was not a drastic improvement in binding affinity.  Future directions for the project 
would be to investigate whether there were increase contacts of the bTat mutants to the RNA 
hairpin loop region using RNase footprinting or NMR studies.  Additionally the methodology 
could be used to find novel peptides which bind to other interesting RNA sequences. 
  
E. Experimental  
i. Peptide library synthesis 
The synthesis of the bTat library and bTat peptide was done manually on non-cleavable 
Tentagel resin beads (0.21 mmol/g loading) on a 0.16 mmol and 0.1 mmol scales, 
respectively.  The resin was swelled using DMF, and each of the FMOC-protected amino 
acids (4 eq.) were coupled onto the peptide using an activator solution of HOBT (4 eq.), 
HBTU (4 eq.), and DIPEA (4 eq.).  The resin was agitated for 1.5 h, and then rinsed 
thoroughly.  FMOC deprotection was done with 20% piperidine in DMF (2 x 15min).  
Coupling reactions and Fmoc deprotections were monitored using the Kaiser test.14
                                                 
14 Kaiser, E.; Colescott, R. L.; Bossinger, C. D.; Cook, P. I. Anal Biochem 1970, 34, 595-8. 
  The side 
chains were deprotected for 3 hours using a cleavage cocktail of TFA:TIPS:Water 
(9.5:0.25:0.25), and then subsequently rinsed with TFA and methanol.  
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ii. Library screening 
The 3’ labeled Cy3-bTAR RNA was purchased as a purified solid from IDT DNA 
Technologies.  The RNA (5 nM or 10 nM) was redissolved in RNase-free PBS (10 mM 
phosphate, 140 mM NaCl, pH 7.4) and annealed by heating to 95°C for 2 min and slow 
cooling.  The RNA stock was aliquoted into smaller samples and stored at -20°C.  For the 
library screening reactions, the resin was swelled with DCM, and then dried using an 
aspirator.  Approximately 50-100mg of resin was weighed into a small, fritted reaction 
vessel.  The resin was rinsed with MeOH, 50% MeOH:DEPC-treated water, DEPC-treated 
water, high salt buffer (10 mM phosphate, 140 mM Na+/K+Cl-, 1 mM MgCl2, pH 7.4) and 
high salt screening buffer (10 mM phosphate, 500 or 1000 mM NaCl, 1 mM MgCl2, 0.01% 
Triton-X, pH 7.4).  The resin was incubated in high salt screening buffer for 30 min, then 
drained and a solution of high salt screening buffer and RNase inhibitor (1 μL) was added.  
To that solution the folded Cy3-bTAR RNA was added and the resin is shaken for 2 h.  The 
resin is drained and rinsed twice with high salt screening buffer, twice with high salt PBS 
buffer, and then twice with high salt screening buffer.  The beads were plated on cell culture 
plates and studied using a Leica DMIRB Inverted Fluorescence/DIC microscope.  Highly 
fluorescent beads were picked out using a pipette and sequenced using Edman degradation. 
iii. Fluorescence Anisotropy Binding Experiments 
The non-labeled bTAR RNA sequences were purchased as a purified, lyophilized powder 
from IDT DNA.  The RNA was dissolved in RNase-free water and annealed by heating to 
95°C for 2 min, then slowly cooling to room temperature.  The folded RNA solution was 
separated into smaller aliquots and stored at -20°C.  The bTatnative peptide and bTat mutant 
peptides were synthesized on PAL-PEG-PS resin (0.07 mmol) using an Applied Biosystems 
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Pioneer synthesizer.  The peptides were fluorescently labeled by coupling overnight 5-(and -
6)-carboxytetramethylrhodamine (0.16 mmol) with the free N-terminus of the peptide using 
HOBT, HBTU, and DIPEA (0.4 mmol of each) in DMF.  Side-chain deprotection and 
cleavage from the resin using a TFA cocktail as previously described.  The peptides were 
purified using a Waters reverse-phase HPLC system to give a bright pink powder.  The 
masses of the peptides were confirmed using ESI-TOF mass spectrometry (Table 3.5).   
The probes were dissolved in RNase-free PBS buffer (10 mM phosphate, 140 mM 
Na+/K+Cl-, 1 mM MgCl2, pH 7.4), and the concentration of the solution was determined 
using UV-Vis (λ559=91000 M-1 cm-1).  The binding experiments were done by titration of a 
concentrated stock of RNA into a 2 nM solution of TAMRA labeled-peptide (excited at 548 
nm and emission monitored at 580 nm).  The anisotropy experiments were preformed at 
25°C in a 1 cm pathlength quartz cuvette that had been rinsed with RNaseZap (Ambion), 
RNase-free water, and methanol.  The anisotropy data was plotted as a function of anisotropy 
versus concentration of bTAR RNA added.  The plot was fitted using equation 1 derived 
from a previous report: 15
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where r is anisotropy, r0 is initial anisotropy value, r∞ is the maximum anisotropy, a is the 
total TAMRA-labeled peptide-intercalator concentration, x is the total concentration of RNA 
added, Kd is the dissociation constant. 
 
 
                                                 
15 Wang, Y.; Killian, J.; Hamasaki, K.; Rando, R. R. Biochemistry 1996, 35, 12338-46. 
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iv. Gel shift assays 
3’-32P RNA labeling.  Approximately 10 μg of bTAR RNA construct was treated with T4 
RNA ligase (2 U/μL), T4 RNA ligase buffer (1X), DMSO (10%), RNase inhibitor (1 U/μL), 
and 32pCp (0.05 mCi) in a total volume of 30 μL and incubated at 4°C overnight.  The 
labeled RNA solution was run through an RNA spin column and loaded onto a 20% 
denaturing polyacrylamide gel for purification.  The labeled RNA was visualized by 
autoradiography, excised from the gel and eluted overnight with elution buffer (0.5 M 
NH4OAc, 1 mM EDTA, 0.1 % SDS, pH 8.0).  After filtration the RNA was precipitated with 
95% ethanol, sodium acetate buffer, and linear acrylamide overnight at -20°C.  The RNA 
was brought up in DEPC-treated water and the concentration was determined by UV 
absorbance using the equation: concentration of RNA SAMPLE = 40 × OD260 × dilution 
factor.     
Gel Shift Assays.  These are modified versions of the procedures used by Athanassiou et 
al.13b The labeled RNA was brought up in DEPC-treated water and annealed at 95°C for 2 
minutes and slowly cooled to room temperature.  The bTat peptides were synthesized using 
the same procedure as above except without the fluorophore label.  They all contained a free 
N-terminus so as to mimic the total charge on the bTat library.  Stock solutions were made by 
weighing out unlabeled peptides and dissolving them in DEPC-treated water to give a 1 mM 
final concentration.  Increasing amounts of peptide solution was added to 0.5 nM bTAR 
RNA and incubated at room temperature in 1X Tris-HCl buffer (50 mM Tris-HCl, 50 mM 
KCl, 0.05% Triton X, 200 mM DTT, pH 8.0) for 30 min.  To each reaction was added 1 uL 
BPB dye.  After the addition of the dye, the total reaction volume was 11 uL, and 8 uL of the 
sample was loaded onto a 12% native polyacrylamide gel.  The gel was electrophoresed in 
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1X TBE buffer at 12W and 4°C.  The gels were exposed to the phosphor imaging screen 
overnight and scanned using a Storm phosphor imager.  The band intensities were analyzed 
using ImageQuant software, and fraction bound was determined by dividing the number of 
radioactive counts in the higher band by the total counts in the lane.  The fraction bound 
values were then normalized by assuming the initial point was 0% bound and the final point 
was fully bound.  The binding constant, Keff, was determined using a 4-parameter logistical 
model which fit the data according to Equation 2:16
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where F is the fraction of RNA bound, Fmax is the fraction bound at infinite peptide 
concentration, F0 is the fraction bound at zero peptide concentration, x is the peptide 
concentration, Keff is the peptide concentration when 50% of the RNA is bound.    
 
 
 
 
 
 
 
 
 
 
                                                 
16 Findlay, J. W.; Dillard, R. F. AAPS J 2007, 9, E260-7. 
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Table 3.5.   Mass Spectrometry Data Obtained for Peptides Studied in this Project 
2647.02646.5bTatYGFhFP(TAMRA)
2092.22092.3bTatYGFhFP
2665.62665.6bTatRGFRK(TAMRA)
2111.32111.4bTatRGFRK
1879.01879.1bTatnoloop(TAMRA)
1467.01467.0bTatnoloop
2515.62515.5bTatnative(TAMRA)
1961.21961.2bTatnative
Observed Mass (Da)Expected Mass (Da)Peptide
 
 
Chapter IV 
THE USE OF SIDE-CHAIN INTERACTIONS TO STABILIZE β-HAIRPIN PEPTIDES 
FOR BINDING TO BIV TAR RNA 
 
A. Background 
In a third study, we used strong side-chain interactions to stabilize a mutant BIV Tat 
(bTat) peptide, BIV2, which was previously designed to bind BIV TAR RNA (bTAR).  
Using our knowledge of β-hairpin stability, we were able to convert the BIV2 peptide, which 
required cyclization to maintain the structure, into an acyclic peptide with stable β-hairpin 
structure.  We investigated whether our newly designed peptides could bind RNA with the 
same binding affinity as the original.  The binding affinity of the linear peptides was 
compared to the cyclic peptide using fluorescence anisotropy and electromobility gel shift 
assays.     
This project was based on work by Athanassiou et al. in which they cyclized the native 
BIV Tat peptide with a DPro-LPro turn template. 1
                                                 
1 (a) Athanassiou, Z.; Dias, R. L.; Moehle, K.; Dobson, N.; Varani, G.; Robinson, J. A. J Am 
Chem Soc 2004, 126, 6906-13.  (b) Leeper, T. C.; Athanassiou, Z.; Dias, R. L.; Robinson, J. 
A.; Varani, G. Biochemistry 2005, 44, 12362-72. (c) Athanassiou, Z.; Patora, K.; Dias, R. L.; 
Moehle, K.; Robinson, J. A.; Varani, G. Biochemistry 2007, 46, 741-51. 
  The native BIV Tat peptide is unstructured 
in solution, but upon binding BIV TAR RNA it forms a β-hairpin structure and lies in the 
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major groove.2
One advantage to using side-chain interactions to provide structure to a peptide system 
instead of cyclization is that it simplifies the synthesis of the peptide.  There is no need for 
solution phase amide coupling which requires additional purification.  Another reason for 
doing this project was to attempt to design a peptide which maintained both its β-sheet 
secondary structure and displayed an RNA binding interface.  For this purpose we designed a 
β-hairpin peptide where one face of the peptide stabilized the peptide through side-chain 
interactions, while the other face displayed residues that mimic a desired binding interaction.  
Using side-chain interactions for stabilization may be better than using cyclization which 
could potentially perturb the structure or interfere with binding.   
  The group made mutations to optimize the cyclized bTat peptide until a new 
sequence, BIV2, was found which had nanomolar binding affinity to bTAR RNA (Figure 
4.1).  BIV2 adopts a stable β-hairpin structure and upon binding RNA one face of the peptide 
makes interactions with the major groove of bTAR while the other face is solvent exposed 
(Figure 4.2a).1  The BIV2 peptide mimics the native bTat peptide in the way that it binds 
RNA, but the designed peptide has a pre-formed structure and eliminates the entropic cost of 
folding (Figure 4.2b).   
In this study we chose to insert a Trp-Trp-Lys-Leu (WWKL) sequence into the non-
hydrogen bonded positions of BIV2 peptide.  This peptide sequence, known as Trp pocket, 
stabilizes β-hairpin structure because the two tryptophans form an aromatic cleft where the 
cationic lysine side chain interacts through cation-π interactions.3
                                                 
2 (a) Puglisi, J. D.; Chen, L.; Blanchard, S.; Frankel, A. D. Science 1995, 270, 1200-3. (b) 
Ye, X.; Kumar, R. A.; Patel, D. J. Chem Biol 1995, 2, 827-40. 
   The leucine also stabilizes 
the structure through hydrophobic interactions to the N-terminal tryptophan.  A small β-
 
3 Riemen, A. J.; Waters, M. L. Biochemistry 2009, 48, 1525-31. 
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hairpin containing this sequence has been shown to be the most thermally stable designed 
hairpin reported to date.   
For BIV2, it was determined that the important residues for RNA binding were Arg1, 
Arg3, Arg5, Arg8, and Ile10, which are all located in the hydrogen bonded positions (as 
determined by the NMR structure, PDB 2A9X).1  Therefore, we were able to replace residues 
Val2, Thr4, Arg9, and Arg11 of the non-hydrogen bonded positions with the Trp pocket 
residues.  Using the NMR structure as a guide, we chose to cut BIV2 between residues Gly6 
and Lys7 in order to make it a linear peptide.  These two residues do not seem to make any 
significant contribution to binding, and seem to be solvent exposed from the NMR structure.  
We also replaced the DPro-LPro turn template with either an Asn-Gly or DPro-Gly turn 
sequence.  Not only do these turns promote β-hairpin formation,4
After synthesizing and characterizing the structure of the newly designed linear peptides, 
we also investigated whether they still bind to BIV TAR RNA.  Initially fluorescence 
anisotropy was used to characterize the binding, but due to fluorophore quenching issues we 
switched to electromobility gel shift assays.  Although the designed peptides do maintain β-
hairpin structure without cyclization, they did not maintain the binding affinity for the RNA 
target 
 they are more flexible than 
the DPro-LPro turn, and will allow the peptide to conform more easily to the RNA.     
                                                 
4 Stanger, H. E.; Gellman, S. H. J Am Chem Soc 1998, 120, 4236-4237. 
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Figure 4.1.  Structure of BIV2 as determined by Robinson et al.1  The residues that interact 
with bTAR RNA are shown in red and pink and the solvent exposed face of the peptide is 
colored blue.  
 
a) b)
 
Figure 4.2.  Structure of the BIV2-bTAR complex as determined by Robinson et al.1  a) 
BIV2 (yellow) lies in the major groove of BIV TAR RNA.  The DPro-LPro turn template 
orients itself in the RNA stem, away from the hairpin loop and bulge regions.  b) 
Superimposed images of BIV2 (yellow, PDB 2A9X) and BIV Tat peptide (green, PDB 
1MNB) binding in a similar orientation to BIV TAR RNA.  The key arginine residues that 
are consistent between the two peptides are labeled and highlight in yellow and red.   
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B. Design and synthesis 
Two peptides, bTatWWKL-NGturn and bTatWWKL-pGturn, were designed based 
on the BIV2 sequence, but differ from that peptide because they are linear and not cyclized 
(Figure 4.3).  Instead the Trp pocket domain has been incorporated on the face of the β-
hairpin which does not interact with bTAR RNA.  We have also added either an Asn-Gly 
(NG) or D-Pro-Gly (pG) turn sequence to help promote β-hairpin formation.  These turn 
sequences represent two different turn types, and we tested both to see which would be a 
better conformation for binding the RNA.  We expected that all of these changes would 
stabilize the β-hairpin structure without the need for a cyclic peptide.    
The peptides were synthesized using standard Fmoc-based solid phase peptide synthesis 
methods.  The extent of folding was determined using circular dichroism and NMR.  The 
peptides were also synthesized with a 5-(6)-carboxytetramethylrhodamine (TAMRA) 
fluorophore on the N-terminus, which allowed for fluorescence anisotropy to be used to 
measure binding of the peptide to the RNA.     
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Figure 4.3.  Sequence and structures of bTatWWKL-NGturn and bTatWWKL-pG turn.  
The WWKL face of the peptide is shown in red, and the turn sequence is shown in blue.   
 
C. Results and discussion 
i. Secondary structure determination: Circular dichroism 
Circular dichroism (CD) was used to determine the global secondary structure of the 
WWKL peptides in solution.  The CD spectra for bTatWWKL-NGturn and bTatWWKL-
pGturn were compared to the CD spectrum for a linear version of the BIV2 peptide, Ac-
KRRIRVpPRVRTRG-NH3+ (Figure 4.4).  Both of the bTatWWKL peptides showed a 
minimum CD signal around 215 nm which is indicative of β-sheet structure.  The CD 
spectrum for the linear version of BIV2 peptide was very different, because it showed a 
minimum around 200 nm which is indicative of a random coil conformation.  This provides 
evidence that the incorporation of the WWKL pocket and the new turn sequences was 
enough to promote β-sheet sheet structure without the need for cyclization.   
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Figure 4.4.  Circular Dichroism Spectra for linear BIV2 (green), bTatWWKL-NGturn 
(blue), and bTatWWKL-pGturn (red).  Studies were done at 100 μM peptide concentration 
in 10 mM sodium phosphate buffer pH 7.5 at 25°C.  Both bTatWWKL peptides fold into a β-
sheet conformation with a minimum mean residue ellipticity around 215 nm.  Linear BIV2 
does not fold into a β-sheet conformation, and instead resembles a random coil conformation 
with a minimum around 200 nm.   
 
ii. Secondary structure determination: One dimensional NMR  
Working in collaboration with Dr. Zach Laughrey, we confirmed the β-hairpin structure 
of the bTatWWKL peptides using one-dimensional NMR.  For well-folded β-hairpin 
peptides the alpha protons, Hα, are significantly downfield shifted as compared to an 
unfolded control.5
                                                 
5  Wishart, D. S.; Sykes, B. D.; Richards, F. M. Biochemistry 1992, 31, 1647-51. 
  The fraction folded can be determined using the equation 1, where the 
unstructured controls are truncated peptides containing either the N-terminal residues 
including the turn or the C-terminal residues including the turn.  The fully folded control was 
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a cyclized version of the bTatWWKL peptides which had cysteine residues on both the N- 
and C-terminus which formed a terminal disulfide bond.  The results confirmed that both 
peptides are highly folded with the exception of the ends which are commonly frayed (Figure 
4.5).  Overall the bTatWWKL-pGturn peptide was determined to be 88% folded, which 
was slightly more than the  bTatWWKL-NGturn peptide which is 82% folded.     
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Figure 4.5.  Fraction folded derived from the Hα chemical shifts.  Both the bTatWWKL-
NGturn (blue) and the bTatWWKL-pGturn (purple) peptides are found to be well-folded 
β-hairpins.  Data was collected and analyzed by Dr. Zach Laughrey. 
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iii. Fluorescence quenching studies 
We had intended to use fluorescence anisotropy to measure the binding of the 
bTatWWKL peptides to bTAR RNA.  However during the initial studies it was observed that 
the fluorescence intensity of the samples was changing over the course of the binding 
experiments.  Therefore, we set up several experiments to investigate when and why 
TAMRA fluorescence was being quenched. 
First, a solution of 0.1 μM TAMRA-labeled bTatWWKL-NGturn peptide was made 
without any RNA added.  The fluorescence intensity of the sample was measured 
immediately and several more times over the course of 45 min (Figure 4.6).  Within 10 
minutes the fluorescence intensity of the sample had decreased by half, and continued to 
decrease until leveling off around 30 min.     
To determine if the decrease in signal was a result of photobleaching, three identical 
samples of bTatWWKL-NGturn were made simultaneously.  A fluorescence scan of one of 
the samples was taken immediately, and the other two samples were stored overnight at room 
temperature.  One of them was wrapped in foiled and stored in the dark, and the other was 
stored on the bench top exposed to light.  The following day the fluorescence intensities for 
both samples were tested using the same fluorimeter settings as the prior day.  Additionally a 
fourth sample, identical to the others, was made and scanned immediately.  The results show 
that no matter the storage conditions, the fluorescence of bTatWWKL-NGturn decreases 
significantly over time (Figure 4.7).  When the fourth sample was made and scanned 
immediately it matched the intensity of the original sample.  This proves that the quenching 
is occurring within the peptide itself and not because of any outside triggers.  We hypothesize 
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that the conformation of the peptide may be changing in solution and during that process the 
environment around the fluorophore is also changing.   
        
 
 
Figure 4.6.  Fluorescence intensity of bTatWWKL-NGturn peptide measured over time.  A 
0.1 μM solution of bTatWWKL-NG in 10 mM phosphate buffer, 140 mM Na+/K+Cl-, 1 mM 
MgCl2 (pH 7.5) was used.  For each scan the excitation and emission slit widths were 10 nm 
each, 900v light was used, and the instrument was set at 15°C.   
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Figure 4.7.  Fluorescence intensity of four separate samples of bTatWWKL-NGturn 
peptide measured at different time points.  Each sample contains 0.1 μM solution of 
bTatWWKL-NG in 10 mM phosphate buffer, 140 mM Na+/K+Cl-, 1 mM MgCl2 (pH 7.5).  
For each scan the excitation and emission slit widths were 10 nm each, 875v light was used, 
and the instrument was set at 15°C.   
 
 
iv. Fluorescence anisotropy studies 
We also investigated whether the anisotropy values of TAMRA-labeled bTatWWKL-
NGturn were affected over time.  To do this experiment, a 0.1 μM solution of bTatWWKL-
NGturn in buffer was made with no RNA added.  The fluorescence anisotropy values were 
measured over time, and no change in the values was seen (Figure 4.8).  From this we can 
assume then that during a binding experiment any change in the fluorescence anisotropy 
value will be due to binding RNA, and not due to fluorescence quenching. 
From our earlier experiments we had determined that the decrease in fluorophore 
intensity stabilized after 30 min.  Even though the fluorescence anisotropy does not seem to 
be affected over time, the samples were allowed to incubate for 30 min before data was 
collected.  This also allowed time for the system to reach equilibrium.  The results showed 
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that both peptides bind bTAR in the low micromolar range, although the bTatWWKL-
pGturn peptide binds slightly better (Figure 4.9, Table 4.1).  The dissociation constant 
determined for bTatWWKL-NGturn was 4.6 ± 1.2 μM, whereas it was 2.1 ± 0.2 μM for 
bTatWWKL-pGturn.  These dissociation constants are about 10-fold higher than what 
Robinson determined for cyclic BIV2 binding to bTAR (Kd = 0.15 μM).1   
 
 
 
Figure 4.8.  Fluorescence anisotropy over time of bTatWWKL-NGturn peptide with no 
RNA added.  A solution of 0.1 μM peptide in 10 mM phosphate buffer, 140 mM Na+/K+Cl-, 
and 1 mM MgCl2 pH 7.5 at 15°C. 
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Figure 4.9.  Fluorescence anisotropy experiments for the bTatWWKL peptides binding to 
bTAR RNA.  A 0.2 μM solution of either bTatWWKL-NGturn (blue) or bTatWWKL-pGturn 
(red) peptides in 10 mM phosphate buffer, 140 mM Na+/K+Cl-, and 1 mM MgCl2 pH 7.5 was 
incubated with increasing concentrations of bTAR RNA for 30 min.    
 
 
 
Table 4.1.  The dissociation constants for bTatWWKL peptides binding to bTAR RNA as 
determined by fluorescence anisotropy.   
 
2.1 (0.2)bTatWWKL-pGturn
4.6 (1.2)bTatWWKL-NGturn
KD (μM) (error)
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v. Electromobility gel shift assays 
We decided to use electromobility gel shift assays (EMSAs) to measure the binding, as 
this was the method that Robinson’s group used to measure BIV2 binding, so we could 
directly compare our results to theirs.  Another advantage to using EMSAs is that we no 
longer needed to label the peptides with TAMRA, and we avoided the fluorescence 
quenching problems. 
For the EMSAs, we used the same buffer conditions that Robinson et al. used, which was 
50 mM Tris-HCl (pH 8.0), 50 mM KCl, 200 mM DTT, and 0.05% Triton X-100.  The only 
difference was that we did not include yeast tRNA in our studies.  We also followed their gel 
conditions, which were using a 12% native polyacrylamide in 0.5X TBE buffer 
electrophoresed at 15W in 4°C.  Running the gel at a low temperature helps ensure that the 
complex remains bound on the gel.  The bTAR RNA was labeled on the 3’ end using 32pCp, 
and the peptide was synthesized without TAMRA on the N-terminus.    
Based on the fluorescence anisotropy results, bTatWWKL-pGturn bound the tightest to 
bTAR RNA, so this peptide used for further studies.  It was expected that this peptide would 
bind the RNA with a Kd of approximately 2 μM, so for the EMSAs we used peptide 
concentrations ranging from 0.025 μM to 50 μM (Figure 4.10).  However, unlike the 
anisotropy data, no binding was detected by the gel shift assay.      
To determine whether there was a problem with the assay conditions, we ran a positive 
control experiment using the native bTat peptide binding to bTAR RNA (Figure 4.11).  This 
Kd for this interaction is known to be approximately 10 nM.6
                                                 
6 a) Chen, L.; Frankel, A. D. Biochemistry 1994, 33, 2708-15. (b) Athanassiou, Z.; Dias, R. 
L.; Moehle, K.; Dobson, N.; Varani, G.; Robinson, J. A. J Am Chem Soc 2004, 126, 6906-13. 
  Our results showed that after 
only 0.025 μM peptide was added, the band corresponding to unbound bTAR was gone and a 
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new band corresponding to the peptide-RNA complex appeared which ran slower on the gel.  
A third band appears after more than 1 μM peptide has been added, and it is suspected that 
this corresponds to large complexes being formed by nonspecific associations.  The binding 
affinity agrees well with the published binding data for the bTat-bTAR interaction, so we can 
conclude that the assay conditions were fine.  
To mimic more exactly the fluorescence anisotropy experiments, we decided to use the 
TAMRA-labeled bTatWWKL-pGturn peptide for the EMSA.  As was done with the 
previous experiments, increasing concentrations of the peptide were incubated with bTAR 
RNA for 30 min prior to electrophoresis (Figure 4.12).  The results show that the band 
corresponding to unbound bTAR began to disappear after 1 μM peptide was added and is 
replaced by a higher band near the top of the gel.  The data were analyzed using ImageQuant 
software and the curve was fit using Equation 2 (Figure 4.13).  The binding constant 
determined for the TAMRA-bTatWWKL-pGturn and BIV TAR RNA interaction was 0.6 
± 0.2 μM, which is very similar to what was determined by fluorescence anisotropy.  We can 
conclude from these data that the TAMRA fluorophore is responsible for the binding of this 
peptide to bTAR RNA.  When the peptide did not contain the label, there was no measurable 
binding detected.    
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Figure 4.10.  Electromobility gel shift assay of bTatWWKL-pGturn bound to bTAR RNA 
(10 nM).  Lane 1: RNA only, Lane 2: 0.025 μM peptide, Lane 3: 0.1 μM peptide, Lane 4: 0.5 
μM peptide, Lane 5: 1 μM peptide, Lane 6: 5 μM peptide, Lane 7: 10 μM peptide, Lane 8: 50 
μM peptide.  Buffer conditions were 50 mM Tris-HCl (pH 8.0), 50 mM KCl, 200 mM DTT, 
and 0.05% Triton X-100.  Gel was a 12% native polyacrylamide in 0.5X TBE buffer 
electrophoresed at 15W in 4°C.  The peptide and RNA were incubated at room temperature 
for 30 min before loading on the gel.  The gel was dried for 1 h and phosphor imaged 
overnight.  The distorted band in lane 8 was caused by a tear in the gel.   
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Figure 4.11.  Electromobility gel shift assay of the native bTat peptide bound to bTAR RNA 
(10 nM).  Lane 1: RNA only, Lane 2: 0.025 μM peptide, Lane 3: 0.1 μM peptide, Lane 4: 0.5 
μM peptide, Lane 5: 1 μM peptide, Lane 6: 5 μM peptide, Lane 7: 10 μM peptide, Lane 8: 50 
μM peptide.  Buffer conditions were 50 mM Tris-HCl (pH 8.0), 50 mM KCl, 200 mM DTT, 
and 0.05% Triton X-100.  Gel was a 12% native polyacrylamide in 0.5X TBE buffer 
electrophoresed at 15W in 4°C.  The peptide and RNA were incubated at room temperature 
for 30 min before loading on the gel.  The gel was dried for 1 h and phosphor imaged 
overnight.   
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Figure 4.12.  Electromobility gel shift assay of the native TAMRA labeled bTatWWKL-
pGturn peptide bound to bTAR RNA (10 nM).  Lane 1: RNA only, Lane 2: 0.025 μM 
peptide, Lane 3: 0.1 μM peptide, Lane 4: 0.5 μM peptide, Lane 5: 1 μM peptide, Lane 6: 5 
μM peptide, Lane 7: 10 μM peptide, Lane 8: 50 μM peptide.  Buffer conditions were 50 mM 
Tris-HCl (pH 8.0), 50 mM KCl, 200 mM DTT, and 0.05% Triton X-100.  Gel was a 12% 
native polyacrylamide in 0.5X TBE buffer electrophoresed at 15W in 4°C.  The peptide and 
RNA were incubated at room temperature for 30 min before loading on the gel.  The gel was 
dried for 1 h and phosphor imaged overnight.   
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Figure 4.13.  Fraction of 3’-p32Cp-BIV TAR RNA that was bound by TAMRA-
bTatWWKL-pGturn as determined by the electromobility gel shift assay.  For each 
reaction 10 nM RNA was used, and the line was fit using Equation 2 and gives a Kd of 0.6 ± 
0.2 μM.  The data reflects the results from one gel shift assay.   
 
 
D. Conclusions 
The goal of this project was to mimic a known interaction between RNA and a cyclic 
peptide by designing a new peptide which was linear but whose structure was stabilized by 
side chain interactions.  This “proof-of-principle” project would provide an example of how a 
stabilizing sequence of amino acids could be incorporated into a different peptide and still 
maintain structure and binding capability.  We also set out to improve the original system by 
using a linear peptide that is both easier to synthesize and more accurately emulates the 
native interaction.   
Our structural experiments proved that it was possible to incorporate the Trp pocket 
domain and promote β-hairpin structure.  The CD experiments proved that when it is not 
cyclized, the BIV2 peptide is unstructured in solution.  However with the addition of the Trp 
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pocket sequence, WWKL, and either an Asn-Gly or DPro-Gly turn sequence the peptide 
displays β-sheet structure.  These results were confirmed using NMR studies.   
We went on to investigate whether the bTatWWKL peptides maintained the low binding 
affinity for BIV TAR RNA that was found for BIV2.  Fluorescence studies were hindered by 
quenching of the TAMRA label on the peptide.  We suspect this may have been caused by 
intramolecular binding of the fluorophore to the rest of peptide, because it occurred even 
when no RNA was added.  As an alternative method to measure binding, we used gel shift 
assays.  Unfortunately no binding was detected for the unlabeled bTatWWKL-pGturn 
peptide to radiolabeled BIV TAR RNA.  Further studies provided evidence that the peptide 
binds with a Kd of 0.6 μM, but only when the TAMRA-label is attached.   We can conclude 
that by stabilizing the structure with the Trp pocket domain, we have altered the 
conformation of the peptide and perturbed binding to RNA.   
In the future, it may be advantageous to revert back to the DPro-LPro turn template from 
BIV2, because that may provide an important contact for binding.  It was significant that we 
were able to stabilize an unstructured peptide by incorporating the Trp pocket domain, but 
the bTat-bTAR interaction may not have be the right system to use for proof-of-principle 
studies.  The BIV2 peptide contained five residues that were important for binding.  
However, it may be better to repeat these experiments with a system that has fewer contacts 
that need to be correctly aligned.   
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E. Experimental section 
i. Peptide synthesis and labeling with fluorophore  
The bTatWWKL peptides were synthesized on PAL-PEG-PS resin (0.1 mmol scale) 
using an Applied Biosystems Pioneer synthesizer.  The peptides were fluorescently labeled 
on the free N-terminus by coupling overnight with 5-(-6)-carboxytetramethylrhodamine (0.16 
mmol), HOBT (0.4 mmol), HBTU (0.4 mmol), and DIPEA (0.4 mmol) in DMF.  Side-chain 
deprotection and cleavage from the resin was done using a TFA:Triisopropylsilane:Water 
mixture (95:2.5:2.5) and bubbling with N2 for 3 hours.  The peptides were isolated by first 
reducing the volume of TFA in a stream of nitrogen, then precipitating with cold diethyl 
ether, followed by extraction using deionized water.  The resulting peptide solution was 
frozen and lyophilized.  The peptides were purified using a Waters semi-preparative HPLC 
system with a reverse-phase C18 column.  The peptides were eluted using Standard A (95% 
Water, 5% Acetonitrile, 0.1% TFA) and Standard B (95% Acetonitrile, 5% Water, 0.1% 
TFA).  The masses of the peptides were confirmed using ESI-TOF mass spectrometry (Table 
4.2). 
ii. Fluorescence quenching experiments 
Time experiments.  The fluorescence of a 100 nM sample of bTatWWKL-NGturn peptide 
was measured on a Varian Cary Eclipse Fluorescence Spectrophotometer.  The sample was 
excited at 549 nm at 900 volts and 10 nm slit widths and the emission was collected from 
578-600 nm.  The fluorescence of the same sample was intermittently measured over the 
time period of 45 min.  In a separate experiment, two identical samples were made up and the 
fluorescence of the first was measured immediately and other was excited 30 min later with 
the same conditions. 
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Photobleaching experiments.  Three samples each containing 100 nM bTatWWKL-NGturn 
were made, and one was used immediately to measure the fluorescence of the sample.  The 
instrument conditions were set at 875 volts and 10 nm slit widths with the excitation at 549 
nm and the emission collected ranging from 570-600 nm.  The other two were stored 
overnight, one in the dark and the other exposed to light, and the fluorescence the tested the 
following day using the same conditions.  Another 100 nM bTatWWKL-NGturn samples 
was then made using the same stock as the previous day.  The fluorescence of this sample 
was also measured using the same instrument conditions.      
iii. Fluorescence anisotropy binding experiments 
The bTAR RNA was purchased as a purified, lyophilized powder from Integrated DNA 
Technologies.  The RNA was dissolved in DEPC-treated water (100 μM) and annealed by 
heating to 95°C for 2 min, then slowly cooling to room temperature.  The TAMRA-labeled 
bTatWWKL peptides were dissolved in DEPC-treated water and the concentration of the 
solution was determined using UV-Vis (ε559=91000 M-1 cm-1).7  The binding experiments 
were done by titrating increasing amounts of folded RNA into 0.2 μM TAMRA-labeled 
peptide in reaction buffer (10 mM phosphate buffer, 140 mM Na+/K+Cl-, 1 mM MgCl2, pH 
7.4).  The anisotropy data were collected at 25°C in a 1 cm pathlength quartz microcuvette 
(excited at 548 nm and emission monitored at 580 nm) on the Cary Eclipse Fluorescence 
Spectrophotometer.  The anisotropy data were plotted as a function of fluorescence 
anisotropy versus concentration of RNA.  The plot was fitted using Equation 2 derived from 
a previous report:8
                                                 
7  Extinction coefficient provided by Integrated DNA Technologies, www.idtdna.com. 
 
 
8 Wang, Y.; Killian, J.; Hamasaki, K.; Rando, R. R. Biochemistry 1996, 35, 12338-46. 
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where r is anisotropy, r0 is initial anisotropy value, r∞ is the maximum anisotropy, a is the 
total concentration of TAMRA-labeled peptide-intercalator, x is the total concentration of 
RNA added, KD is the dissociation constant. 
iv. Gel shift assays 
3’-32P RNA labeling.  Approximately 10 μg of bTAR RNA construct was treated with T4 
RNA ligase (2 U/μL), T4 RNA ligase buffer (1X), DMSO (10%), RNase inhibitor (1 U/μL), 
and 32pCp (0.05 mCi) and incubated at 4°C overnight.  The labeled RNA solution was run 
through an RNA spin column and loaded onto a 20% denaturing polyacrylamide gel for 
purification.  The labeled RNA was visualized by autoradiography, excised from the gel and 
eluted overnight with elution buffer (0.5 M NH4OAc, 1 mM EDTA, 0.1 % SDS).  After 
filtration the RNA was precipitated with 95% ethanol, sodium acetate buffer, and linear 
acrylamide overnight at -20°C.  The RNA was brought up in DEPC-treated water and the 
concentration was determined by UV absorbance using the equation: concentration of RNA 
SAMPLE = 40 × OD260 × dilution factor.     
Gel shift assays.  The labeled RNA was brought up in DEPC-treated water and annealed at 
95°C for 2 min and slowly cooled to room temperature.  The bTatWWKL-pGturn peptide 
was synthesized using the same procedure as above except without the fluorophore label and 
instead contained an N-terminal acetyl cap.  Stock solutions were made by dissolving the 
peptides in DEPC-treated water and measuring the tryptophan absorbance (ε280= 11380 M-1 
cm-1) in the presence of 5M guanidine hydrochloride.  Increasing amounts of peptide solution 
was added to 10 nM bTAR RNA and incubated at room temperature in 0.5X Tris buffer (50 
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mM Tris-HCl, 50 mM KCl, 0.05% Triton X, 200 mM DTT, pH 8.0) for 30 minutes.  To each 
reaction was added 1 uL 80% glycerol BPB dye.  After the addition of the dye, the total 
reaction volume was 11 uL, and 10 uL of the sample was loaded onto a 12% native 
polyacrylamide gel.  The gel was electrophoresed in 0.5X TBE buffer at 15W and 4°C.  The 
gels were exposed to the phosphor imaging screen overnight and scanned using a Storm 
phosphor imager.   
 
 
Table 4.2.  Mass spectrometry data for peptides used in this study. 
2218.22218.3bTatWWKL-pGturn (TAMRA)
2235.62235.3bTatWWKL-NGturn (TAMRA)
Observed mass (Da)Expected mass (Da)Peptide
 
Chapter V 
DESIGN OF HIGHLY STRUCTURED β-HAIRPIN PEPTIDES WITH IMPROVED 
RESISTENCE TO PROTEOLYSIS  
(Reproduced, in part, with permission from Cline, L.L.; Waters, M.L. accepted for 
publication in Peptide Science.) 
 
A. Background 
The use of peptides as drugs, especially those taken through oral ingestion, is hindered by 
the fact that peptides are readily degraded by proteases in vivo.  Despite the disadvantages of 
peptide drugs, the advantages could include higher potency, higher specificity, and fewer 
problems with toxicity than small organic drugs.1
One approach has been to design peptidomimetics that resemble L-α-amino acids but are 
more resistant to proteolytic cleavage.  Hamamoto et al. have incorporated D-amino acids 
into antimicrobial peptides and found that the unnatural peptides retained the ability to lyse 
bacteria but were more stable to trypsin cleavage than the L-amino acid counterparts.
  Therefore efforts are being made to find 
ways of making peptides more resistant to proteases.   
2
                                                 
1 Marx, V. Chem Eng News 2005, 83, 17-24. 
  The 
incorporation of D-amino acids has also been used to improve peptidomimetic vaccines.  
 
2 Hamamoto, K.; Kida, Y.; Zhang, Y.; Shimizu, T.; Kuwano, K. Microbiol Immunol 2002, 
46, 741-9. 
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Tugyi et al. have incorporated D-Thr and D-Pro into the N- and C-terminus of peptide 
immunogens, which added resistance to enzymatic degradation and still bound to the 
appropriate antibodies.3  Additionally Saikumari et al. have reported the design of peptides 
that are resistant to trypsin cleavage when a D-Pro-L-Pro or D-Pro-Gly sequence is placed near 
the cleavage site.  The use of D-Pro also hindered the degradation of the peptides by 
proteinase K, subtilisin, elastase, and collagenase.4
Another example of the use of unnatural amino acids in peptides is the incorporaton of β- 
and γ-amino acids in place of α-amino acids.  The Seebach lab has found that peptides 
containing all β- and all γ-amino acids were stable to fifteen different peptidases in vitro.
  
5  A 
similar approach by Porter et al. showed that β-peptides that were designed to mimic 
antimicrobial α-peptides were also resistant to proteolytic degradation and retained their 
activity.6
Previously our group has designed an all α-amino acid peptide, WKWK, which has a 
high propensity to form a β-hairpin and has been characterized by NMR to be 95% folded in 
  The advantages to these approaches are that β-peptides form complementary 
secondary structures to native motifs such as helices, β-sheets, and hairpins.  However, many 
of the unnatural amino acids used to make these peptides are not commercially available and 
need to be manually synthesized.  In addition, there is no way of expressing the unnatural 
peptides in bacteria. 
                                                 
3 Tugyi, R.; Uray, K.; Ivan, D.; Fellinger, E.; Perkins, A.; Hudecz, F. Proc Natl Acad Sci U S 
A 2005, 102, 413-8. 
 
4 Saikumari, Y. K.; Ravindra, G.; Balaram, P. Protein Pept Lett 2006, 13, 471-6. 
 
5 (a) Frackenpohl, J.; Arvidsson, P. I.; Schreiber, J. V.; Seebach, D. Chembiochem 2001, 2, 
445-55. (b) Hook, D. F.; Bindschadler, P.; Mahajan, Y. R.; Sebesta, R.; Kast, P.; Seebach, D. 
Chem Biodivers 2005, 2, 591-632. 
 
6 Porter, E. A.; Weisblum, B.; Gellman, S. H. J Am Chem Soc 2002, 124, 7324-30. 
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aqueous environment (Figure 5.1).7  This highly structured peptide provides the ideal system 
to study whether or not β-hairpin secondary structure in small peptides can provide 
protection from peptidase degradation.  Recent studies in this field have used FRET based 
assay both in vivo and in vitro to study structure and stability of small peptides.8  We have 
used HPLC based experiments which remove the need for bulky GFP-derived fluorophores 
that may interfere with the enzyme binding and function.  We have chosen to test the stability 
of the peptides against three different types of proteases.  α-Chymotrypsin and trypsin are 
serine endopeptidases found in the pancreas which cleave specifically at bulky aromatic 
residues and basic residues, respectively.  Figure 5.2 shows examples of the possible cut sites 
for these enzymes degrading the WKWK peptide.  Pronase E is a zinc-dependent 
metalloendopeptidase from Streptomyces griseus which shows no preference for cleavage 
site.   
 
Figure 5.1. Structure and sequence of the WKWK peptide. 
 
                                                 
7 Butterfield, S. M.; Waters, M. L. J Am Chem Soc 2003, 125, 9580-1.(b) Butterfield, S. M.; 
Sweeney, M. M.; Waters, M. L. J Org Chem 2005, 70, 1105-14. 
 
8 Cheng, Z.; Campbell, R. E. Chembiochem 2006, 7, 1147-50. 
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Figure 5.2. Possible cut sites on the WKWK peptide for α-chymotrypsin (red) and trypsin 
(blue) proteases.  Both proteases cleave the C-terminal peptide bond. 
 
B. Design and synthesis  
To correlate secondary structure and peptidase resistance, peptides were designed with 
varying propensities to fold into a β-hairpin (Figure 5.3).  Each of the peptides was based on 
the WKWK peptide scaffold, which contains all α-amino acids.  An unstructured version of 
this peptide which has all the same residues in a scrambled sequence was synthesized as a 
control (Figure 5.3a). One of the enzymes used in this study, α-chymotrypsin, is an 
endopeptidase from bovine pancreas known to readily cleave proteins and peptides after 
bulky aromatic residues such as Trp, Tyr, and Phe, and more slowly cleave after Asn, His, 
Met, and Leu.9
 
  Therefore WKWK-scrambled was designed so that the residues flanking 
the amide bond where cleavage occurs remained consistent to those in the parent peptide.   
                                                 
9 Voet, D.; Voet, J. Biochemistry; 3rd ed.; John Wiley & Sons, Inc: Hoboken, NJ, 2004. 
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(a)
(b)
(c) (d)
(e) (f)
 
Figure 5.3.  Sequence and structures of all the peptides used in the protease studies.  (a) 
WKWK-scrambled. (b) WKWK. (c) WKFK. (d) WKFK-pGturn. (e) WKWK-pGturn. 
(f) Trp Pocket.  Residues that are highlighted in red are different from the WKWK peptide. 
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C. Results and discussion  
i. Structural characterization of the peptides 
Circular dichroism studies were performed to confirm that WKWK exists as a folded β-
hairpin at physiological pH and temperature, whereas WKWK-scrambled is unstructured 
(Figure 5.4).  WKWK-scrambled showed a characteristic CD signal for random coil 
peptides whereas WKWK has a minimum signal around 210 nm, which is slightly shifted 
from the typical minimum of 215 nm for β-sheet peptides.  This is likely due to the 
contribution of Trp-Trp exciton coupling, as indicated by the maximum at 226 nm. 
 
 
Figure 5.4. Circular Dichroism Spectra for WKWK and WKWK-scrambled peptides.  
Studies were done at 100 μM peptide concentration in 10 mM sodium phosphate buffer pH 
7.6 at 25°C and 37°C.  WKWK (red and blue) folds into a β-sheet conformation with a 
minimum mean residue ellipticity around 212 nm.  WKWK-scrambled (black) is shown to 
be in a random coil conformation.   
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ii. NMR characterization of peptide folding 
For all the other peptides used in this study, mutations were made to the WKWK peptide 
to alter the stability of the folded structure (Table 5.1).  Folding and stability of the hairpins 
was investigated by NMR and circular dichroism (CD).  One-dimensional NMR studies were 
preformed to determine the fraction folding for the peptides based on Hα chemical shifts and 
glycine splitting as described in the Experimental section.10  Apart from the unfolded control, 
the WKFK peptide was the least folded at 67%.  This peptide has Trp9 mutated to Phe, 
which decreases the strength of its cross-strand interactions with Trp2 and Lys4 and has a 
lower β-sheet propensity.  By incorporating a D-proline in the turn region of WKFK 
(WKFK-pGturn) the turn becomes more rigid and the fraction folding increases to 86%.  To 
increase the extent of folding, a D-proline was also incorporated into the WKWK peptide.  It 
was also possible to make a more stable β-hairpin peptide by increasing the cross strand 
interactions of the peptide.  The Trp pocket peptide has been shown to create an aromatic 
pocket with which the lysine side chain can interact and create a cation-π interaction.  This 
peptide which contains all α-amino acids is the most well folded small β-hairpin peptide 
reported to date.11
 
    
 
 
 
 
 
 
 
 
 
 
                                                 
10 Griffiths-Jones, S. R.; Maynard, A. J.; Searle, M. S. J Mol Biol 1999, 292, 1051-69. 
11 Riemen, A. J.; Waters, M. L. Biochemistry 2009, 48, 1525-31. 
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Table 5.1. Sequences of the β-hairpin peptides used in this study and the corresponding 
percent folded values at 25°C. 
>99% b,c (98%)d
>98%c
96%b (96%)d
86%c
67% b
0%a
Percent Folded
Ref 11Ac-RWVWVNGOKILQ-NH2Trp pocket
This workAc-RWVKVpGOWIKQ-NH2WKWK-pGturn
Ref 7aAc-RWVKVNGOWIKQ-NH2WKWK
This workAc-RWVKVpGOFIKQ-NH2WKFK-pGturn
Ref 7bAc-RWVKVNGOFIKQ-NH2WKFK
This workAc-KWVRWIKQVONG-NH2WKWK-scrambled
SourceSequencePeptide name
 
(a)  The percent folded of WKWK-scrambled was estimated from the CD data.             (b)  
Determined using 1D NMR glycine splitting data.  (c)  Determined based on Hα chemical 
shifts.  Conditions: 50 mM NaOAc-d3 (pD 4.0), and experiments were done at 25°C.  (d) 
Value in parentheses is the fraction folded at 37°C.  
 
 
iii. Peptidase studies using α-chymotrypsin 
α-Chymotrypsin cleaves on the C-terminal side of aromatic amino acids.  All the peptides 
studied contain two aromatic residues that which are followed by a branched aliphatic amino 
acid, so differences in the rate of cleavage are not a result of differences in the neighboring 
residue. The unstructured peptide was used to determine the concentration of enzyme for 
each reaction.  Conditions were optimized to give a t1/2 of 7 min for the scrambled peptide as 
a basis for comparison.  The reactions were quenched with glacial acetic acid at various time 
points up to 5 h, and the decrease of the full-length peptide was monitored with RP-HPLC.  
An example of the resulting HPLC trace is shown in Figure 5.5.  To analyze the data, the 
parent peak was integrated using Empower software and plotted as a function of time.   
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Figure 5.5.  Example of how RP-HPLC was used to monitor the degradation of peptide by 
enzyme.  The full length peptide peak is highlighted in red, and disappears at increasing time 
points. Acetic acid, which was used to both quench the reaction and as an internal control, 
elutes at 3 minutes.    
 
 
The structure of the β-hairpin peptides significantly affected the peptide degradation by 
α-chymotrypsin (Figure 5.6).  After 15 minutes there was no full-length WKWK-scrambled 
remaining, but all the structured peptides were still completely intact.  The WKFK peptide 
was degraded with a half-life of approximately 36 min, and the WKWK peptide was 
degraded by 50% in approximately 198 min.  The other two peptides containing D-Pro in the 
turn were completely stable to the enzyme even after 5 hours.  All of the peptides have the 
same number of cleavage sites for α-chymotrypsin, therefore any difference in the rate of 
cleavage is due to the accessibility of the aromatic residues to the enzyme.  Analysis by mass 
spectrometry shows that in the case of WKWK the enzyme first cleaves either Trp2 or Trp9 
and then shortens the peptides further by cutting at the second site (Table 5.2).  Since 
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WKFK-pGturn and WKWK-pGturn demonstrated complete resistance over 5 h, Trp 
pocket, which is the most well-folded, was not investigated with this enzyme.     
To further demonstrate that the structure of the peptide is the reason for the enzymatic 
resistance, equal concentrations of WKWK and WKWK-scrambled were reacted with α-
chymotrypsin (Figure 5.7).  After 15 min, the parent peak for WKWK-scrambled is 
completely degraded whereas the WKWK peptide has been untouched by the enzyme.  A 
similar experiment was also done by incubating WKWK-pGturn alone with α-
chymotrypsin for 5 h and then adding WKWK-scrambled peptide (Figure 5.8).  WKWK-
pGturn was not cleaved during the 5 hours or after WKWK-scrambled was added, 
however the unstructured peptide was completely cleaved within 30 min of incubation.  This 
experiment confirms that the enzyme is still active after 5 h, and that the structure of the 
peptide is inhibiting the degradation. 
 
Figure 5.6. HPLC analysis of peptide degradation by α-chymotrypsin.  The WKWK-
scrambled is completely degraded after 15 min.  The WKFK, WKFK-pGturn, WKWK, 
and WKWK-pGturn peptides are all substantially more resistant to enzymatic degradation.  
Experiments were done in duplicate at physiological conditions.   
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Table 5.2.  Percentage of total peak area for the full-length WKWK peptide and each of the 
cleavage products from α-chymotrypsin degradation 
21.735.010.72.330.3300 m
Peak Area (%)a
a Each reaction was analyzed using RP-HPLC and peaks were identified by mass spectrometry.  The percent peak area was calculated 
by dividing the individual peak area by the total area of all peaks.   
16.130.511.33.139.1240 m
11.222.711.23.651.3180 m
6.015.19.54.265.1120 m
1.98.36.62.780.560 m
0.74.04.22.089.130 m
0.02.02.61.294.215 m
0.00.50.71.297.65 m
H3N+-VKVNGOW-CO2-
Mass= 815.4
Ac-RW-CO2-
Mass= 402.2 g/mol
H3N+-VNGOWIKQ-NH2
Mass= 1183.6 g/mol
Ac-RWVKVNGOW-CO2-
Mass= 1199.6 g/mol
Full Length WKWK
Ac-RWVKVNGOWIKQ-NH2
Mass= 1567.8 g/mol
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Figure 5.7. HPLC trace of WKWK-scrambled and WKWK alone and then an equimolar 
mixture of the two reacted with α-chymotrypsin.  (a) Reactions were quenched at varying 
time points.  The WKWK peptide elutes at 20 min and WKWK-scrambled elutes at 27 
minutes.  The WKWK-scrambled peak decreases within 5 min and a new peak grows in 
beside it, whereas the full-length WKWK peak is still present after 15 min. (b) Overlay view 
of the relevant portion of the graph. 
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Figure 5.8. HPLC trace of α-chymotrypsin degradation of WKWK-pGturn over five hours 
and then subsequent addition of WKWK-scrambled peptide to the solution.   The plot 
shows WKWK-pGturn alone and reactions with the enzyme after 1 h  and 5 h.  WKWK-
scrambled peptide was then added and aliquots were quenched after 5 m, 10 m, 15 m, and 
30 m.  The full-length WKWK-pGturn elutes at approximately 20.5 min and the full-length 
WKWK-scrambled peptide elutes at approximately 27.0 min.  All other peaks correspond to 
acetic acid (3.0 min) or degradation products.   
 
iv. Peptidase studies using trypsin 
Trypsin cleaves after basic amino acids such as Arg and Lys.  Degradation studies show 
that unlike α-chymotrypsin, the peptides were not completely stable to trypsin.  However, the 
structured peptides were still substantially more stable than the unstructured control (Figure 
5.9).  The degradation times correlated well with the extent of folding.  WKFK and WKFK-
pGturn both degraded at the same rate with a half-life of approximately 23 min, but this was 
still four times slower than the half-life for the unstructured peptide.  The similar rate for 
WKFK and WKFK-pGturn suggests that the more rigid turn did not deter the enzyme from 
cleaving the peptides.  The Trp pocket peptide was the most stable to trypsin.  However, this 
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peptide had one less basic residue than the other peptides, which could be the cause of the 
increased resistance.  
 
 
Figure 5.9. HPLC analysis of peptide degradation by trypsin.  The WKWK-scrambled 
peptide is completely degraded after 15 minutes.  The WKFK, WKFK-pGturn, WKWK, 
WKWK-pGturn, and Trp pocket peptides are all substantially more resistant to enzymatic 
degradation.  Experiments were done in duplicate at physiological conditions. 
 
 
v. Peptidase studies using pronase E 
The most aggressive enzyme tested in these experiments was pronase E, which is a non-
specific serine protease found in S. griseus.  This enzyme degraded the least folded β-hairpin 
peptide WKFK in the same amount of time it degraded the WKWK-scrambled peptide, 
however the other peptides demonstrated resistance (Figure 5.10).  The WKFK peptide, 
which is only 67% folded, may be flexible enough for the enzyme to cleave it quickly, but as 
the peptides become more folded the pronase E is less able to cut the peptides.  It is 
interesting to note that different rates of degradation are observed with pronase E even 
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though the terminal residues of β-hairpins are frayed.  For this enzyme the fraction folded did 
not directly correlate with the degradation rate.  Instead, both WKFK-pGturn and WKWK-
pGturn were much more peptidase-resistant than their analogs with an Asn-Gly turn 
sequence.  The WKFK-pGturn peptide is equally resistant to enzyme cleavage as WKWK 
although WKFK-pGturn is less folded.  The same trend was seen for WKWK-pGturn 
which is slightly less folded than the Trp pocket peptide, but is more resistant to pronase E.  
The fact that both WKWK-pGturn and WKFK-pGturn contain D-proline must cause the 
slower rates of degradation, because of the rigidity of the β-hairpin structure.   
 
Figure 5.10. HPLC analysis of peptide degradation by pronase E.  The WKWK-scrambled 
is completely degraded after 15 min.  The WKFK, WKFK-pGturn, WKWK, WKWK-
pGturn, and Trp pocket peptides are all substantially more resistant to enzymatic 
degradation.  Experiments were done in duplicate at physiological conditions. 
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Table 5.3. Approximate half-life for proteolytic degradation of the β-hairpin peptides 
30117n/dbTrp pocket
5164>300WKWK-pGturn
2036198WKWK
2123>300WKFK-pGturn
62336WKFK
557WKWK-scrambled
Pronase ETrypsinα-ChymotrypsinPeptide name
Approximate t1/2 (minutes)
a
 
(a) Approximate time when 50% of the uncleaved peptide is remaining 
(b) Not determined 
 
 
D. Conclusions 
This study used in vitro experiments to demonstrate that β-hairpin structure, even in a 
small 12-residue peptide, can add resistance to proteolytic degradation. The structures were 
stabilized by incorporation of cross-strand cation-π interactions and/or of a more rigid D-Pro-
Gly turn sequence. The results from all the experiments are summarized in Table 5.3, and it 
shows that for trypsin there was a direct correlation between fraction folded and stability.  
For both α-chymotrypsin and pronase E an increase in fraction folded is beneficial, but the 
use of unnatural D-proline residue in the turn also added to its resistance.   
We have shown with the Trp Pocket peptide that increasing the side chain-side chain 
interactions to promote structure added to the proteolytic resistance.  Therefore the peptide 
WKWK-pGturn which contained both a rigid β-turn and strong side chain interactions 
demonstrated the greatest resistance across the set of enzymes tested. Although these 
peptides did not completely block degradation, this may be an advantage for applications 
 146 
where the peptide needs to be degradable over time.  For the design of peptide based drugs, 
the use of a highly structured peptide is a viable way to add resistance to proteolysis without 
using cyclic peptides or unnatural amino acids.  Moreover, the combination of peptide 
structure with unnatural amino acids, such as D-proline, can provide even greater resistance in 
some cases.  
E. Ongoing work: protease studies in a biological system 
The in vitro studies proved that β-hairpin structure can help to add resistance to 
proteolytic degradation.  However, those studies were done in a controlled system and only 
tested a single enzyme at a time.  We wanted to investigate whether our structured peptides, 
which we’ve nicknamed “protectides”, were still more stable than an unstructured control in 
a more biologically relevant system.   
For this reason we began collaborating with the Allbritton Lab in order to test ex vivo the 
ability of our protectides to block the degradation of a Protein Kinase C (PKC) substrate.  
The studies will be done with cell lysate and if the results are promising the protectides will 
be microinjected into whole cells for testing.  There are very few peptidases found in the 
cytoplasm of the cell, and of those that are known to be either aminopeptidases or 
endopeptidases.  The crystal structures of these enzymes show that most of these enzymes 
have a deep cleft through which the peptide substrate is threaded.12
                                                 
12 (a) Fulop, V.; Bocskei, Z.; Polgar, L. Cell 1998, 94, 161-70.  (b) Aertgeerts, K.; Ye, S.; 
Tennant, M. G.; Kraus, M. L.; Rogers, J.; Sang, B. C.; Skene, R. J.; Webb, D. R.; Prasad, G. 
S. Protein Sci 2004, 13, 412-21. (c) Brandstetter, H.; Kim, J. S.; Groll, M.; Huber, R. Nature 
2001, 414, 466-70. (d) Guhaniyogi, J.; Sohar, I.; Das, K.; Stock, A. M.; Lobel, P. J Biol 
Chem 2009, 284, 3985-97. (e) Pal, A.; Kraetzner, R.; Gruene, T.; Grapp, M.; Schreiber, K.; 
Gronborg, M.; Urlaub, H.; Becker, S.; Asif, A. R.; Gartner, J.; Sheldrick, G. M.; Steinfeld, R. 
J Biol Chem 2009, 284, 3976-84. (f) Ray, K.; Hines, C. S.; Coll-Rodriguez, J.; Rodgers, D. 
W. J Biol Chem 2004, 279, 20480-9. 
  To protect the PKC 
substrate against aminopeptidases, we have attached the protectides to the N-terminus.  We 
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hypothesize that the structural stability of the protectides will also hinder degradation by 
endopeptidases, because it will be difficult to thread the structured peptide through the 
enzyme’s deep cleft.  The Allbritton lab will utilize capillary electrophoresis (CE) to track 
the activity of the PKC enzyme by monitoring phosphorylation of a fluorophore-labeled 
substrate.  If the PKC substrate is being degraded by endogenous proteases, this can also be 
detected by this method.  Enzyme activity is dependent on the structural stability of the 
substrate peptide and by attaching our WKWK-derived protectides we hope to increase 
resistance to proteolysis.  Using the developed CE methodology we will be able to test the 
stability of the PKC substrate covalently linked to the series of WKWK protectides in a 
cellular environment.       
The protectides were attached to the N-terminus of a PKC substrate with the sequence 
RFRRFQTLKIKAKA (Figure 5.11).  This sequence was used by Newton et al. and is known 
to be a good substrate for all isoforms of PKC, but is not efficiently phosphorylated by other 
kinases.13
                                                 
13 (a) Violin, J. D.; Zhang, J.; Tsien, R. Y.; Newton, A. C. J Cell Biol 2003, 161, 899-909. (b) 
Gallegos, L. L.; Kunkel, M. T.; Newton, A. C. J Biol Chem 2006, 281, 30947-56. (c) 
Nishikawa, K.; Toker, A.; Johannes, F. J.; Songyang, Z.; Cantley, L. C. J Biol Chem 1997, 
272, 952-60. 
  We also chose this particular substrate because it was used by others for in cell 
studies, and its efficiency and specificity are well-studied in that environment.  We have 
incorporated a two unit polyethylene glycol (PEG2) linker between the two pieces to create 
some distance from the protein binding site and the protectides.  The PEG2 linker also helps 
to increase the solubility of the large complex which aids in the synthesis.  As a requirement 
for the CE method, we have labeled the protectide portion with (6)-carboxyfluorescein (6-
FAM) through a lysine side chain.  The lysine is positioned near the β-hairpin turn and has 
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been previously shown not to be disruptive to the peptide structure.14
 
  In total we aim to 
make five protectide-PKC complexes (Table 5.4).  The protectide sequences were the most 
folded peptides from the previous studies, as well as the unstructured WKWK-scrambled 
sequence as a negative control and a cyclic WKWK sequence.   
 
Figure 5.11. Diagram of the Protectide-Peg2-PKC complexes.  Both the site of PKC 
phosphorylaion and the site of fluorescein attachment are shown.    
 
 
 
 
Table 5.4.  Proposed sequences for the series of Protectide-Peg2-PKC complexes  
 
HN-RWVKVNGK(FAM)WIKQC-Peg2-RFRRFQTLKIKAKA-NH2cycWKWK-Peg2-PKC
Ac-RWVWVNGK(FAM)KILQ-Peg2-RFRRFQTLKIKAKA-NH2TrpPkt-Peg2-PKC
Ac-RWVKVpGK(FAM)WIKQ-Peg2-RFRRFQTLKIKAKA-NH2WKWKpGturn-Peg2-PKC
Ac-RWVKVNGK(FAM)WIKQ-Peg2-RFRRFQTLKIKAKA-NH2WKWK-Peg2-PKC
Ac-K(FAM)WVRWIKQVKNG-Peg2-RFRRFQTLKIKAKA-NH2WKWKscram-Peg2-PKC
SequenceName
 
 
 
The synthetic scheme for these large complexes was relatively straightforward using 
solid phase peptide synthesis, but it was not trivial (Scheme 5.1).  One issue was that the 
overall size of the complex, 28 residues total, is not ideal for an on-bead synthesis.  The 
                                                 
14 Cooper, W. J.; Waters, M. L. Org Lett 2005, 7, 3825-3828. 
 149 
yields tend to be much lower for long peptides and the increase in truncated sequences makes 
the purification more difficult.  The 6-FAM was coupled to the lysine side chain after 
orthogonal deprotection of the amine.  This step is done immediately before cleavage from 
the bead.  The synthesis of the fully folded cycWKWK-Peg2-PKC complex will involve 
bromo-acetylation of the N-terminus on bead and then intramolecular cyclization through a 
cysteine side chain in solution (Scheme 5.2).15
 
   This type of cyclization was chosen over the 
commonly used disulfide bond due to its stability in the reducing cellular environment.  
Three protectide-PKC complexes have been synthesized thus far, WKWKscram-Peg2-PKC, 
WKWK- Peg2-PKC, and TrpPkt-Peg2-PKC.  The synthesis issues were overcome by 
increasing the coupling times and purifying the peptides twice.  Several other derivatives of 
the WKWK peptide series are currently being made, and the Allbritton lab is carrying out the 
CE analysis of peptide degradation.       
 
                                                 
15 Ivanov, B.; Grzesik, W.; Robey, F. A. Bioconjug Chem 1995, 6, 269-77. 
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Scheme 5.1. Synthesis of the linear Protectide-Peg2-PKC complexes 
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Scheme 5.2. Synthesis of the cycWKWK-Peg2-PKC complex 
 
F. Experimental section 
i. Peptide synthesis and purification 
Peptides were synthesized on either an Applied Biosystems Pioneer or Creosalus Tetras 
automated peptide synthesizer.  All the peptides were synthesized using standard solid phase 
peptide synthesis protocols with Fmoc-protected amino acids and Fmoc-PAL-PEG-PS resin.  
Peptides were synthesized on a 0.1 mmol scale and capped at the N-terminus with an acetyl 
group.  All the peptides were cleaved and deprotected by treating the resin with a (95:2.5:2.5) 
TFA:Triisopropylsilane:Water mixture and bubbling with N2 for 3 h.  The peptides were 
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isolated by first reducing the volume of TFA in a stream of nitrogen, then precipitating with 
cold diethyl ether, followed by extraction using deionized water.  The resulting peptide 
solution was frozen and lyophilized.  The peptides were purified using a Waters semi-
preparative HPLC system with a reverse-phase C18 column.  The peptides were eluted using 
Standard A (95% Water, 5% Acetonitrile, 0.1% TFA) and Standard B (95% Acetonitrile, 5% 
Water, 0.1% TFA).  The masses of the peptides were confirmed using ESI-TOF mass 
spectrometry (Table 5.5). 
ii. Peptide concentration determination 
Approximately 15 mg of peptide was brought up in 2-3 mL of 10 mM sodium phosphate, 
140 mM Na+/K+Cl- buffer (pH 7.6).  UV-Vis was used to determine the concentration of the 
peptide stocks by dilution into 6 M guanidine hydrochloride and measuring absorbance at 
280nm (Trp ε280=5690 M-1cm-1). 
iii. Peptidase concentration 
Enzymes were purchased from Sigma-Aldrich, Pronase E from Streptomyces griseus (EC 
3.4.24.31) as a solid, α-chymotrypsin from bovine pancreas (3.4.21.1) as a lyophilized 
powder, and trypsin from bovine pancreas as a lyophilized powder containing lactose.  
Pronase E, α-chymotrypsin, and trypsin were brought up in 10 mM sodium phosphate, 140 
mM NaCl buffer, pH 7.6, to approximately 0.1 mg/mL, 0.031 mg/mL, and 0.011 mg/mL, 
respectively.  For each enzyme, the volume used was 6 μL, 10 μL, and 5 μL, respectively, 
and these values were based on the amount of enzyme that completely cleaved WKWK-
scrambled peptide in 15 min.     
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iv. Peptidase degradation reactions 
The procedure for peptidase studies was adapted from Seebach et al.5a  For each reaction, 
0.5 mM peptide in the phosphate buffer (140 mM Na+/K+Cl- buffer pH 7.6) was reacted with 
the appropriate concentration of enzyme at 37°C.  A 75 μL aliquot was removed after 5, 10, 
15, 30, 45, 60, 120, 180, 240, and 300 minute time points, quenched with 10 μL glacial acetic 
acid and 15 μL of buffer, bringing the final volume to 100 μL.  A 40 μL aliquot was directly 
injected on the analytical RP-HPLC using a gradient of 0% Standard B for 5 min, 36% 
Standard B in 24 min, 100% Standard B in 11 min.  Examples of the HPLC analysis from the 
chymotrypsin reactions are shown in Figures 5.12-5.16, the trypsin reactions are shown in 
Figures 5.17-5.22, and the pronase reactions are shown in Figures 5.23-5.28.  The acetic acid 
peak, which elutes from the HPLC column around 3 min, was used as an internal control to 
account for differences in the injection volumes from the autosampler. The parent peak and 
the acetic acid peak were integrated using the Empower Pro software.  To determine the 
fraction of full-length peptide remaining at each of the time points, the peak area for the full-
length peptide was divided by the peak area at the zero time point.  The points were plotted 
as an average of two runs.    
v. Circular dichroism 
Studies were done using an Aviv Model 62DS Circular Dichroism Spectrometer.  A 
wavelength scan (185nm-260nm) was done of both WKWK-scrambled and WKWK in 10 
mM sodium phosphate buffer (pH 7.6) at 37°C in a 0.1 cm cell.  The peptide concentration 
was 100 μM in both cases and the scans were done in triplicate.    
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vi. NMR spectroscopy 
NMR experiments were performed at room temperature.  Samples were made at a 
concentration of 1 mM peptide in D2O buffered to pD 4.0 (uncorrected) with 50 mM 
NaOAc-d3.  Fraction folded determinations were done using the glycine splitting method, 
which compares the extent of glycine splitting for the desired peptide to the glycine splitting 
of a fully folded control.  In the case of WKWK-pGturn, a cyclic version cycWKWK-
pGturn was synthesized but for the WKFK-pGturn the peptide was compared to data that 
had been previously collected by Butterfield et al.16  One dimensional NMR spectra were 
collected using 32K data points and between 8 and 64 scans using 1-3 s presaturation 
(Figures 5.29, 5.30, 5.31).  Two-dimensional TOCSY experiments were used to determine 
the α-H chemical shifts (Tables 5.6, 5.7, and 5.8) and confirm the results found using the 
glycine splitting method.  The experiments were done with pulse sequences from the 
Chempack software experiments, and 16-64 scans were done in the first dimension and 64-
256 scans in the second dimension.  All spectra were analyzed using standard window 
functions (sinebell and Gaussian).  The peak assignments were made using standard methods 
as described by Wüthrich.17
vii. Determination of fraction folded 
  
Fraction folded was determined based on Hα and/or Gly chemical shifts, as compared to 
random coil and fully folded control peptides.  To determine the unfolded chemical shifts, 7-
mers were synthesized as unstructured controls and disulfide-bonded cyclic peptides were 
synthesized for fully folded controls. The chemical shifts of the fully folded state were taken 
                                                 
16 Butterfield, S. M., The University of North Carolina at Chapel Hill, 2004. 
17 Wüthrich, K. NMR of Proteins and Nucleic Acids; John Wiley & Sons, Inc: New York, 
1986. 
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from the cyclic peptides.  The fraction folded at each residue was determined from equation 
1, 
Fraction Folded = [δobs – δ0]/[ δ100 – δ0],        [Equation 1] 
where δobs is the observed Hα chemical shift, δ100 is the Hα chemical shift of the cyclic 
peptides, and δ0 is the Hα chemical shift of the unfolded 7-mers. The overall fraction folded 
for the entire peptide was obtained by averaging the fraction folded of resides Val3, Orn8, 
and Ile10. These residues are in hydrogen bonded positions have been shown to be the most 
reliable in determining fraction folded.18
Fraction Folded = [ΔδGly Obs]/[ ΔδGly 100], [Equation 2] 
  The overall fraction fold was also determined using 
the extent of Hα glycine splitting observed in the turn residue Gly10 given in equation 2. 
where ΔδGly Obs is the difference in the glycine Hα chemical shifts of the observed, and ΔδGly 
100 is the difference in the glycine Hα chemical shifts of the cyclic peptides. 
viii. Synthesis and purification of PKC-protectides 
 Peptides were synthesized on either the Creosalus Tetras automated peptide synthesizer.  
All the peptides were synthesized using standard solid phase peptide synthesis protocols with 
Fmoc-protected amino acids and Fmoc-PAL-PEG-PS resin.  For the addition of the FMOC-
PEG2-OH amino acid (purchased from Novabiochem) only 2 equivalents of the amino acid 
were used and the stirring time was increased to two hours.  The same conditions were used 
for the addition of FMOC-Lys(ivDde)-OH.  Peptides were synthesized on a 0.065 mmol 
scale and all were capped with an N-terminal acetyl group except for cycWKWK-PKC.  
Before cleaving from the resin, the ivDde protecting group was removed by reacting with 10 
mL of 2% hydrazine in DMF (3 x 3 min).  The single isomer (6)-carboxyfluorescein was 
                                                 
18 Syud, F. A., Espinosa, J.F., Gellman, S.H. J Am Chem Soc 1999, 121, 11577–11578. 
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then coupled to the free lysine side chain overnight and in the dark using HOBT/HBTU 
activator solution (4 equivalents of each) and 4 equivalents of DIPEA.  All the peptides were 
cleaved and deprotected by treating the resin with a (95:2.5:2.5) 
TFA:Triisopropylsilane:Water mixture and bubbling with N2 for 3 hours.  The peptides were 
isolated by first reducing the volume of TFA in a stream of nitrogen, then precipitating with 
cold diethyl ether, followed by extraction using deionized water.  The resulting peptide 
solution was frozen and lyophilized.  The peptides were twice purified using a Waters semi-
preparative HPLC system with a reverse-phase C18 column.  The peptides were eluted using 
Standard A (95% Water, 5% acetonitrile, 0.1% TFA) and Standard B (95% acetonitrile, 5% 
Water, 0.1% TFA).  The masses of the peptides were confirmed using ESI-TOF mass 
spectrometry. 
ix. Cyclization reaction for cyc-WKWK-PKC 
The cyclization reaction was a modified procedure from Ivanov et al.15  Before cleaving 
the cyc-WKWK-PKC peptide from the resin, the N-terminal FMOC group was deprotected 
and the resin was swelled with DCM.  In a separate scintillation vial, bromoacetic acid (8 eq., 
0.52 mmol), diisopropyl carbodiimide (4 eq., 0.26 mmol), and DMF (4 mL) were stirred at 
0°C for 30 min.  This solution was then added to the resin along with DIPEA (4 eq., 0.26 
mmol) and the reaction proceeded for 1.5 hours or until the reaction is completed as 
determined by the Kaiser test.  The resin was then thoroughly rinsed with DMF and DCM, 
dried, and cleaved for 3 hours with the standard TFA cocktail as described above.  The 
peptides were isolated by precipitating with cold diethyl ether and extraction with deionized 
water.  The resulting peptide solution was frozen and lyophilized.  The peptide was then 
redissolved in 10 mL of water (minimal DMSO may be added to help dissolve) and 6 
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equivalents of triethylamine (0.39 mmol) was added to initiate cyclization.  The reaction was 
stirred overnight and then lyophilized to dryness for subsequent purification using HPLC.        
 
 
 
 
Table 5.5.  Mass Spectrometry Data Obtained for Peptides Studied in this Work  
3872.33872.2TrpPkt-Peg2-PKC
3887.93887.2WKWK-Peg2-PKC
3887.23887.2WKWKscram-Peg2-PKC
1551.01551.0WKWK-pGturn
1568.01567.9WKWK
1512.21511.9WKFK-pGturn
1528.51528.9WKFK
1568.11567.9WKWK-scrambled
Observed mass (Da)Expected mass (Da)Peptide
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Figure 5.12.  RP-HPLC analysis of WKWK-scrambled peptide incubated with α-
chymotrypsin for various amounts of time.  Reactions were quenched with acetic acid at (a) 0 
m, (b) 5 m, (c) 10 m, and (d) 15 m.  Absorbance was monitored at 220 nm.   
 
 
 
Figure 5.13.  RP-HPLC analysis of WKFK peptide incubated with α-chymotrypsin for 
various amounts of time.  Reactions were quenched with acetic acid at (a) 0 m, (b) 5 m, (c) 
10 m, (d) 15 m, (e) 30 m, (f) 45 m, (g) 1 h, and (h) 5 h.  Absorbance was monitored at 220 
nm.   
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Figure 5.14.  RP-HPLC analysis of WKFK-pGturn peptide incubated with α-chymotrypsin 
for various amounts of time.  Reactions were quenched with acetic acid at (a) 0 m, (b) 15 m, 
(c) 30 m, (d) 1 h, (e) 2 h, (f) 3 h, (g) 4 h, and (h) 5 h.  Absorbance was monitored at 220 nm.   
 
 
Figure 5.15.  RP-HPLC analysis of WKWK peptide incubated with α-chymotrypsin for 
various amounts of time.  Reactions were quenched with acetic acid at (a) 0 m, (b) 15 m, (c) 
30 m, (d) 1 h, (e) 2 h, (f) 3 h, (g) 4 h, and (h) 5 h.  Absorbance was monitored at 220 nm.   
 
 160 
 
Figure 5.16.  RP-HPLC analysis of WKWK-pGturn peptide incubated with α-
chymotrypsin for various amounts of time.  Reactions were quenched with acetic acid at (a) 0 
m, (b) 15 m, (c) 30 m, (d) 1 h, (e) 2 h, (f) 3 h, (g) 4 h, and (h) 5 h.  Absorbance was 
monitored at 220 nm.   
 
 
Figure 5.17.  RP-HPLC analysis of WKWK-scrambled peptide incubated with trypsin for 
various amounts of time.  Reactions were quenched with acetic acid at (a) 0 m, (b) 5 m, (c) 
10 m, and (d) 15 m.  Absorbance was monitored at 220 nm.   
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Figure 5.18.  RP-HPLC analysis of WKFK peptide incubated with trypsin for various 
amounts of time.  Reactions were quenched with acetic acid at (a) 0 m, (b) 5 m, (c) 15 m, (d) 
30 m, (e) 45 m, (f) 1 h, (g) 2 h, and (h) 5 h.  Absorbance was monitored at 220 nm.   
 
 
Figure 5.19.  RP-HPLC analysis of WKFK-pGturn peptide incubated with trypsin for 
various amounts of time.  Reactions were quenched with acetic acid at (a) 0 m, (b) 5 m, (c) 
15 m, (d) 30 m, (e) 45 m, (f) 1 h, (g) 2 h, and (h) 5 h.  Absorbance was monitored at 220 nm.   
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Figure 5.20.  RP-HPLC analysis of WKWK peptide incubated with trypsin for various 
amounts of time.  Reactions were quenched with acetic acid at (a) 0 m, (b) 5 m, (c) 15 m, (d) 
30 m, (e) 45 m, (f) 1 h, (g) 2 h, and (h) 5 h.  Absorbance was monitored at 220 nm.   
 
 
Figure 5.21.  RP-HPLC analysis of WKWK-pGturn peptide incubated with trypsin for 
various amounts of time.  Reactions were quenched with acetic acid at (a) 0 m, (b) 5 m, (c) 
15 m, (d) 30 m, (e) 45 m, (f) 1 h, (g) 2 h, and (h) 5 h.  Absorbance was monitored at 220 nm.   
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Figure 5.22.  RP-HPLC analysis of Trp pocket peptide incubated with trypsin for various 
amounts of time.  Reactions were quenched with acetic acid at (a) 0 m, (b) 15 m, (c) 30 m, 
(d) 1 h, (e) 2 h, (f) 3 h, (g) 4 h, and (h) 5 h.  Absorbance was monitored at 220 nm.   
 
 
Figure 5.23.  RP-HPLC analysis of WKWK-scrambled peptide incubated with pronase for 
various amounts of time.  Reactions were quenched with acetic acid at (a) 0 m, (b) 5 m, (c) 
10 m, and (d) 15 m.  Absorbance was monitored at 220 nm.   
 
 164 
 
Figure 5.24.  RP-HPLC analysis of WKFK peptide incubated with pronase for various 
amounts of time.  Reactions were quenched with acetic acid at (a) 0 m, (b) 5 m, (c) 10 m, (d) 
15 m, (e) 30 m, (f) 45 m, (g) 1 h, and (h) 5 h.  Absorbance was monitored at 220 nm.   
 
 
Figure 5.25.  RP-HPLC analysis of WKFK-pGturn peptide incubated with pronase for 
various amounts of time.  Reactions were quenched with acetic acid at (a) 0 m, (b) 5 m, (c) 
15 m, (d) 30 m, (e) 45 m, (f) 1 h, (g) 2 h, and (h) 5 h.  Absorbance was monitored at 220 nm.   
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Figure 5.26.  RP-HPLC analysis of WKWK peptide incubated with pronase for various 
amounts of time.  Reactions were quenched with acetic acid at (a) 0 m, (b) 5 m, (c) 15 m, (d) 
30 m, (e) 45 m, (f) 1 h, (g) 2 h, and (h) 5 h.  Absorbance was monitored at 220 nm.   
 
 
Figure 5.27.  RP-HPLC analysis of WKWK-pGturn peptide incubated with pronase for 
various amounts of time.  Reactions were quenched with acetic acid at (a) 0 m, (b) 5 m, (c) 
15 m, (d) 30 m, (e) 1 h, (f) 2 h, (g) 3 h, and (h) 5 h.  Absorbance was monitored at 220 nm.   
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Figure 5.28.  RP-HPLC analysis of Trp pocket peptide incubated with pronase for various 
amounts of time.  Reactions were quenched with acetic acid at (a) 0 m, (b) 5 m, (c) 15 m, (d) 
30 m, (e) 45 m, (f) 1 h, (g) 2 h, and (h) 5 h.  Absorbance was monitored at 220 nm.   
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Figure 5.29. 1HNMR of WKWK-pGturn peptide: Ac-Arg-Trp-Val-Lys-Val-DPro-Gly-
Orn-Trp-Ile-Lys-Gln-NH2 
 
Table 5.6. Proton Chemical Shift Assignments for WKWK-pGturn peptide 
 
1.9
1.15, 0.21
1.81
3.2, 3.01
1.81
2.29, 1.92
1.75
1.15, 0.14
1.97
3.2, 3.04
1.75
β
2.25
0.55
0.85
1.72
1.92
0.83
0.47
0.86
1.62
γ
0.55
0.85
3.01
3.74
0.95
3.17
δ
4.30
3.95
4.70
5.08
4.70
4.30, 3.71
4.30
4.46
4.27
4.65
5.17
4.46
α
Gln
2.52Lys
Ile
Trp
Orn
Gly
DPro
Val
2.31Lys
Val
Trp
Arg
εResidue
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Figure 5.30.  1HNMR of cycWKWK-pGturn peptide: Ac-Cys-Arg-Trp-Val-Lys-Val-
DPro-Gly-Orn-Phe-Ile-Lys-Gln-Cys-NH2 
 
Table 5.7. Proton Chemical Shift Assignments for cycWKWK-pGturn peptide 
 
2.201.814.56Gln
2.995.10Cys
2.96, 2.36
1.21
1.89
3.2, 3.02
1.89
2.29, 1.92
1.89
1.18
1.83
3.21, 2.99
1.83
β
0.59
0.88
1.7
1.92
0.85
0.48
0.88
1.60
γ
0.23
0.88
3.04
3.74
-0.05
3.18
δ
5.20
4.05
4.68
5.16
4.68
4.31, 3.74
4.36
4.48
4.26
4.68
5.33
4.68
α
Cys
2.56Lys
Ile
Trp
Orn
Gly
DPro
Val
2.29Lys
Val
Trp
Arg
εResidue
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Figure 5.31.  1HNMR of WKFK-pGturn peptide: Ac-Arg-Trp-Val-Lys-Val-DPro-Gly-
Orn-Phe-Ile-Lys-Gln-NH2 
 
 
Table 5.8. Proton Chemical Shift Assignments for WKFK-pGturn peptide 
 
1.84
1.27, 0.47
1.84
3.01
1.84
2.27, 1.95
1.97
1.60, 0.58
1.84
3.01, 2.86
1.7
β
2.23
0.66
0.86
1.72
1.95
0.87
0.86
0.86
1.57
γ
0.66
0.86
3.0
3.74
1.30
3.13
δ
4.27
3.96
4.59
5.06
4.63
4.33, 3.73
4.32
4.49
4.44
4.59
5.13
4.44
α
Gln
2.56Lys
Ile
Phe
Orn
Gly
DPro
Val
2.59Lys
Val
Trp
Arg
εResidue
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